BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 945524 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CO)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C21H23F3N2O6S/c1-20(2,3)32-19(28)25-14-7-8-18-17(10-14)26(11-15(12-27)31-18)33(29,30)16-6-4-5-13(9-16)21(22,23)24/h4-10,15,27H,11-12H2,1-3H3,(H,25,28)/t15-/m1/s1 CWBFRURKHWFRRD-OAHLLOKOSA-N 352481 (R)-tert-butyl (2-(hydroxymethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 1::US9809561, 1 Nuclear receptor ROR-gamma Human 3.01 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352481&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187073 386393646 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945525 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CO)CN(c2c1)S(=O)(=O)c1cc(Br)cnc1Cl InChI=1S/C19H21BrClN3O6S/c1-19(2,3)30-18(26)23-12-4-5-15-14(7-12)24(9-13(10-25)29-15)31(27,28)16-6-11(20)8-22-17(16)21/h4-8,13,25H,9-10H2,1-3H3,(H,23,26)/t13-/m1/s1 SJBRCIPTYOMBRO-CYBMUJFWSA-N 352482 (R)-tert-butyl (4-((5-bromo-2- chloropyridin-3-yl)sulfonyl-2- (hydroxymethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 2A::US9809561, 2A Nuclear receptor ROR-gamma Human 8.59 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352482&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187359 386393647 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945526 Cc1nn(cc1S(=O)(=O)N1C[C@H](CO)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C19H24F2N4O6S/c1-11-16(9-24(23-11)17(20)21)32(28,29)25-8-13(10-26)30-15-6-5-12(7-14(15)25)22-18(27)31-19(2,3)4/h5-7,9,13,17,26H,8,10H2,1-4H3,(H,22,27)/t13-/m1/s1 KAUHVYWIKJLPEW-CYBMUJFWSA-N 352483 (R)-4-((6-((tert- butoxycarbonyl)amino)-2- (hydroxymethyl)-2H- benzo[b][1,4]oxazin-4(3H)- yl)sulfonyl)-1-(difluoromethyl)-3- methyl-1H-pyrazol-2-e::US10745364, Example 2B::US9809561, 2B Nuclear receptor ROR-gamma Human 8.55 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352483&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187353 386393648 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945527 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CO)CN(c2c1)S(=O)(=O)c1cccc(Cl)c1 InChI=1S/C20H23ClN2O6S/c1-20(2,3)29-19(25)22-14-7-8-18-17(10-14)23(11-15(12-24)28-18)30(26,27)16-6-4-5-13(21)9-16/h4-10,15,24H,11-12H2,1-3H3,(H,22,25)/t15-/m1/s1 WMYHWVQAEMHQEQ-OAHLLOKOSA-N 352484 US10745364, Example 2C::US9809561, 2C::[(R)-4-(3-chloro-benzenesulfonyl)-2- hydroxymethyl-3,4-dihydro-2H- benzo[1,4]oxazin-6-yl]-carbamic acid tert-butyl ester Nuclear receptor ROR-gamma Human 4.57 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352484&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187356 386393649 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945528 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CO)CN(c2c1)S(=O)(=O)c1cncc(Br)c1 InChI=1S/C19H22BrN3O6S/c1-19(2,3)29-18(25)22-13-4-5-17-16(7-13)23(10-14(11-24)28-17)30(26,27)15-6-12(20)8-21-9-15/h4-9,14,24H,10-11H2,1-3H3,(H,22,25)/t14-/m1/s1 LAFGGASVRJYFCM-CQSZACIVSA-N 352485 (R)-tert-butyl (4-((5-bromopyridin-3- yl)sulfonyl)-2-(hydroxymethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 2D::US9809561, 2D Nuclear receptor ROR-gamma Human 7.99 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352485&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187354 386393650 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945529 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CO)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C18H24N4O6S/c1-18(2,3)28-17(24)20-12-5-6-16-15(7-12)22(9-13(11-23)27-16)29(25,26)14-8-19-21(4)10-14/h5-8,10,13,23H,9,11H2,1-4H3,(H,20,24)/t13-/m1/s1 HMBMJWIPHRKWKC-CYBMUJFWSA-N 352486 (R)-tert-butyl (2-(hydroxymethyl)-4- ((1-methyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 2E::US9809561, 2E Nuclear receptor ROR-gamma Human 238 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352486&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187351 386393651 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945530 Cc1cccc(c1)S(=O)(=O)N1C[C@H](CO)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C21H26N2O6S/c1-14-6-5-7-17(10-14)30(26,27)23-12-16(13-24)28-19-9-8-15(11-18(19)23)22-20(25)29-21(2,3)4/h5-11,16,24H,12-13H2,1-4H3,(H,22,25)/t16-/m1/s1 NQDMMWJOSKAWND-MRXNPFEDSA-N 352487 (R)-tert-butyl (2-(hydroxymethyl)-4- ((3-(methylsulfonyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin- 6-yl)carbamate::US10745364, Example 2F::US9809561, 2F Nuclear receptor ROR-gamma Human 9.74 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352487&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267863 386393652 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945531 Cc1cnc(Cl)c(c1)S(=O)(=O)N1C[C@H](CO)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C20H24ClN3O6S/c1-12-7-17(18(21)22-9-12)31(27,28)24-10-14(11-25)29-16-6-5-13(8-15(16)24)23-19(26)30-20(2,3)4/h5-9,14,25H,10-11H2,1-4H3,(H,23,26)/t14-/m1/s1 KBBNPFHNLMFXOK-CQSZACIVSA-N 352489 (R)-tert-butyl (4-((2-chloro-5- methylpyridin-3-yl)sulfonyl)-2- (hydroxymethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 2G::US9809561, 2G Nuclear receptor ROR-gamma Human 15.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352489&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187355 386393653 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945532 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CO)CN(c2c1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C21H23N3O6S/c1-21(2,3)30-20(26)23-15-7-8-19-18(10-15)24(12-16(13-25)29-19)31(27,28)17-6-4-5-14(9-17)11-22/h4-10,16,25H,12-13H2,1-3H3,(H,23,26)/t16-/m1/s1 CMCBIMWASOUNQU-MRXNPFEDSA-N 352490 (R)-tert-butyl (4-((3- cyanophenyl)sulfonyl)-2- (hydroxymethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 2H::US9809561, 2H Nuclear receptor ROR-gamma Human 11.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352490&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187361 386393654 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945533 Cc1c[nH]c(=O)c(c1)S(=O)(=O)N1C[C@H](CO)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C20H25N3O7S/c1-12-7-17(18(25)21-9-12)31(27,28)23-10-14(11-24)29-16-6-5-13(8-15(16)23)22-19(26)30-20(2,3)4/h5-9,14,24H,10-11H2,1-4H3,(H,21,25)(H,22,26)/t14-/m1/s1 XEOAUUGCMZMRIB-CQSZACIVSA-N 352491 (R)-tert-butyl (2-(hydroxymethyl)-4-((5-methyl-2-oxo-1,2-dihydropyridin-3-yl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 3::US9809561, 3 Nuclear receptor ROR-gamma Human 325 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352491&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267864 386393655 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945534 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(C)(C)O InChI=1S/C22H27FN2O6S/c1-21(2,3)31-20(26)24-15-8-11-18-17(12-15)25(13-19(30-18)22(4,5)27)32(28,29)16-9-6-14(23)7-10-16/h6-12,19,27H,13H2,1-5H3,(H,24,26)/t19-/m1/s1 PFXKPKYGAOXMEJ-LJQANCHMSA-N 352492 US10745364, Example 4A::US9809561, 4A Nuclear receptor ROR-gamma Human 28.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352492 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352492&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118180770 386393656 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945535 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(C)(C)O InChI=1S/C22H27FN2O6S/c1-21(2,3)31-20(26)24-15-8-11-18-17(12-15)25(13-19(30-18)22(4,5)27)32(28,29)16-9-6-14(23)7-10-16/h6-12,19,27H,13H2,1-5H3,(H,24,26)/t19-/m0/s1 PFXKPKYGAOXMEJ-IBGZPJMESA-N 352493 US10745364, Example 4B::US9809561, 4B Nuclear receptor ROR-gamma Human 6.77 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352493&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118180771 386393657 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945536 CC(F)(F)C(C)(C)OC(=O)Nc1ccc2OC(CN(c2c1)S(=O)(=O)c1ccc(F)c(F)c1)C(=O)C(F)(F)F InChI=1S/C22H19F7N2O6S/c1-20(2,21(3,25)26)37-19(33)30-11-4-7-16-15(8-11)31(10-17(36-16)18(32)22(27,28)29)38(34,35)12-5-6-13(23)14(24)9-12/h4-9,17H,10H2,1-3H3,(H,30,33) JTZNZHJJEMGVEE-UHFFFAOYSA-N 458497 US10745364, Example 5 Nuclear receptor ROR-gamma Human 25.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458497&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903310 441289766 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945537 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)C(=O)C(F)(F)F InChI=1S/C20H19ClF6N4O6S/c1-4-30-9-14(16(21)29-30)38(34,35)31-8-13(15(32)19(22,23)24)36-12-6-5-10(7-11(12)31)28-17(33)37-18(2,3)20(25,26)27/h5-7,9,13H,4,8H2,1-3H3,(H,28,33)/t13-/m0/s1 BHCJBWDRSDKDKZ-ZDUSSCGKSA-N 352496 US10745364, Example 6::US9809561, 6 Nuclear receptor ROR-gamma Human 11.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352496&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267865 386393659 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945538 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C20H21F4N3O5S/c1-19(2,20(22,23)24)32-18(28)26-13-5-8-17-16(9-13)27(11-14(10-25)31-17)33(29,30)15-6-3-12(21)4-7-15/h3-9,14H,10-11,25H2,1-2H3,(H,26,28)/t14-/m0/s1 ZPKQDVHUKORNQV-AWEZNQCLSA-N 352497 US10745364, Example 7::US9809561, 7 Nuclear receptor ROR-gamma Human 83.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352497&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118180779 386393660 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945539 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)OCc3ccccc3)CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)C(F)(F)F InChI=1S/C28H26ClF4N3O7S/c1-27(2,28(31,32)33)43-26(38)35-18-8-11-24-23(12-18)36(44(39,40)20-9-10-22(30)21(29)13-20)15-19(42-24)14-34-25(37)41-16-17-6-4-3-5-7-17/h3-13,19H,14-16H2,1-2H3,(H,34,37)(H,35,38)/t19-/m0/s1 JLYXOUOGRYGJEM-IBGZPJMESA-N 352498 US10745364, Example 8::US9809561, 8 Nuclear receptor ROR-gamma Human 31.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352498&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186931 386393661 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945540 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)NC3CCOCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C26H30F4N4O7S/c1-25(2,26(28,29)30)41-24(36)33-18-5-8-22-21(13-18)34(42(37,38)20-6-3-16(27)4-7-20)15-19(40-22)14-31-23(35)32-17-9-11-39-12-10-17/h3-8,13,17,19H,9-12,14-15H2,1-2H3,(H,33,36)(H2,31,32,35)/t19-/m0/s1 NWQAVNQSLMJINX-IBGZPJMESA-N 352499 US10745364, Example 9::US9809561, 9 Nuclear receptor ROR-gamma Human 4.23 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352499&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187169 386393662 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945541 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CNC(=O)OCc3ccccc3)CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C28H29ClFN3O7S/c1-28(2,3)40-27(35)32-19-9-12-25-24(13-19)33(41(36,37)21-10-11-23(30)22(29)14-21)16-20(39-25)15-31-26(34)38-17-18-7-5-4-6-8-18/h4-14,20H,15-17H2,1-3H3,(H,31,34)(H,32,35)/t20-/m0/s1 NGVZNTZNMVPXJQ-FQEVSTJZSA-N 352500 (S)-tert-butyl (2- (((benzyloxy)carbonyl)aminomethyl)- 4-((3-chloro-4- fluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10A::US9809561, 10A Nuclear receptor ROR-gamma Human 41.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352500&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187177 386393663 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945542 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)OCc3ccccc3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C28H27F4N3O7S/c1-27(2,28(30,31)32)42-26(37)34-20-10-13-24-23(14-20)35(43(38,39)22-11-8-19(29)9-12-22)16-21(41-24)15-33-25(36)40-17-18-6-4-3-5-7-18/h3-14,21H,15-17H2,1-2H3,(H,33,36)(H,34,37)/t21-/m0/s1 MANLUKQKALMTHD-NRFANRHFSA-N 352501 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2- (((benzyloxy)carbonyl)aminomethyl)- 4-((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10B::US9809561, 10B Nuclear receptor ROR-gamma Human 159 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352501&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187183 386393664 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945543 COC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H26FN3O7S/c1-22(2,3)33-21(28)25-15-7-10-19-18(11-15)26(13-16(32-19)12-24-20(27)31-4)34(29,30)17-8-5-14(23)6-9-17/h5-11,16H,12-13H2,1-4H3,(H,24,27)(H,25,28)/t16-/m0/s1 CLNJLKXXARITFY-INIZCTEOSA-N 352502 (S)-tert-butyl (2- (((methoxy)carbonyl)aminomethyl)- 4-((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10C::US9809561, 10C Nuclear receptor ROR-gamma Human 22.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352502&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187190 386393665 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945544 CNC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H27FN4O6S/c1-22(2,3)33-21(29)26-15-7-10-19-18(11-15)27(13-16(32-19)12-25-20(28)24-4)34(30,31)17-8-5-14(23)6-9-17/h5-11,16H,12-13H2,1-4H3,(H,26,29)(H2,24,25,28)/t16-/m0/s1 SQDMUGQRMDRVFS-INIZCTEOSA-N 352503 (S)-tert-butyl (4-((4- fluorophenyl)sulfonyl)-2-((3- methylureido)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10D::US9809561, 10D Nuclear receptor ROR-gamma Human 10.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352503&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187185 386393666 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945545 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)NC3CC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C24H26F4N4O6S/c1-23(2,24(26,27)28)38-22(34)31-16-7-10-20-19(11-16)32(39(35,36)18-8-3-14(25)4-9-18)13-17(37-20)12-29-21(33)30-15-5-6-15/h3-4,7-11,15,17H,5-6,12-13H2,1-2H3,(H,31,34)(H2,29,30,33)/t17-/m0/s1 DENQCPQLTNGKLT-KRWDZBQOSA-N 352504 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2-((3-cyclopropylureido)methyl)- 4-((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10E::US9809561, 10E Nuclear receptor ROR-gamma Human 18.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352504&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187180 386393667 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945546 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)NC3CCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C25H28F4N4O6S/c1-24(2,25(27,28)29)39-23(35)32-17-8-11-21-20(12-17)33(40(36,37)19-9-6-15(26)7-10-19)14-18(38-21)13-30-22(34)31-16-4-3-5-16/h6-12,16,18H,3-5,13-14H2,1-2H3,(H,32,35)(H2,30,31,34)/t18-/m0/s1 XFYIHVVJOCHAAO-SFHVURJKSA-N 352505 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2-((3-cyclobutylureido)methyl)-4- ((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10F::US9809561, 10F Nuclear receptor ROR-gamma Human 47.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352505&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187179 386393668 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945547 CC(C)(C)NC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H30F4N4O6S/c1-23(2,3)32-21(34)30-13-17-14-33(40(36,37)18-9-6-15(26)7-10-18)19-12-16(8-11-20(19)38-17)31-22(35)39-24(4,5)25(27,28)29/h6-12,17H,13-14H2,1-5H3,(H,31,35)(H2,30,32,34)/t17-/m0/s1 IWTMHKFDQNXKQQ-KRWDZBQOSA-N 352506 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2-((3-(tert-butyl)ureido)methyl)- 4-((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10G::US9809561, 10G Nuclear receptor ROR-gamma Human 29.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352506 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352506&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187182 386393669 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945548 CC(C)NC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H28F4N4O6S/c1-14(2)30-21(33)29-12-17-13-32(39(35,36)18-8-5-15(25)6-9-18)19-11-16(7-10-20(19)37-17)31-22(34)38-23(3,4)24(26,27)28/h5-11,14,17H,12-13H2,1-4H3,(H,31,34)(H2,29,30,33)/t17-/m0/s1 FFDUHRMHBFZJOY-KRWDZBQOSA-N 352507 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (4-((4-fluorophenyl)sulfonyl)-2- ((3-isopropylureido)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10H::US9809561, 10H Nuclear receptor ROR-gamma Human 19.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352507&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187176 386393670 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945549 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)Nc3ccsc3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C25H24F4N4O6S2/c1-24(2,25(27,28)29)39-23(35)32-16-5-8-21-20(11-16)33(41(36,37)19-6-3-15(26)4-7-19)13-18(38-21)12-30-22(34)31-17-9-10-40-14-17/h3-11,14,18H,12-13H2,1-2H3,(H,32,35)(H2,30,31,34)/t18-/m0/s1 VWILGNIHNSIUQS-SFHVURJKSA-N 352508 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (4-((4-fluorophenyl)sulfonyl)-2- ((3-(thiophen-3-yl)ureido)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin- 6-yl)carbamate::US10745364, Example 10i::US9809561, 10i Nuclear receptor ROR-gamma Human 72.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352508&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187181 386393671 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945550 CCNC(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H26F4N4O6S/c1-4-28-20(32)29-12-16-13-31(38(34,35)17-8-5-14(24)6-9-17)18-11-15(7-10-19(18)36-16)30-21(33)37-22(2,3)23(25,26)27/h5-11,16H,4,12-13H2,1-3H3,(H,30,33)(H2,28,29,32)/t16-/m0/s1 KKMYPMVOMIAIAN-INIZCTEOSA-N 352509 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2-((3-ethylureido)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10J::US9809561, 10J Nuclear receptor ROR-gamma Human 10.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352509&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187186 386393672 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945551 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNC(=O)NC3CCCCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C27H32F4N4O6S/c1-26(2,27(29,30)31)41-25(37)34-19-10-13-23-22(14-19)35(42(38,39)21-11-8-17(28)9-12-21)16-20(40-23)15-32-24(36)33-18-6-4-3-5-7-18/h8-14,18,20H,3-7,15-16H2,1-2H3,(H,34,37)(H2,32,33,36)/t20-/m0/s1 POMXJXLNVFHFBD-FQEVSTJZSA-N 352510 (S)-1,1,1-trifluoro-2-methylpropan-2- yl (2-((3-cyclohexylureido)methyl)-4- ((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 10K::US9809561, 10K Nuclear receptor ROR-gamma Human 195 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352510&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187175 386393673 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945552 CN1CCN(C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C(F)(F)F)ccc3O2)S(=O)(=O)c2ccc(F)c(Cl)c2)S1(=O)=O InChI=1S/C23H25ClF4N4O7S2/c1-22(2,23(26,27)28)39-21(33)29-14-4-7-20-19(10-14)32(40(34,35)16-5-6-18(25)17(24)11-16)13-15(38-20)12-31-9-8-30(3)41(31,36)37/h4-7,10-11,15H,8-9,12-13H2,1-3H3,(H,29,33)/t15-/m0/s1 OMBJDRKZBOFAAO-HNNXBMFYSA-N 359636 (R)-1,1,1-trifluoro-2-methylpropan-2-yl(4-((3-chloro-4-fluorophenyl)sulfonyl)-2-((5-methyl-1,1-dioxido-1,2,5-thiadiazolidin-2-yl)methyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (11)::US10221146, Example 11::US10745364, Example 11 Nuclear receptor ROR-gamma Human 5.79 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359636&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163273 386399090 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945553 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C21H24F4N4O7S2/c1-20(2,21(23,24)25)36-19(30)28-14-6-9-18-17(10-14)29(12-15(35-18)11-27-38(33,34)26-3)37(31,32)16-7-4-13(22)5-8-16/h4-10,15,26-27H,11-12H2,1-3H3,(H,28,30)/t15-/m0/s1 JCVWBVMJFYHNSO-HNNXBMFYSA-N 352512 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-(((N-methylsulfamoyl)amino)methyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 12::US9809561, 12 Nuclear receptor ROR-gamma Human 2.72 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352512&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633066 386393675 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945554 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNS(=O)(=O)N3CCOCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C24H28F4N4O8S2/c1-23(2,24(26,27)28)40-22(33)30-17-5-8-21-20(13-17)32(41(34,35)19-6-3-16(25)4-7-19)15-18(39-21)14-29-42(36,37)31-9-11-38-12-10-31/h3-8,13,18,29H,9-12,14-15H2,1-2H3,(H,30,33)/t18-/m0/s1 UQCBJOBYZKGFGQ-SFHVURJKSA-N 352513 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2- ((morpholine-4-sulfonamido)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13A::US9809561, 13A Nuclear receptor ROR-gamma Human 7.25 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352513&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187161 386393676 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945555 CCN(CC)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H30F4N4O7S2/c1-5-31(6-2)41(36,37)29-14-18-15-32(40(34,35)19-10-7-16(25)8-11-19)20-13-17(9-12-21(20)38-18)30-22(33)39-23(3,4)24(26,27)28/h7-13,18,29H,5-6,14-15H2,1-4H3,(H,30,33)/t18-/m0/s1 TUFHVRFVSGCEGP-SFHVURJKSA-N 352514 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N,N- diethylsulfamoyl)amino)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13B::US9809561, 13B Nuclear receptor ROR-gamma Human 12.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352514&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633069 386393677 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945556 CN(C)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H26F4N4O7S2/c1-21(2,22(24,25)26)37-20(31)28-15-7-10-19-18(11-15)30(38(32,33)17-8-5-14(23)6-9-17)13-16(36-19)12-27-39(34,35)29(3)4/h5-11,16,27H,12-13H2,1-4H3,(H,28,31)/t16-/m0/s1 RLAAILQKLBPFCU-INIZCTEOSA-N 352515 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N,N- dimethylsulfamoyl)amino)methyl)-4- ((4-fluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13C::US9809561, 13C Nuclear receptor ROR-gamma Human 7.32 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352515&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187159 386393678 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945557 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNS(=O)(=O)N3CCCCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C25H30F4N4O7S2/c1-24(2,25(27,28)29)40-23(34)31-18-8-11-22-21(14-18)33(41(35,36)20-9-6-17(26)7-10-20)16-19(39-22)15-30-42(37,38)32-12-4-3-5-13-32/h6-11,14,19,30H,3-5,12-13,15-16H2,1-2H3,(H,31,34)/t19-/m0/s1 GCHIBILFBPIMIW-IBGZPJMESA-N 352516 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2- ((piperidine-1-sulfonamido)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13D::US9809561, 13D Nuclear receptor ROR-gamma Human 11.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352516&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187261 386393679 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945558 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNS(=O)(=O)N3CCCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C24H28F4N4O7S2/c1-23(2,24(26,27)28)39-22(33)30-17-7-10-21-20(13-17)32(40(34,35)19-8-5-16(25)6-9-19)15-18(38-21)14-29-41(36,37)31-11-3-4-12-31/h5-10,13,18,29H,3-4,11-12,14-15H2,1-2H3,(H,30,33)/t18-/m0/s1 SFWQUQVLEGRYNH-SFHVURJKSA-N 352517 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2- ((pyrrolidine-1-sulfonamido)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13E::US9809561, 13E Nuclear receptor ROR-gamma Human 6.61 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352517&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187248 386393680 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945559 CC1CCCCN1S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C26H32F4N4O7S2/c1-17-6-4-5-13-33(17)43(38,39)31-15-20-16-34(42(36,37)21-10-7-18(27)8-11-21)22-14-19(9-12-23(22)40-20)32-24(35)41-25(2,3)26(28,29)30/h7-12,14,17,20,31H,4-6,13,15-16H2,1-3H3,(H,32,35)/t17?,20-/m0/s1 KMKVCBKXJAHJTI-OZBJMMHXSA-N 352518 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-4-((4-fluorophenyl)sulfonyl)-2- ((2-methylpiperidine-1- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13F::US9809561, 13F Nuclear receptor ROR-gamma Human 14.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352518&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187249 386393681 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945560 CC1CN(CC(C)O1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C26H32F4N4O8S2/c1-16-13-33(14-17(2)40-16)44(38,39)31-12-20-15-34(43(36,37)21-8-5-18(27)6-9-21)22-11-19(7-10-23(22)41-20)32-24(35)42-25(3,4)26(28,29)30/h5-11,16-17,20,31H,12-15H2,1-4H3,(H,32,35)/t16?,17?,20-/m0/s1 XPRGYHOKIVPMGY-UHYCVJNDSA-N 352519 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-2-((2,6-dimethylmorpholine-4- sulfonamido)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13G::US9809561, 13G Nuclear receptor ROR-gamma Human 56.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352519&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187265 386393682 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945561 CC1CCN(CC1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C26H32F4N4O7S2/c1-17-10-12-33(13-11-17)43(38,39)31-15-20-16-34(42(36,37)21-7-4-18(27)5-8-21)22-14-19(6-9-23(22)40-20)32-24(35)41-25(2,3)26(28,29)30/h4-9,14,17,20,31H,10-13,15-16H2,1-3H3,(H,32,35)/t20-/m0/s1 SICNUIVBJLZYPD-FQEVSTJZSA-N 352520 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-((4- methylpiperidine-1- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13H::US9809561, 13H Nuclear receptor ROR-gamma Human 36.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352520&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187262 386393683 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945562 CC1CN(CCO1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H30F4N4O8S2/c1-16-14-32(10-11-39-16)43(37,38)30-13-19-15-33(42(35,36)20-7-4-17(26)5-8-20)21-12-18(6-9-22(21)40-19)31-23(34)41-24(2,3)25(27,28)29/h4-9,12,16,19,30H,10-11,13-15H2,1-3H3,(H,31,34)/t16?,19-/m0/s1 QUIPKRMAMQBJPV-CVMIBEPCSA-N 352521 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-4-((4-fluorophenyl)sulfonyl)-2- ((2-methylmorpholine-4- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13i::US9809561, 13i Nuclear receptor ROR-gamma Human 15.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352521&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187264 386393684 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945563 CN(C1CC1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H28F4N4O7S2/c1-23(2,24(26,27)28)39-22(33)30-16-6-11-21-20(12-16)32(40(34,35)19-9-4-15(25)5-10-19)14-18(38-21)13-29-41(36,37)31(3)17-7-8-17/h4-6,9-12,17-18,29H,7-8,13-14H2,1-3H3,(H,30,33)/t18-/m0/s1 OSWNGEIPWWUIPJ-SFHVURJKSA-N 352522 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N-cyclopropyl-N- methylsulfamoyl)amino)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13J::US9809561, 13J Nuclear receptor ROR-gamma Human 5.74 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352522&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187267 386393685 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945564 CN(C1CCCC1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C26H32F4N4O7S2/c1-25(2,26(28,29)30)41-24(35)32-18-10-13-23-22(14-18)34(42(36,37)21-11-8-17(27)9-12-21)16-20(40-23)15-31-43(38,39)33(3)19-6-4-5-7-19/h8-14,19-20,31H,4-7,15-16H2,1-3H3,(H,32,35)/t20-/m0/s1 BAGMNZPMKSMTTQ-FQEVSTJZSA-N 352523 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N-cyclopentyl-N- methylsulfamoyl)amino)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13K::US9809561, 13K Nuclear receptor ROR-gamma Human 27.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352523&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187166 386393686 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945565 CN(CC(F)(F)F)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H25F7N4O7S2/c1-21(2,23(28,29)30)41-20(35)32-15-6-9-19-18(10-15)34(42(36,37)17-7-4-14(24)5-8-17)12-16(40-19)11-31-43(38,39)33(3)13-22(25,26)27/h4-10,16,31H,11-13H2,1-3H3,(H,32,35)/t16-/m0/s1 QTUOUHAUOMFTSB-INIZCTEOSA-N 352524 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-(((N- methyl-N-(2,2,2- trifluoroethyl)sulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13L::US9809561, 13L Nuclear receptor ROR-gamma Human 9.33 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352524&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187165 386393687 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945566 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C21H23ClF4N4O7S2/c1-20(2,21(24,25)26)37-19(31)29-12-4-7-18-17(8-12)30(11-13(36-18)10-28-39(34,35)27-3)38(32,33)14-5-6-16(23)15(22)9-14/h4-9,13,27-28H,10-11H2,1-3H3,(H,29,31)/t13-/m0/s1 GTYRKJSXHUYVJO-ZDUSSCGKSA-N 352525 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(((N-methylsulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13M::US9809561, 13M Nuclear receptor ROR-gamma Human 5.42 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352525&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187167 386393688 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945567 CC(C)(OC(=O)Nc1ccc2O[C@@H](CNS(=O)(=O)N3CCCCC3)CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)C(F)(F)F InChI=1S/C25H29ClF4N4O7S2/c1-24(2,25(28,29)30)41-23(35)32-16-6-9-22-21(12-16)34(42(36,37)18-7-8-20(27)19(26)13-18)15-17(40-22)14-31-43(38,39)33-10-4-3-5-11-33/h6-9,12-13,17,31H,3-5,10-11,14-15H2,1-2H3,(H,32,35)/t17-/m0/s1 NSVBASDXYNJAGQ-KRWDZBQOSA-N 352526 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-((piperidine-1-sulfonamido)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13N::US9809561, 13N Nuclear receptor ROR-gamma Human 20.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352526&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187163 386393689 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945568 CC1CCCCN1S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C26H31ClF4N4O7S2/c1-16-6-4-5-11-34(16)44(39,40)32-14-18-15-35(43(37,38)19-8-9-21(28)20(27)13-19)22-12-17(7-10-23(22)41-18)33-24(36)42-25(2,3)26(29,30)31/h7-10,12-13,16,18,32H,4-6,11,14-15H2,1-3H3,(H,33,36)/t16?,18-/m0/s1 VNMGKZNGTGEICN-DAFXYXGESA-N 352527 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-4-((3-chloro-4- fluorophenyl)sulfonyl)-2-((2- methylpiperidine-1- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13o::US9809561, 13o Nuclear receptor ROR-gamma Human 27.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352527&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163251 386393690 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945569 CC1CN(CCO1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C25H29ClF4N4O8S2/c1-15-13-33(8-9-40-15)44(38,39)31-12-17-14-34(43(36,37)18-5-6-20(27)19(26)11-18)21-10-16(4-7-22(21)41-17)32-23(35)42-24(2,3)25(28,29)30/h4-7,10-11,15,17,31H,8-9,12-14H2,1-3H3,(H,32,35)/t15?,17-/m0/s1 BXRMPFFUKMGKDC-LWKPJOBUSA-N 352528 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-4-((3-chloro-4- fluorophenyl)sulfonyl)-2-((2- methylmorpholine-4- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13P::US9809561, 13P Nuclear receptor ROR-gamma Human 15.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352528&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187162 386393691 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945570 CN(CC(F)(F)F)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C23H24ClF7N4O7S2/c1-21(2,23(29,30)31)42-20(36)33-13-4-7-19-18(8-13)35(43(37,38)15-5-6-17(25)16(24)9-15)11-14(41-19)10-32-44(39,40)34(3)12-22(26,27)28/h4-9,14,32H,10-12H2,1-3H3,(H,33,36)/t14-/m0/s1 ABLIAYGAFPKZPU-AWEZNQCLSA-N 352529 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(((N-methyl-N-(2,2,2- trifluoroethyl)sulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13Q::US9809561, 13Q Nuclear receptor ROR-gamma Human 15.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352529&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633072 386393692 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945571 CC(C)CN(C)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C25H31ClF4N4O7S2/c1-15(2)13-33(5)43(38,39)31-12-17-14-34(42(36,37)18-7-8-20(27)19(26)11-18)21-10-16(6-9-22(21)40-17)32-23(35)41-24(3,4)25(28,29)30/h6-11,15,17,31H,12-14H2,1-5H3,(H,32,35)/t17-/m0/s1 PPOHBJILRNMELT-KRWDZBQOSA-N 352530 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(((N-isobutyl-N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13R::US9809561, 13R Nuclear receptor ROR-gamma Human 24.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352530&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187270 386393693 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945572 CC1CCN(C1)S(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C25H29ClF4N4O7S2/c1-15-8-9-33(13-15)43(38,39)31-12-17-14-34(42(36,37)18-5-6-20(27)19(26)11-18)21-10-16(4-7-22(21)40-17)32-23(35)41-24(2,3)25(28,29)30/h4-7,10-11,15,17,31H,8-9,12-14H2,1-3H3,(H,32,35)/t15?,17-/m0/s1 RPQBRQBORRYQFD-LWKPJOBUSA-N 352531 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)-4-((3-chloro-4- fluorophenyl)sulfonyl)-2-((3- methylpyrrolidine-1- sulfonamido)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13S::US9809561, 13S Nuclear receptor ROR-gamma Human 14.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352531&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187254 386393694 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945573 CCNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C22H25ClF4N4O7S2/c1-4-28-40(35,36)29-11-14-12-31(39(33,34)15-6-7-17(24)16(23)10-15)18-9-13(5-8-19(18)37-14)30-20(32)38-21(2,3)22(25,26)27/h5-10,14,28-29H,4,11-12H2,1-3H3,(H,30,32)/t14-/m0/s1 GMTOZGZKGSDDFH-AWEZNQCLSA-N 352532 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(((N-ethylsulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13T::US9809561, 13T Nuclear receptor ROR-gamma Human 9.19 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352532&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187256 386393695 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945574 CC(C)NS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C23H27ClF4N4O7S2/c1-13(2)31-41(36,37)29-11-15-12-32(40(34,35)16-6-7-18(25)17(24)10-16)19-9-14(5-8-20(19)38-15)30-21(33)39-22(3,4)23(26,27)28/h5-10,13,15,29,31H,11-12H2,1-4H3,(H,30,33)/t15-/m0/s1 WSLVIXSPFYUGME-HNNXBMFYSA-N 352533 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(((N- isopropylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13U::US9809561, 13U Nuclear receptor ROR-gamma Human 8.80 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352533&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187263 386393696 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945575 CCNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H26F4N4O7S2/c1-4-27-39(34,35)28-12-16-13-30(38(32,33)17-8-5-14(23)6-9-17)18-11-15(7-10-19(18)36-16)29-20(31)37-21(2,3)22(24,25)26/h5-11,16,27-28H,4,12-13H2,1-3H3,(H,29,31)/t16-/m0/s1 FYQSYGPFDGJNGG-INIZCTEOSA-N 352534 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N-ethylsulfamoyl)amino)methyl)- 4-((4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13V::US9809561, 13V Nuclear receptor ROR-gamma Human 5.30 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352534&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187251 386393697 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945576 CC(C)NS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H28F4N4O7S2/c1-14(2)30-40(35,36)28-12-17-13-31(39(33,34)18-8-5-15(24)6-9-18)19-11-16(7-10-20(19)37-17)29-21(32)38-22(3,4)23(25,26)27/h5-11,14,17,28,30H,12-13H2,1-4H3,(H,29,32)/t17-/m0/s1 HYNHNDAPGPNSQJ-KRWDZBQOSA-N 352535 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-(((N- isopropylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13W::US9809561, 13W Nuclear receptor ROR-gamma Human 6.00 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352535&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187257 386393698 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945577 CC(C)(C)NS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H30F4N4O7S2/c1-22(2,3)31-41(36,37)29-13-17-14-32(40(34,35)18-9-6-15(25)7-10-18)19-12-16(8-11-20(19)38-17)30-21(33)39-23(4,5)24(26,27)28/h6-12,17,29,31H,13-14H2,1-5H3,(H,30,33)/t17-/m0/s1 WWRXRTVEBKOFLQ-KRWDZBQOSA-N 352536 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(((N-(tert- butyl)sulfamoyl)amino)methyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 13X::US9809561, 13X Nuclear receptor ROR-gamma Human 10.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352536&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187282 386393699 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945578 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(F)c1 InChI=1S/C21H23F5N4O7S2/c1-20(2,21(24,25)26)37-19(31)29-12-4-7-18-17(8-12)30(11-13(36-18)10-28-39(34,35)27-3)38(32,33)14-5-6-15(22)16(23)9-14/h4-9,13,27-28H,10-11H2,1-3H3,(H,29,31)/t13-/m0/s1 LQGLEJVONAPOHK-ZDUSSCGKSA-N 352537 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3,4-difluorophenyl)sulfonyl)-2- (((N-methylsulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13Y::US9809561, 13Y Nuclear receptor ROR-gamma Human 3.04 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352537 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352537&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187391 386393700 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945579 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](CNS(=O)(=O)NC)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H31F3N6O8S2/c1-6-30-13-18(19(29-30)37-7-2)40(33,34)31-12-15(11-27-41(35,36)26-5)38-17-9-8-14(10-16(17)31)28-20(32)39-21(3,4)22(23,24)25/h8-10,13,15,26-27H,6-7,11-12H2,1-5H3,(H,28,32)/t15-/m0/s1 DOSODBMLIDOJRN-HNNXBMFYSA-N 352538 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-ethoxy-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13Z::US9809561, 13Z Nuclear receptor ROR-gamma Human 5.82 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352538&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187387 386393701 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945580 CCn1cc(c(C)n1)S(=O)(=O)N1C[C@H](CNS(=O)(=O)NC)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H29F3N6O7S2/c1-6-29-12-18(13(2)28-29)38(32,33)30-11-15(10-26-39(34,35)25-5)36-17-8-7-14(9-16(17)30)27-19(31)37-20(3,4)21(22,23)24/h7-9,12,15,25-26H,6,10-11H2,1-5H3,(H,27,31)/t15-/m0/s1 UPXVUGMIUYFCKI-HNNXBMFYSA-N 352539 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((1-ethyl-3-methyl-1H-pyrazol-4- yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AA::US9809561, 13AA Nuclear receptor ROR-gamma Human 5.90 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352539&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187394 386393702 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945581 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CNS(=O)(=O)NC)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C20H26ClF3N6O7S2/c1-5-29-11-16(17(21)28-29)38(32,33)30-10-13(9-26-39(34,35)25-4)36-15-7-6-12(8-14(15)30)27-18(31)37-19(2,3)20(22,23)24/h6-8,11,13,25-26H,5,9-10H2,1-4H3,(H,27,31)/t13-/m0/s1 FSCPIHBPYSGBMI-ZDUSSCGKSA-N 352540 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AB::US9809561, 13AB Nuclear receptor ROR-gamma Human 3.92 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352540&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187389 386393703 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945582 CCn1cc(c(OCC(F)F)n1)S(=O)(=O)N1C[C@H](CNS(=O)(=O)NC)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H29F5N6O8S2/c1-5-32-11-17(19(31-32)39-12-18(23)24)42(35,36)33-10-14(9-29-43(37,38)28-4)40-16-7-6-13(8-15(16)33)30-20(34)41-21(2,3)22(25,26)27/h6-8,11,14,18,28-29H,5,9-10,12H2,1-4H3,(H,30,34)/t14-/m0/s1 BYPJTBCMUGLLAX-AWEZNQCLSA-N 352541 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-(2,2-difluoroethoxy)-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AC::US9809561, 13AC Nuclear receptor ROR-gamma Human 8.07 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352541&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187392 386393704 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945583 CCOc1nn(CC(F)F)cc1S(=O)(=O)N1C[C@H](CNS(=O)(=O)NC)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H29F5N6O8S2/c1-5-39-19-17(11-32(31-19)12-18(23)24)42(35,36)33-10-14(9-29-43(37,38)28-4)40-16-7-6-13(8-15(16)33)30-20(34)41-21(2,3)22(25,26)27/h6-8,11,14,18,28-29H,5,9-10,12H2,1-4H3,(H,30,34)/t14-/m0/s1 GOIXANGOLMTZBG-AWEZNQCLSA-N 352542 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((1-(2,2-difluoroethyl)-3-ethoxy-1H- pyrazol-4-yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AD::US9809561, 13AD Nuclear receptor ROR-gamma Human 5.11 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352542&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187395 386393705 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945584 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cn(nc1C)C(F)F InChI=1S/C20H25F5N6O7S2/c1-11-16(10-30(29-11)17(21)22)39(33,34)31-9-13(8-27-40(35,36)26-4)37-15-6-5-12(7-14(15)31)28-18(32)38-19(2,3)20(23,24)25/h5-7,10,13,17,26-27H,8-9H2,1-4H3,(H,28,32)/t13-/m0/s1 FVLDKEGFOZQKIC-ZDUSSCGKSA-N 352543 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((1-(difluoromethyl)-3-methyl-1H- pyrazol-4-yl)sulfonyl)-2-(((N- methylsulfamoyl)amino)methyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AE::US9809561, 13AE Nuclear receptor ROR-gamma Human 4.81 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352543&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187396 386393706 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945585 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1c(OC)nn2CCCc12 InChI=1S/C22H29F3N6O8S2/c1-21(2,22(23,24)25)39-20(32)28-13-7-8-17-16(10-13)31(12-14(38-17)11-27-41(35,36)26-3)40(33,34)18-15-6-5-9-30(15)29-19(18)37-4/h7-8,10,14,26-27H,5-6,9,11-12H2,1-4H3,(H,28,32)/t14-/m0/s1 OCEIZLQMUPRIKW-AWEZNQCLSA-N 352544 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((2-methoxy-5,6-dihydro-4H- pyrrolo[1,2-b]pyrazol-3-yl)sulfonyl)-2- (((N-methylsulfamoyl)amino)methyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 13AF::US9809561, 13AF Nuclear receptor ROR-gamma Human 3.93 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352544&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633158 386393707 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945586 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CSc3ccccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H26F3N3O5S2/c1-25(2,3)37-24(33)31-18-10-11-22-21(14-18)32(15-19(36-22)16-38-23-9-4-5-12-30-23)39(34,35)20-8-6-7-17(13-20)26(27,28)29/h4-14,19H,15-16H2,1-3H3,(H,31,33)/t19-/m1/s1 WMHXJDMRFGAKDY-LJQANCHMSA-N 352545 (R)-tert-butyl (2-((pyridin-2-ylthio)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 14::US9809561, 14 Nuclear receptor ROR-gamma Human 4.13 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352545&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186957 386393708 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945587 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CSC3CCCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H31F3N2O5S2/c1-25(2,3)36-24(32)30-18-11-12-23-22(14-18)31(15-19(35-23)16-37-20-8-4-5-9-20)38(33,34)21-10-6-7-17(13-21)26(27,28)29/h6-7,10-14,19-20H,4-5,8-9,15-16H2,1-3H3,(H,30,32)/t19-/m1/s1 ZRHDOWNUFWCZMK-LJQANCHMSA-N 352546 (R)-tert-butyl (2- ((cyclopentylthio)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15A::US9809561, 15A Nuclear receptor ROR-gamma Human 7.39 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352546&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187200 386393709 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945588 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CSCc3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H29F3N2O5S2/c1-27(2,3)38-26(34)32-21-12-13-25-24(15-21)33(16-22(37-25)18-39-17-19-8-5-4-6-9-19)40(35,36)23-11-7-10-20(14-23)28(29,30)31/h4-15,22H,16-18H2,1-3H3,(H,32,34)/t22-/m1/s1 ISTARZVPMCVNCT-JOCHJYFZSA-N 352547 (R)-tert-butyl (2-((benzylthio)methyl)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15B::US9809561, 15B Nuclear receptor ROR-gamma Human 9.54 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352547&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187198 386393710 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945589 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CSC(C)(C)C)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H31F3N2O5S2/c1-23(2,3)35-22(31)29-17-10-11-21-20(13-17)30(14-18(34-21)15-36-24(4,5)6)37(32,33)19-9-7-8-16(12-19)25(26,27)28/h7-13,18H,14-15H2,1-6H3,(H,29,31)/t18-/m1/s1 ZZKXBKARHBKZGR-GOSISDBHSA-N 352548 (R)-tert-butyl (2-((tert-butylthio)methyl)- 4-((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15C::US9809561, 15C Nuclear receptor ROR-gamma Human 7.75 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352548&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187202 386393711 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945590 Cc1nc(SC[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)[nH]c1C 352549 (R)-tert-butyl (2-(((4,5-dimethyl-1H- imidazol-2-yl)thio)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15D::US9809561, 15D Nuclear receptor ROR-gamma Human 10.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352549&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187201 386393712 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945591 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CSc3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H27F3N2O5S2/c1-26(2,3)37-25(33)31-19-12-13-24-23(15-19)32(16-20(36-24)17-38-21-9-5-4-6-10-21)39(34,35)22-11-7-8-18(14-22)27(28,29)30/h4-15,20H,16-17H2,1-3H3,(H,31,33)/t20-/m1/s1 QCZXWZIEXATCFV-HXUWFJFHSA-N 352550 (R)-tert-butyl (2-((phenylthio)methyl)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15E::US9809561, 15E Nuclear receptor ROR-gamma Human 5.88 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352550&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633073 386393713 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945592 CSC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H25F3N2O5S2/c1-21(2,3)32-20(28)26-15-8-9-19-18(11-15)27(12-16(31-19)13-33-4)34(29,30)17-7-5-6-14(10-17)22(23,24)25/h5-11,16H,12-13H2,1-4H3,(H,26,28)/t16-/m1/s1 LJPLVDKQCMCBOF-MRXNPFEDSA-N 352551 (R)-tert-butyl (2-((methylthio)methyl)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 15F::US9809561, 15F Nuclear receptor ROR-gamma Human 5.18 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352551&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633155 386393714 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945593 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)c3ccccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H26F3N3O7S2/c1-25(2,3)39-24(33)31-18-10-11-22-21(14-18)32(41(36,37)20-8-6-7-17(13-20)26(27,28)29)15-19(38-22)16-40(34,35)23-9-4-5-12-30-23/h4-14,19H,15-16H2,1-3H3,(H,31,33)/t19-/m1/s1 RMOMCWVYEBFWES-LJQANCHMSA-N 352552 (R)-tert-butyl (2-((pyridin-2-ylsulfonyl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 18::US9809561, 16::US9809561, 18 Nuclear receptor ROR-gamma Human 4.16 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352552&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187535 386393715 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945594 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)C(C)(C)C)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H31F3N2O7S2/c1-23(2,3)37-22(31)29-17-10-11-21-20(13-17)30(14-18(36-21)15-38(32,33)24(4,5)6)39(34,35)19-9-7-8-16(12-19)25(26,27)28/h7-13,18H,14-15H2,1-6H3,(H,29,31)/t18-/m1/s1 DFGDPXBFMRSCNE-GOSISDBHSA-N 352553 (R)-tert-butyl (2-((tert- butylsulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17A::US9809561, 17A Nuclear receptor ROR-gamma Human 5.55 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352553&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187381 386393716 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945595 Cc1nc([nH]c1C)S(=O)(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352554 (R)-tert-butyl (2-(((4,5-dimethyl-1H- imidazol-2-yl)sulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17B::US9809561, 17B Nuclear receptor ROR-gamma Human 11.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352554&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187386 386393717 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945596 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)c3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H27F3N2O7S2/c1-26(2,3)39-25(33)31-19-12-13-24-23(15-19)32(41(36,37)22-11-7-8-18(14-22)27(28,29)30)16-20(38-24)17-40(34,35)21-9-5-4-6-10-21/h4-15,20H,16-17H2,1-3H3,(H,31,33)/t20-/m1/s1 YPUMJLZVQKNYKA-HXUWFJFHSA-N 352555 (R)-tert-butyl (2- ((phenylsulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17C::US9809561, 17C Nuclear receptor ROR-gamma Human 4.81 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352555&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187388 386393718 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945597 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)C3CCCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H31F3N2O7S2/c1-25(2,3)38-24(32)30-18-11-12-23-22(14-18)31(15-19(37-23)16-39(33,34)20-8-4-5-9-20)40(35,36)21-10-6-7-17(13-21)26(27,28)29/h6-7,10-14,19-20H,4-5,8-9,15-16H2,1-3H3,(H,30,32)/t19-/m1/s1 BWHAAPAIULZRMN-LJQANCHMSA-N 352556 (R)-tert-butyl (2- ((cyclopentylsulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17D::US9809561, 17D Nuclear receptor ROR-gamma Human 5.13 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352556&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187382 386393719 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945598 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)Cc3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H29F3N2O7S2/c1-27(2,3)40-26(34)32-21-12-13-25-24(15-21)33(42(37,38)23-11-7-10-20(14-23)28(29,30)31)16-22(39-25)18-41(35,36)17-19-8-5-4-6-9-19/h4-15,22H,16-18H2,1-3H3,(H,32,34)/t22-/m1/s1 LNVSMCRBAGYKPT-JOCHJYFZSA-N 352557 (R)-tert-butyl (2- ((benzylsulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17E::US9809561, 17E Nuclear receptor ROR-gamma Human 7.84 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352557&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187385 386393720 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945599 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(C)(=O)=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H25F3N2O7S2/c1-21(2,3)34-20(28)26-15-8-9-19-18(11-15)27(12-16(33-19)13-35(4,29)30)36(31,32)17-7-5-6-14(10-17)22(23,24)25/h5-11,16H,12-13H2,1-4H3,(H,26,28)/t16-/m1/s1 HTKNUBAZKHWLPK-MRXNPFEDSA-N 352558 (R)-tert-butyl (2- ((methylsulfonyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 17F::US9809561, 17F Nuclear receptor ROR-gamma Human 3.86 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352558&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187380 386393721 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945600 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)c3ccccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H26F3N3O7S2/c1-25(2,3)39-24(33)31-18-10-11-22-21(14-18)32(41(36,37)20-8-6-7-17(13-20)26(27,28)29)15-19(38-22)16-40(34,35)23-9-4-5-12-30-23/h4-14,19H,15-16H2,1-3H3,(H,31,33)/t19-/m1/s1 RMOMCWVYEBFWES-LJQANCHMSA-N 352552 (R)-tert-butyl (2-((pyridin-2-ylsulfonyl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 18::US9809561, 16::US9809561, 18 Nuclear receptor ROR-gamma Human 3.28 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352552&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187535 386393715 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945601 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)NC3CC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O7S2/c1-23(2,3)37-22(31)28-17-9-10-21-20(12-17)30(13-18(36-21)14-38(32,33)29-16-7-8-16)39(34,35)19-6-4-5-15(11-19)24(25,26)27/h4-6,9-12,16,18,29H,7-8,13-14H2,1-3H3,(H,28,31)/t18-/m1/s1 SWAQXQNIZXBPRH-GOSISDBHSA-N 352560 (R)-tert-butyl (2-((N- cyclopropylsulfamoyl)methyl)-4- ((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 19A::US9809561, 19A Nuclear receptor ROR-gamma Human 6.32 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352560&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187206 386393722 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945602 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)NCC(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H25F6N3O7S2/c1-21(2,3)39-20(33)31-15-7-8-19-18(10-15)32(11-16(38-19)12-40(34,35)30-13-22(24,25)26)41(36,37)17-6-4-5-14(9-17)23(27,28)29/h4-10,16,30H,11-13H2,1-3H3,(H,31,33)/t16-/m1/s1 VDPLZEJMHKJERP-MRXNPFEDSA-N 352561 (R)-tert-butyl (2-((N-(2,2,2- trifluoroethyl)sulfamoyl) methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 19B::US9809561, 19B Nuclear receptor ROR-gamma Human 13.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352561&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187209 386393723 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945603 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CS(=O)(=O)N3CCOCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O8S2/c1-24(2,3)39-23(32)29-18-7-8-22-21(14-18)31(41(35,36)20-6-4-5-17(13-20)25(26,27)28)15-19(38-22)16-40(33,34)30-9-11-37-12-10-30/h4-8,13-14,19H,9-12,15-16H2,1-3H3,(H,29,32)/t19-/m1/s1 UFRBCEYBJPUOMX-LJQANCHMSA-N 352562 (R)-tert-butyl (2- ((morpholinosulfonyl) methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 19C::US9809561, 19C Nuclear receptor ROR-gamma Human 6.11 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352562&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187207 386393724 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945604 CCNS(=O)(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H28F3N3O7S2/c1-5-27-37(31,32)14-17-13-29(38(33,34)18-8-6-7-15(11-18)23(24,25)26)19-12-16(9-10-20(19)35-17)28-21(30)36-22(2,3)4/h6-12,17,27H,5,13-14H2,1-4H3,(H,28,30)/t17-/m1/s1 IQYPOKCKIVQTIT-QGZVFWFLSA-N 352563 (R)-tert-butyl (2-((N- ethylsulfamoyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 19D::US9809561, 19D Nuclear receptor ROR-gamma Human 5.33 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352563&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187212 386393725 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945605 CN(C)S(=O)(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H28F3N3O7S2/c1-22(2,3)36-21(30)27-16-9-10-20-19(12-16)29(13-17(35-20)14-37(31,32)28(4)5)38(33,34)18-8-6-7-15(11-18)23(24,25)26/h6-12,17H,13-14H2,1-5H3,(H,27,30)/t17-/m1/s1 SJWRQMWVAVRCMY-QGZVFWFLSA-N 352564 (R)-tert-butyl (2-((N,N- dimethylsulfamoyl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 19E::US9809561, 19E Nuclear receptor ROR-gamma Human 5.08 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352564&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187208 386393726 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945606 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H27F3N4O6S/c1-6-27-12-17(18(26-27)32-7-2)35(30,31)28-11-13(3)33-16-9-8-14(10-15(16)28)25-19(29)34-20(4,5)21(22,23)24/h8-10,12-13H,6-7,11H2,1-5H3,(H,25,29)/t13-/m0/s1 LBCWYARSLKWIHI-ZDUSSCGKSA-N 359690 1,1,1-trifluoro-2-methylpropan-2-yl (S)-(4-((3-ethoxy-1-ethyl-1H-pyrazol-4-yl)sulfonyl)-2-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (20)::US10221146, Example 20::US10745364, Example 20 Nuclear receptor ROR-gamma Human 10.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359690&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187211 386399143 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945607 C[C@@H]1[C@H](CO)Oc2ccc(NC(=O)OCC(C)(C)C)cc2N1S(=O)(=O)c1cccc(c1)C#N InChI=1S/C23H27N3O6S/c1-15-21(13-27)32-20-9-8-17(25-22(28)31-14-23(2,3)4)11-19(20)26(15)33(29,30)18-7-5-6-16(10-18)12-24/h5-11,15,21,27H,13-14H2,1-4H3,(H,25,28)/t15-,21+/m1/s1 XVMODHPPFRBRMY-VFNWGFHPSA-N 352566 US10745364, Example 21::US9809561, 21::[(2R,3R)-4-(3-cyano-benzenesulfonyl)-2-hydroxymethyl-3-methyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid 2,2-dimethyl-propyl ester Nuclear receptor ROR-gamma Human 693 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352566&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267868 386393728 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945608 C[C@@H]1COc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc2N1S(=O)(=O)c1ccc(F)cc1 InChI=1S/C20H20F4N2O5S/c1-12-11-30-17-9-6-14(25-18(27)31-19(2,3)20(22,23)24)10-16(17)26(12)32(28,29)15-7-4-13(21)5-8-15/h4-10,12H,11H2,1-3H3,(H,25,27)/t12-/m1/s1 LBCXGUZNPCHRLX-GFCCVEGCSA-N 352568 (R)-1,1,1-trifluoro-2-methylpropan-2-yl 4-(4-fluorophenylsulfonyl)-3-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-ylcarbamate::US10745364, Example 22A::US9809561, 22B Nuclear receptor ROR-gamma Human 920 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352568&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186973 386393730 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945609 C[C@H]1COc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc2N1S(=O)(=O)c1ccc(F)cc1 InChI=1S/C20H20F4N2O5S/c1-12-11-30-17-9-6-14(25-18(27)31-19(2,3)20(22,23)24)10-16(17)26(12)32(28,29)15-7-4-13(21)5-8-15/h4-10,12H,11H2,1-3H3,(H,25,27)/t12-/m0/s1 LBCXGUZNPCHRLX-LBPRGKRZSA-N 352567 (S)-1,1,1-trifluoro-2-methylpropan-2-yl 4-(4-fluorophenylsulfonyl)-3-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-ylcarbamate::US10745364, Example 22B::US9809561, 22A Nuclear receptor ROR-gamma Human 10.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352567&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186976 386393729 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945610 CC(C)(OC(=O)Nc1ccc2OC[C@H](CO)N(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C20H20F4N2O6S/c1-19(2,20(22,23)24)32-18(28)25-13-5-8-17-16(9-13)26(14(10-27)11-31-17)33(29,30)15-6-3-12(21)4-7-15/h3-9,14,27H,10-11H2,1-2H3,(H,25,28)/t14-/m0/s1 HAMXYVLBSBQPTB-AWEZNQCLSA-N 352570 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-3-(hydroxymethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 23A::US9809561, 23B Nuclear receptor ROR-gamma Human 4674 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352570&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187197 386393732 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945611 CC(C)(OC(=O)Nc1ccc2OC[C@@H](CO)N(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C20H20F4N2O6S/c1-19(2,20(22,23)24)32-18(28)25-13-5-8-17-16(9-13)26(14(10-27)11-31-17)33(29,30)15-6-3-12(21)4-7-15/h3-9,14,27H,10-11H2,1-2H3,(H,25,28)/t14-/m1/s1 HAMXYVLBSBQPTB-CQSZACIVSA-N 352569 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-3-(hydroxymethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 23B::US9809561, 23A Nuclear receptor ROR-gamma Human 27.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352569&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187199 386393731 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945612 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CN3C(=O)COC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C24H24N4O8S/c1-24(2,3)36-22(30)26-16-7-8-20-19(10-16)28(37(32,33)18-6-4-5-15(9-18)11-25)13-17(35-20)12-27-21(29)14-34-23(27)31/h4-10,17H,12-14H2,1-3H3,(H,26,30)/t17-/m0/s1 IHFDCUPKIHEZLU-KRWDZBQOSA-N 352571 US10745364, Example 24::US9809561, 24::[(S)-4-(3-cyano-benzenesulfonyl)-2-(2,4-dioxo-oxazolidin-3-ylmethyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid tert-butyl ester Nuclear receptor ROR-gamma Human 11.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352571&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187210 386393733 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945613 O=C(Nc1ccc2O[C@@H](CN3C(=O)COC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C#N)O[C@@H]1C[C@@H]2CC[C@H]1C2 InChI=1S/C27H26N4O8S/c28-12-17-2-1-3-21(9-17)40(35,36)31-14-20(13-30-25(32)15-37-27(30)34)38-23-7-6-19(11-22(23)31)29-26(33)39-24-10-16-4-5-18(24)8-16/h1-3,6-7,9,11,16,18,20,24H,4-5,8,10,13-15H2,(H,29,33)/t16-,18+,20+,24-/m1/s1 RWHVLHJBRBXWJY-JAOJYNAYSA-N 352572 (1S,2R,4R)-bicyclo[2.2.1]heptan-2-yl ((S)- 4-((3-cyanophenyl)sulfonyl)-2-((2,4- dioxooxazolidin-3-yl)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 25A::US9809561, 25A Nuclear receptor ROR-gamma Human 12.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352572&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187311 386393734 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945614 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CN3C(=O)COC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C25H26N4O8S/c1-25(2,3)15-36-23(31)27-17-7-8-21-20(10-17)29(38(33,34)19-6-4-5-16(9-19)11-26)13-18(37-21)12-28-22(30)14-35-24(28)32/h4-10,18H,12-15H2,1-3H3,(H,27,31)/t18-/m0/s1 IUTYWGQJJYBAGR-SFHVURJKSA-N 352573 (S)-neopentyl (4-((3- cyanophenyl)sulfonyl)-2-((2,4- dioxooxazolidin-3-yl)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 25B::US9809561, 25B Nuclear receptor ROR-gamma Human 11.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352573&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633113 386393735 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945615 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CN2C(=O)COC2=O)Oc2ccc(NC(=O)OC3C[C@@H]4CC[C@H]3C4)cc12 InChI=1S/C24H27N5O8S/c1-27-12-18(9-25-27)38(33,34)29-11-17(10-28-22(30)13-35-24(28)32)36-20-5-4-16(8-19(20)29)26-23(31)37-21-7-14-2-3-15(21)6-14/h4-5,8-9,12,14-15,17,21H,2-3,6-7,10-11,13H2,1H3,(H,26,31)/t14-,15+,17+,21?/m1/s1 OKVPMBHEPPKJBV-HRKYDNSHSA-N 352574 (1S,4R)-bicyclo[2.2.1]heptan-2-yl ((S)-2- ((2,4-dioxooxazolidin-3-yl)methyl)-4-((1- methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 25C::US9809561, 25C Nuclear receptor ROR-gamma Human 623 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352574&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187315 386393736 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945616 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CN2C(=O)COC2=O)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C21H25N5O8S/c1-21(2,3)34-19(28)23-13-5-6-17-16(7-13)26(35(30,31)15-8-22-24(4)11-15)10-14(33-17)9-25-18(27)12-32-20(25)29/h5-8,11,14H,9-10,12H2,1-4H3,(H,23,28)/t14-/m0/s1 VVACOLJHYBYJKX-AWEZNQCLSA-N 352575 (S)-tert-butyl (2-((2,4-dioxooxazolidin-3- yl)methyl)-4-((1-methyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 25D::US9809561, 25D Nuclear receptor ROR-gamma Human 203 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352575&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187319 386393737 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945617 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CN2C(=O)COC2=O)Oc2ccc(NC(=O)OCC(C)(C)C)cc12 InChI=1S/C22H27N5O8S/c1-22(2,3)13-34-20(29)24-14-5-6-18-17(7-14)27(36(31,32)16-8-23-25(4)11-16)10-15(35-18)9-26-19(28)12-33-21(26)30/h5-8,11,15H,9-10,12-13H2,1-4H3,(H,24,29)/t15-/m0/s1 MUIVNNHJXPPSBF-HNNXBMFYSA-N 352576 (S)-neopentyl (2-((2,4-dioxooxazolidin-3- yl)methyl)-4-((1-methyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 25E::US9809561, 25E Nuclear receptor ROR-gamma Human 168 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352576&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187229 386393738 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945618 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CN2C(=O)COC2=O)Oc2ccc(NC(=O)OCC3CCCCO3)cc12 InChI=1S/C23H27N5O9S/c1-26-12-18(9-24-26)38(32,33)28-11-17(10-27-21(29)14-36-23(27)31)37-20-6-5-15(8-19(20)28)25-22(30)35-13-16-4-2-3-7-34-16/h5-6,8-9,12,16-17H,2-4,7,10-11,13-14H2,1H3,(H,25,30)/t16?,17-/m0/s1 PZKLMNNZHCHVBH-DJNXLDHESA-N 352577 (tetrahydro-2H-pyran-2-yl)methyl ((S)-2- ((2,4-dioxooxazolidin-3-yl)methyl)-4-((1- methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 25F::US9809561, 25F Nuclear receptor ROR-gamma Human 9593 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352577&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187230 386393739 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945619 O=C(Nc1ccc2O[C@@H](CN3C(=O)COC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C#N)O[C@H]1CC2CCC1C2 InChI=1S/C27H26N4O8S/c28-12-17-2-1-3-21(9-17)40(35,36)31-14-20(13-30-25(32)15-37-27(30)34)38-23-7-6-19(11-22(23)31)29-26(33)39-24-10-16-4-5-18(24)8-16/h1-3,6-7,9,11,16,18,20,24H,4-5,8,10,13-15H2,(H,29,33)/t16?,18?,20-,24-/m0/s1 RWHVLHJBRBXWJY-PCHMQVOASA-N 352578 (2S)-bicyclo[2.2.1]heptan-2-yl ((S)-4-((3- cyanophenyl)sulfonyl)-2-((2,4- dioxooxazolidin-3-yl)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 25G::US9809561, 25G Nuclear receptor ROR-gamma Human 51.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352578&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187231 386393740 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945620 Cn1cc(cn1)S(=O)(=O)N1C[C@H](CN2C(=O)COC2=O)Oc2ccc(NC(=O)O[C@H]3CC4CCC3C4)cc12 InChI=1S/C24H27N5O8S/c1-27-12-18(9-25-27)38(33,34)29-11-17(10-28-22(30)13-35-24(28)32)36-20-5-4-16(8-19(20)29)26-23(31)37-21-7-14-2-3-15(21)6-14/h4-5,8-9,12,14-15,17,21H,2-3,6-7,10-11,13H2,1H3,(H,26,31)/t14?,15?,17-,21-/m0/s1 OKVPMBHEPPKJBV-DJHAQQLZSA-N 352579 (2S)-bicyclo[2.2.1]heptan-2-yl ((S)-2-((2,4- dioxooxazolidin-3-yl)methyl)-4-((1- methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 25H::US9809561, 25H Nuclear receptor ROR-gamma Human 108 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352579&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187234 386393741 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945621 CN(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C23H28N4O5S/c1-23(2,3)32-22(28)25-17-9-10-21-20(12-17)27(15-18(31-21)14-26(4)5)33(29,30)19-8-6-7-16(11-19)13-24/h6-12,18H,14-15H2,1-5H3,(H,25,28)/t18-/m0/s1 PZCGSPKTBRCWBK-SFHVURJKSA-N 352580 [(S)-4-(3-cyano-benzenesulfonyl)-2-dimethylaminomethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid tert-butyl ester ::US10745364, Example 26::US9809561, 26 Nuclear receptor ROR-gamma Human 30.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352580&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187233 386393742 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945622 CN(C)C[C@H]1CN(c2cc(NC(=O)OCC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C24H30N4O5S/c1-24(2,3)16-32-23(29)26-18-9-10-22-21(12-18)28(15-19(33-22)14-27(4)5)34(30,31)20-8-6-7-17(11-20)13-25/h6-12,19H,14-16H2,1-5H3,(H,26,29)/t19-/m0/s1 IDVUCGFYPZMREI-IBGZPJMESA-N 352581 [(S)-4-(3-cyano-benzenesulfonyl)-2-dimethylaminomethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid 2,2-dimethyl-propyl ester::US10745364, Example 27::US9809561, 27 Nuclear receptor ROR-gamma Human 29.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352581&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185295 386393743 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945623 CN(C)C[C@H]1CN(c2cc(NC(=O)OC3C[C@@H]4CC[C@H]3C4)ccc2O1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C26H30N4O5S/c1-29(2)15-21-16-30(36(32,33)22-5-3-4-18(11-22)14-27)23-13-20(8-9-24(23)34-21)28-26(31)35-25-12-17-6-7-19(25)10-17/h3-5,8-9,11,13,17,19,21,25H,6-7,10,12,15-16H2,1-2H3,(H,28,31)/t17-,19+,21+,25?/m1/s1 AYZQJWYEZKIORS-KNECTAOWSA-N 352582 (1S,4R)-bicyclo[2.2.1]heptan-2-yl ((S)-4-((3-cyanophenyl)sulfonyl)-2- ((dimethylamino)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 28A::US9809561, 28A Nuclear receptor ROR-gamma Human 190 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352582&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187555 386393744 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945624 CN(C)C[C@H]1CN(c2cc(NC(=O)O[C@@H]3C[C@@H]4CC[C@H]3C4)ccc2O1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C26H30N4O5S/c1-29(2)15-21-16-30(36(32,33)22-5-3-4-18(11-22)14-27)23-13-20(8-9-24(23)34-21)28-26(31)35-25-12-17-6-7-19(25)10-17/h3-5,8-9,11,13,17,19,21,25H,6-7,10,12,15-16H2,1-2H3,(H,28,31)/t17-,19+,21+,25-/m1/s1 AYZQJWYEZKIORS-WPLIGNBTSA-N 352583 (1S,2R,4R)-bicyclo[2.2.1]heptan-2-yl ((S)-4-((3-cyanophenyl)sulfonyl)-2- ((dimethylamino)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 28B::US9809561, 28B Nuclear receptor ROR-gamma Human 20.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352583&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187553 386393745 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945625 CN(C)C[C@H]1CN(c2cc(NC(=O)OCC(C)(C)C)ccc2O1)S(=O)(=O)c1cnn(C)c1 InChI=1S/C21H31N5O5S/c1-21(2,3)14-30-20(27)23-15-7-8-19-18(9-15)26(12-16(31-19)11-24(4)5)32(28,29)17-10-22-25(6)13-17/h7-10,13,16H,11-12,14H2,1-6H3,(H,23,27)/t16-/m0/s1 WWTUWLCFKZFOLK-INIZCTEOSA-N 352584 (S)-neopentyl (2-((dimethylamino)methyl)- 4-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 28C::US9809561, 28C Nuclear receptor ROR-gamma Human 450 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352584&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187554 386393746 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945626 CN(C)C[C@H]1CN(c2cc(NC(=O)OC3CC4CCC3C4)ccc2O1)S(=O)(=O)c1cnn(C)c1 InChI=1S/C23H31N5O5S/c1-26(2)12-18-13-28(34(30,31)19-11-24-27(3)14-19)20-10-17(6-7-21(20)32-18)25-23(29)33-22-9-15-4-5-16(22)8-15/h6-7,10-11,14-16,18,22H,4-5,8-9,12-13H2,1-3H3,(H,25,29)/t15?,16?,18-,22?/m0/s1 HFTQVJGCOLLFDV-RRYXTEJGSA-N 352585 US10745364, Example 28D::US9809561, 28D::bicyclo[2.2.1]heptan-2-yl ((S)-2- ((dimethylamino)methyl)-4-((1-methyl-1H- pyrazol-4-yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 848 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352585&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187552 386393747 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945627 CN(C)C[C@H]1CN(c2cc(NC(=O)O[C@H]3CC4CCC3C4)ccc2O1)S(=O)(=O)c1cnn(C)c1 InChI=1S/C23H31N5O5S/c1-26(2)12-18-13-28(34(30,31)19-11-24-27(3)14-19)20-10-17(6-7-21(20)32-18)25-23(29)33-22-9-15-4-5-16(22)8-15/h6-7,10-11,14-16,18,22H,4-5,8-9,12-13H2,1-3H3,(H,25,29)/t15?,16?,18-,22-/m0/s1 HFTQVJGCOLLFDV-MNXHBVJMSA-N 352586 (2S)-bicyclo[2.2.1]heptan-2-yl ((S)-2- ((dimethylamino)methyl)-4-((1-methyl-1H- pyrazol-4-yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 28E::US9809561, 28E Nuclear receptor ROR-gamma Human 190 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352586&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186992 386393748 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945628 CN(C)C[C@H]1CN(c2cc(NC(=O)OC3CCOCC3)ccc2O1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C24H28N4O6S/c1-27(2)15-20-16-28(35(30,31)21-5-3-4-17(12-21)14-25)22-13-18(6-7-23(22)33-20)26-24(29)34-19-8-10-32-11-9-19/h3-7,12-13,19-20H,8-11,15-16H2,1-2H3,(H,26,29)/t20-/m0/s1 DNBNAVMLZPJWDK-FQEVSTJZSA-N 352587 (S)-tetrahydro-2H-pyran-4-yl (4-((3- cyanophenyl)sulfonyl)-2- ((dimethylamino)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 28F::US9809561, 28F Nuclear receptor ROR-gamma Human 1765 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352587&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186990 386393749 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945629 COC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H25F3N2O7S/c1-22(2,3)35-21(30)27-15-8-9-19-18(11-15)28(13-16(34-19)12-20(29)33-4)36(31,32)17-7-5-6-14(10-17)23(24,25)26/h5-11,16H,12-13H2,1-4H3,(H,27,30)/t16-/m0/s1 AZQHUYXSYIFUPW-INIZCTEOSA-N 352588 (S)-methyl 2-(6-((tert-butoxycarbonyl)amino)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)acetate::US10745364, Example 29::US9809561, 29 Nuclear receptor ROR-gamma Human 3.76 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352588&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187014 386393750 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945630 COC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C22H24ClFN2O7S/c1-22(2,3)33-21(28)25-13-5-8-19-18(9-13)26(12-14(32-19)10-20(27)31-4)34(29,30)15-6-7-17(24)16(23)11-15/h5-9,11,14H,10,12H2,1-4H3,(H,25,28)/t14-/m0/s1 XERXRTPMRJQSRB-AWEZNQCLSA-N 352589 (S)-methyl 2-(6-((tert- butoxycarbonyl)amino)-4-((3-chloro-4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-2-yl)acetate::US10745364, Example 30A::US9809561, 30A Nuclear receptor ROR-gamma Human 2.24 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352589&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187245 386393751 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945631 COC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C23H24F4N2O7S/c1-22(2,3)36-21(31)28-13-5-8-19-18(9-13)29(12-14(35-19)10-20(30)34-4)37(32,33)15-6-7-17(24)16(11-15)23(25,26)27/h5-9,11,14H,10,12H2,1-4H3,(H,28,31)/t14-/m0/s1 JKOISIZQBNEFBN-AWEZNQCLSA-N 352590 (S)-methyl 2-(6-((tert- butoxycarbonyl)amino)-4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetate::US10745364, Example 30B::US9809561, 30B Nuclear receptor ROR-gamma Human 3.13 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352590&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187247 386393752 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945632 COC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(OC)c1 InChI=1S/C23H27FN2O8S/c1-23(2,3)34-22(28)25-14-6-9-19-18(10-14)26(13-15(33-19)11-21(27)32-5)35(29,30)16-7-8-17(24)20(12-16)31-4/h6-10,12,15H,11,13H2,1-5H3,(H,25,28)/t15-/m0/s1 LKQUZSVMRAJVBG-HNNXBMFYSA-N 352591 (S)-methyl 2-(6-((tert- butoxycarbonyl)amino)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-2-yl)acetate::US10745364, Example 30C::US9809561, 30C Nuclear receptor ROR-gamma Human 2.15 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352591&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187242 386393753 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945633 COC(=O)C[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H25F3N2O7S/c1-22(2,3)35-21(30)27-15-8-9-19-18(11-15)28(13-16(34-19)12-20(29)33-4)36(31,32)17-7-5-6-14(10-17)23(24,25)26/h5-11,16H,12-13H2,1-4H3,(H,27,30)/t16-/m1/s1 AZQHUYXSYIFUPW-MRXNPFEDSA-N 352592 (R)-methyl 2-(6-((tert- butoxycarbonyl)amino)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetate::US10745364, Example 30D::US9809561, 30D Nuclear receptor ROR-gamma Human 15.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352592&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187244 386393754 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945634 COC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C23H21F7N2O7S/c1-21(2,23(28,29)30)39-20(34)31-12-4-7-18-17(8-12)32(11-13(38-18)9-19(33)37-3)40(35,36)14-5-6-16(24)15(10-14)22(25,26)27/h4-8,10,13H,9,11H2,1-3H3,(H,31,34)/t13-/m0/s1 XMPSPMOLZSFNRS-ZDUSSCGKSA-N 352594 (S)-methyl 2-(4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-6- ((((1,1,1-trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-3,4-dihydro-2H- benzo[b][1,4]oxazin-2-yl)acetate::US10745364, Example 30E::US9809561, 30E Nuclear receptor ROR-gamma Human 4.94 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352594&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187246 386393755 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945635 Cc1nn(cc1S(=O)(=O)N1C[C@H](CC(O)=O)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C20H24F2N4O7S/c1-11-16(10-25(24-11)18(21)22)34(30,31)26-9-13(8-17(27)28)32-15-6-5-12(7-14(15)26)23-19(29)33-20(2,3)4/h5-7,10,13,18H,8-9H2,1-4H3,(H,23,29)(H,27,28)/t13-/m0/s1 AEXRBIUZTFHJEZ-ZDUSSCGKSA-N 352595 US10745364, Example 31::US9809561, 31::[(S)-6-tert-butoxycarbonylamino-4-(1-difluoromethyl-3-methyl-1H-pyrazole-4-sulfonyl)-3,4-dihydro-2H-benzo[1,4]oxazin-2-yl]-acetic acid Nuclear receptor ROR-gamma Human 54.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352595&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187435 386393756 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945636 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(O)=O)Oc2ccc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C22H25FN2O8S/c1-22(2,3)33-21(28)24-13-5-8-18-17(9-13)25(12-14(32-18)10-20(26)27)34(29,30)15-6-7-16(23)19(11-15)31-4/h5-9,11,14H,10,12H2,1-4H3,(H,24,28)(H,26,27)/t14-/m0/s1 JTXPAAWPXSHMDD-AWEZNQCLSA-N 352596 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((4-fluoro-3-methoxyphenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetic acid::US10745364, Example 32A::US9809561, 32A Nuclear receptor ROR-gamma Human 16.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352596&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186979 386393757 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945637 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C22H22F4N2O7S/c1-21(2,3)35-20(31)27-12-4-7-18-17(8-12)28(11-13(34-18)9-19(29)30)36(32,33)14-5-6-16(23)15(10-14)22(24,25)26/h4-8,10,13H,9,11H2,1-3H3,(H,27,31)(H,29,30)/t13-/m0/s1 ACNOCRZFFOUHIM-ZDUSSCGKSA-N 352597 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetic acid::US10745364, Example 32B::US9809561, 32B Nuclear receptor ROR-gamma Human 9.56 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352597&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186980 386393758 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945638 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C21H22ClFN2O7S/c1-21(2,3)32-20(28)24-12-4-7-18-17(8-12)25(11-13(31-18)9-19(26)27)33(29,30)14-5-6-16(23)15(22)10-14/h4-8,10,13H,9,11H2,1-3H3,(H,24,28)(H,26,27)/t13-/m0/s1 GSRASZJHXDQHTL-ZDUSSCGKSA-N 352598 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((3-chloro-4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetic acid::US10745364, Example 32C::US9809561, 32C Nuclear receptor ROR-gamma Human 51.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352598&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187318 386393759 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945639 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H23F3N2O7S/c1-21(2,3)34-20(30)26-14-7-8-18-17(10-14)27(12-15(33-18)11-19(28)29)35(31,32)16-6-4-5-13(9-16)22(23,24)25/h4-10,15H,11-12H2,1-3H3,(H,26,30)(H,28,29)/t15-/m0/s1 KWKKYDBYIJDYMQ-HNNXBMFYSA-N 352599 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetic acid::US10745364, Example 32D::US9809561, 32D Nuclear receptor ROR-gamma Human 19.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352599&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187323 386393760 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945640 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C21H23FN2O7S/c1-21(2,3)31-20(27)23-14-6-9-18-17(10-14)24(12-15(30-18)11-19(25)26)32(28,29)16-7-4-13(22)5-8-16/h4-10,15H,11-12H2,1-3H3,(H,23,27)(H,25,26)/t15-/m0/s1 ZTBQFPRNTQWJTK-HNNXBMFYSA-N 352600 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((4-fluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-2-yl)acetic acid::US10745364, Example 32E::US9809561, 32E Nuclear receptor ROR-gamma Human 563 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352600&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187325 386393761 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945641 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H25FN2O7S/c1-22(2,3)13-31-21(28)24-15-6-9-19-18(10-15)25(12-16(32-19)11-20(26)27)33(29,30)17-7-4-14(23)5-8-17/h4-10,16H,11-13H2,1-3H3,(H,24,28)(H,26,27)/t16-/m0/s1 GAPMYRIVKASHKA-INIZCTEOSA-N 352601 (S)-2-(4-((4-fluorophenyl)sulfonyl)-6- (((neopentyloxy)carbonyl)amino)-3,4- dihydro-2H-benzo[b][1,4]oxazin-2- yl)acetic acid::US10745364, Example 32F::US9809561, 32F Nuclear receptor ROR-gamma Human 242 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352601&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187328 386393762 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945642 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1cccc(Cl)c1 InChI=1S/C21H23ClN2O7S/c1-21(2,3)31-20(27)23-14-7-8-18-17(10-14)24(12-15(30-18)11-19(25)26)32(28,29)16-6-4-5-13(22)9-16/h4-10,15H,11-12H2,1-3H3,(H,23,27)(H,25,26)/t15-/m0/s1 WFDIDLSIWIHBEE-HNNXBMFYSA-N 352602 (S)-2-(6-((tert-butoxycarbonyl)amino)-4- ((3-chlorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-2-yl)acetic acid::US10745364, Example 32G::US9809561, 32G Nuclear receptor ROR-gamma Human 81.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352602&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187326 386393763 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945643 CC(C)(OC(=O)Nc1ccc2O[C@@H](CC(O)=O)CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(F)(F)F InChI=1S/C22H19F7N2O7S/c1-20(2,22(27,28)29)38-19(34)30-11-3-6-17-16(7-11)31(10-12(37-17)8-18(32)33)39(35,36)13-4-5-15(23)14(9-13)21(24,25)26/h3-7,9,12H,8,10H2,1-2H3,(H,30,34)(H,32,33)/t12-/m0/s1 LCPAPTUUKXDFLA-LBPRGKRZSA-N 352603 (S)-2-(4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-6- ((((1,1,1-trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-3,4-dihydro-2H- benzo[b][1,4]oxazin-2-yl)acetic acid::US10745364, Example 32H::US9809561, 32H Nuclear receptor ROR-gamma Human 26.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352603&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187334 386393764 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945644 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)C(O)=O InChI=1S/C20H20ClFN2O7S/c1-20(2,3)31-19(27)23-11-4-7-16-15(8-11)24(10-17(30-16)18(25)26)32(28,29)12-5-6-14(22)13(21)9-12/h4-9,17H,10H2,1-3H3,(H,23,27)(H,25,26)/t17-/m1/s1 VDDSOWOELFTSCB-QGZVFWFLSA-N 352604 (R)-6-((tert-butoxycarbonyl)amino)-4-((3-chloro-4-fluorophenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylic Acid ::US10745364, Example 33::US9809561, 33 Nuclear receptor ROR-gamma Human 43.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352604&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187223 386393765 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945645 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(O)=O InChI=1S/C20H21FN2O7S/c1-20(2,3)30-19(26)22-13-6-9-16-15(10-13)23(11-17(29-16)18(24)25)31(27,28)14-7-4-12(21)5-8-14/h4-10,17H,11H2,1-3H3,(H,22,26)(H,24,25)/t17-/m1/s1 CALONTOYEVCEOM-QGZVFWFLSA-N 352605 (R)-6-((tert-butoxycarbonyl)amino)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazine-2-carboxylic acid::US10745364, Example 34A::US9809561, 34A Nuclear receptor ROR-gamma Human 156 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352605&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187568 386393766 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945646 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(O)=O InChI=1S/C21H23FN2O8S/c1-21(2,3)32-20(27)23-12-5-8-16-15(9-12)24(11-18(31-16)19(25)26)33(28,29)13-6-7-14(22)17(10-13)30-4/h5-10,18H,11H2,1-4H3,(H,23,27)(H,25,26)/t18-/m1/s1 LXXFWICLJKMWHB-GOSISDBHSA-N 352606 (R)-6-((tert-butoxycarbonyl)amino)-4-((4- fluoro-3-methoxyphenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazine-2- carboxylic acid::US10745364, Example 34B::US9809561, 34B Nuclear receptor ROR-gamma Human 60.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352606&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187570 386393767 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945647 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(O)=O)C(F)(F)F InChI=1S/C21H17F7N2O7S/c1-19(2,21(26,27)28)37-18(33)29-10-3-6-15-14(7-10)30(9-16(36-15)17(31)32)38(34,35)11-4-5-13(22)12(8-11)20(23,24)25/h3-8,16H,9H2,1-2H3,(H,29,33)(H,31,32)/t16-/m1/s1 XUMWCOYRTHORNC-MRXNPFEDSA-N 352607 (R)-4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-6- ((((1,1,1-trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-3,4-dihydro-2H- benzo[b][1,4]oxazine-2-carboxylic acid::US10745364, Example 34C::US9809561, 34C Nuclear receptor ROR-gamma Human 54.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352607&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187560 386393768 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945648 Cc1nn(cc1S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(O)=O)C(F)F InChI=1S/C19H22F2N4O7S/c1-10-15(9-24(23-10)17(20)21)33(29,30)25-8-14(16(26)27)31-13-6-5-11(7-12(13)25)22-18(28)32-19(2,3)4/h5-7,9,14,17H,8H2,1-4H3,(H,22,28)(H,26,27)/t14-/m1/s1 MTBXLXGSSADAGR-CQSZACIVSA-N 352608 (R)-6-((tert-butoxycarbonyl)amino)-4-((1- (difluoromethyl)-3-methyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazine-2-carboxylic acid::US10745364, Example 34D::US9809561, 34D Nuclear receptor ROR-gamma Human 182 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352608&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187562 386393769 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945649 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(O)=O InChI=1S/C21H20F4N2O7S/c1-20(2,3)34-19(30)26-11-4-7-16-15(8-11)27(10-17(33-16)18(28)29)35(31,32)12-5-6-14(22)13(9-12)21(23,24)25/h4-9,17H,10H2,1-3H3,(H,26,30)(H,28,29)/t17-/m1/s1 GQMYYKDRCFHQRS-QGZVFWFLSA-N 352609 (R)-6-((tert-butoxycarbonyl)amino)-4-((4- fluoro-3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazine-2- carboxylic acid::US10745364, Example 34E::US9809561, 34E Nuclear receptor ROR-gamma Human 58.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352609&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187561 386393770 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945650 Cc1nn(cc1S(=O)(=O)N1C[C@H](CC(=O)N2CCC2)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C23H29F2N5O6S/c1-14-19(13-29(27-14)21(24)25)37(33,34)30-12-16(11-20(31)28-8-5-9-28)35-18-7-6-15(10-17(18)30)26-22(32)36-23(2,3)4/h6-7,10,13,16,21H,5,8-9,11-12H2,1-4H3,(H,26,32)/t16-/m0/s1 OTMABCIUOUPGCO-INIZCTEOSA-N 352610 US10745364, Example 35::US9809561, 35::[(S)-2-(2-azetidin-1-yl-2-oxo-ethyl)-4-(1-difluoromethyl-3-methyl-1H-pyrazole-4-sulfonyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid tert-butyl ester Nuclear receptor ROR-gamma Human 17.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352610&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187438 386393771 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945651 CC(OC(=O)Nc1ccc2O[C@@H](CC(=O)N3CCC3)CN(c2c1)S(=O)(=O)c1cn(nc1C)C(F)F)C(C)(C)C InChI=1S/C25H33F2N5O6S/c1-15-21(14-31(29-15)23(26)27)39(35,36)32-13-18(12-22(33)30-9-6-10-30)38-20-8-7-17(11-19(20)32)28-24(34)37-16(2)25(3,4)5/h7-8,11,14,16,18,23H,6,9-10,12-13H2,1-5H3,(H,28,34)/t16?,18-/m0/s1 PFUWQJSKCOMFDU-DAFXYXGESA-N 352611 US10745364, Example 36::US9809561, 36::[(S)-2-(2-azetidin-1-yl-2-oxo-ethyl)-4-(1-difluoromethyl-3-methyl-1H-pyrazole-4-sulfonyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-carbamic acid 1,2,2-trimethyl-propyl ester Nuclear receptor ROR-gamma Human 10.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352611&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187558 386393772 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945652 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(N)=O)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C21H24FN3O6S/c1-21(2,3)31-20(27)24-14-6-9-18-17(10-14)25(12-15(30-18)11-19(23)26)32(28,29)16-7-4-13(22)5-8-16/h4-10,15H,11-12H2,1-3H3,(H2,23,26)(H,24,27)/t15-/m0/s1 ZEEFELUXABOCKZ-HNNXBMFYSA-N 352612 (S)-tert-butyl (2-(2- amino-2-oxoethyl)-4- ((4-fluorophenyl)sulfonyl)- 3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37A::US9809561, 37A Nuclear receptor ROR-gamma Human 3.89 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352612&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187329 386393773 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945653 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(N)=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H24F3N3O6S/c1-21(2,3)34-20(30)27-14-7-8-18-17(10-14)28(12-15(33-18)11-19(26)29)35(31,32)16-6-4-5-13(9-16)22(23,24)25/h4-10,15H,11-12H2,1-3H3,(H2,26,29)(H,27,30)/t15-/m0/s1 YQHZTSNBZXYWAZ-HNNXBMFYSA-N 352613 (S)-tert-butyl (2-(2- amino-2-oxoethyl)-4- ((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H-benzo [b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37B::US9809561, 37B Nuclear receptor ROR-gamma Human 3.66 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352613&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187321 386393774 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945654 CNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H26FN3O6S/c1-22(2,3)32-21(28)25-15-7-10-19-18(11-15)26(13-16(31-19)12-20(27)24-4)33(29,30)17-8-5-14(23)6-9-17/h5-11,16H,12-13H2,1-4H3,(H,24,27)(H,25,28)/t16-/m0/s1 NKLVWTYVZAPMAZ-INIZCTEOSA-N 352614 (S)-tert-butyl (4-((4- fluorophenyl) sulfonyl)-2-(2- (methylamino)-2-oxoethyl)- 3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37C::US9809561, 37C Nuclear receptor ROR-gamma Human 7.09 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352614&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187330 386393775 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945655 CNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H26F3N3O6S/c1-22(2,3)35-21(31)28-15-8-9-19-18(11-15)29(13-16(34-19)12-20(30)27-4)36(32,33)17-7-5-6-14(10-17)23(24,25)26/h5-11,16H,12-13H2,1-4H3,(H,27,30)(H,28,31)/t16-/m0/s1 MOQVMXJXXXULEZ-INIZCTEOSA-N 352615 (S)-tert-butyl (2-(2- (methylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo [b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37D::US9809561, 37D Nuclear receptor ROR-gamma Human 4.80 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352615&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187331 386393776 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945656 CN(C)C(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O6S/c1-23(2,3)36-22(32)28-16-9-10-20-19(12-16)30(14-17(35-20)13-21(31)29(4)5)37(33,34)18-8-6-7-15(11-18)24(25,26)27/h6-12,17H,13-14H2,1-5H3,(H,28,32)/t17-/m0/s1 MPGTXFANONZLKE-KRWDZBQOSA-N 352616 (S)-tert-butyl (2-(2- (dimethylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo [b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37E::US9809561, 37E Nuclear receptor ROR-gamma Human 6.01 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352616&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187327 386393777 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945657 CN(C)C(=O)CC1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H28FN3O6S/c1-23(2,3)33-22(29)25-16-8-11-20-19(12-16)27(14-17(32-20)13-21(28)26(4)5)34(30,31)18-9-6-15(24)7-10-18/h6-12,17H,13-14H2,1-5H3,(H,25,29) CGNDHUOSKSAYMS-UHFFFAOYSA-N 352617 US10745364, Example 37F::US9809561, 37F::tert-butyl (2-(2- (dimethylamino)-2- oxoethyl)-4-((4- fluorophenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352617&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187332 386393778 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945658 CNC(=O)C[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C22H25ClFN3O6S/c1-22(2,3)33-21(29)26-13-5-8-19-18(9-13)27(12-14(32-19)10-20(28)25-4)34(30,31)15-6-7-17(24)16(23)11-15/h5-9,11,14H,10,12H2,1-4H3,(H,25,28)(H,26,29)/t14-/m1/s1 FTOKLVWMRBWTNV-CQSZACIVSA-N 352618 (R)-tert-butyl (4-((3-chloro-4- fluorophenyl) sulfonyl)-2-(2- (methylamino)-2-oxoethyl)- 3,4-dihydro- 2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 37G::US9809561, 37G Nuclear receptor ROR-gamma Human 19.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352618&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187449 386393779 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945659 CNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C22H25ClFN3O6S/c1-22(2,3)33-21(29)26-13-5-8-19-18(9-13)27(12-14(32-19)10-20(28)25-4)34(30,31)15-6-7-17(24)16(23)11-15/h5-9,11,14H,10,12H2,1-4H3,(H,25,28)(H,26,29)/t14-/m0/s1 FTOKLVWMRBWTNV-AWEZNQCLSA-N 352619 (S)-tert-butyl (4-((3-chloro-4- fluorophenyl) sulfonyl)-2-(2- (methylamino)-2-oxoethyl)- 3,4-dihydro- 2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 37H::US9809561, 37H Nuclear receptor ROR-gamma Human 2.81 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352619&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187450 386393780 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945660 CNC(=O)CC1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C22H22ClF4N3O6S/c1-21(2,22(25,26)27)36-20(32)29-12-4-7-18-17(8-12)30(11-13(35-18)9-19(31)28-3)37(33,34)14-5-6-16(24)15(23)10-14/h4-8,10,13H,9,11H2,1-3H3,(H,28,31)(H,29,32) FXFZTTIPVHPWPM-UHFFFAOYSA-N 352620 1,1,1-trifluoro-2- methylpropan-2-yl (4- ((3-chloro-4-fluorophenyl) sulfonyl)-2-(2- (methylamino)-2- oxoethyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37i::US9809561, 37i Nuclear receptor ROR-gamma Human 4.83 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352620&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187454 386393781 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945661 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CC(=O)N3CCOC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H28F3N3O7S/c1-24(2,3)38-23(33)29-17-7-8-21-20(12-17)31(14-18(37-21)13-22(32)30-9-10-36-15-30)39(34,35)19-6-4-5-16(11-19)25(26,27)28/h4-8,11-12,18H,9-10,13-15H2,1-3H3,(H,29,33)/t18-/m1/s1 QODOUEHQTFLWPL-GOSISDBHSA-N 352621 (R)-tert-butyl (2-(2- (oxazolidin-3-yl)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37J::US9809561, 37J Nuclear receptor ROR-gamma Human 1.96 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352621&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187464 386393782 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945662 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCC3CCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H32F3N3O6S/c1-26(2,3)39-25(35)32-19-10-11-23-22(13-19)33(16-20(38-23)14-24(34)31-15-17-6-4-7-17)40(36,37)21-9-5-8-18(12-21)27(28,29)30/h5,8-13,17,20H,4,6-7,14-16H2,1-3H3,(H,31,34)(H,32,35)/t20-/m0/s1 PSADGVMHYNZQPA-FQEVSTJZSA-N 352622 (S)-tert-butyl (2-(2- ((cyclobutylmethyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H-benzo [b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37K::US9809561, 37K Nuclear receptor ROR-gamma Human 6.88 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352622&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187452 386393783 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945663 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCCC(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H27F6N3O6S/c1-23(2,3)40-22(36)33-16-7-8-20-19(12-16)34(14-17(39-20)13-21(35)32-10-9-24(26,27)28)41(37,38)18-6-4-5-15(11-18)25(29,30)31/h4-8,11-12,17H,9-10,13-14H2,1-3H3,(H,32,35)(H,33,36)/t17-/m0/s1 PPKGLTUTJUASFS-KRWDZBQOSA-N 352623 (S)-tert-butyl (2- (2-oxo-2-((3,3,3- trifluoropropyl)amino) ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6- yl)carbamate::US10745364, Example 37L::US9809561, 37L Nuclear receptor ROR-gamma Human 7.55 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352623&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187448 386393784 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945664 CC(C)CNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H32F3N3O6S/c1-16(2)14-30-23(33)13-19-15-32(39(35,36)20-8-6-7-17(11-20)26(27,28)29)21-12-18(9-10-22(21)37-19)31-24(34)38-25(3,4)5/h6-12,16,19H,13-15H2,1-5H3,(H,30,33)(H,31,34)/t19-/m0/s1 OXZMAQJWMQNZTQ-IBGZPJMESA-N 352624 (S)-tert-butyl (2-(2- (isobutylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37M::US9809561, 37M Nuclear receptor ROR-gamma Human 7.90 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352624&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633129 386393785 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945665 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3cn[nH]c3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352625 (S)-tert-butyl (2-(2- (((1H-pyrazol-4- yl)methyl)amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37N::US9809561, 37N Nuclear receptor ROR-gamma Human 7.06 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352625&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187269 386393786 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945666 Cn1cc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)cn1 InChI=1S/C27H30F3N5O6S/c1-26(2,3)41-25(37)33-19-8-9-23-22(11-19)35(42(38,39)21-7-5-6-18(10-21)27(28,29)30)16-20(40-23)12-24(36)31-13-17-14-32-34(4)15-17/h5-11,14-15,20H,12-13,16H2,1-4H3,(H,31,36)(H,33,37)/t20-/m0/s1 CHQJXZWFAQTUFR-FQEVSTJZSA-N 352626 (S)-tert-butyl (2-(2- (((1-methyl-1H- pyrazol-4-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37o::US9809561, 37o Nuclear receptor ROR-gamma Human 5.74 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352626&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187289 386393787 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945667 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3cc[nH]n3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352627 (S)-tert-butyl (2-(2- (((1H-pyrazol-3- yl)methyl)amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37P::US9809561, 37P Nuclear receptor ROR-gamma Human 7.64 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352627&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187272 386393788 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945668 CC(C)n1cc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)cn1 InChI=1S/C29H34F3N5O6S/c1-18(2)36-16-19(15-34-36)14-33-26(38)13-22-17-37(44(40,41)23-8-6-7-20(11-23)29(30,31)32)24-12-21(9-10-25(24)42-22)35-27(39)43-28(3,4)5/h6-12,15-16,18,22H,13-14,17H2,1-5H3,(H,33,38)(H,35,39)/t22-/m0/s1 SIDXNESUOGHILX-QFIPXVFZSA-N 352628 (S)-tert-butyl (2-(2- (((1-isopropyl-1H- pyrazol-4-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37Q::US9809561, 37Q Nuclear receptor ROR-gamma Human 10.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352628&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187276 386393789 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945669 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3cnn4ccccc34)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C30H30F3N5O6S/c1-29(2,3)44-28(40)36-21-10-11-26-25(14-21)38(45(41,42)23-8-6-7-20(13-23)30(31,32)33)18-22(43-26)15-27(39)34-16-19-17-35-37-12-5-4-9-24(19)37/h4-14,17,22H,15-16,18H2,1-3H3,(H,34,39)(H,36,40)/t22-/m0/s1 ZSJDBAGHIXMNQN-QFIPXVFZSA-N 352629 (S)-tert-butyl (2-(2- oxo-2-((pyrazolo[1,5- a]pyridin-3-ylmethyl) amino)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37R::US9809561, 37R Nuclear receptor ROR-gamma Human 3.79 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352629&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187275 386393790 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945670 CCn1ccc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)n1 InChI=1S/C28H32F3N5O6S/c1-5-35-12-11-20(34-35)16-32-25(37)15-21-17-36(43(39,40)22-8-6-7-18(13-22)28(29,30)31)23-14-19(9-10-24(23)41-21)33-26(38)42-27(2,3)4/h6-14,21H,5,15-17H2,1-4H3,(H,32,37)(H,33,38)/t21-/m0/s1 UEKSFDQUHQBWEQ-NRFANRHFSA-N 352630 (S)-tert-butyl (2- (2-(((1-ethyl-1H- pyrazol-3-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37S::US9809561, 37S Nuclear receptor ROR-gamma Human 4.47 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352630&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187290 386393791 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945671 Cn1ncc2CN(Cc12)C(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H30F3N5O6S/c1-27(2,3)42-26(38)33-19-8-9-24-22(11-19)36(43(39,40)21-7-5-6-18(10-21)28(29,30)31)15-20(41-24)12-25(37)35-14-17-13-32-34(4)23(17)16-35/h5-11,13,20H,12,14-16H2,1-4H3,(H,33,38)/t20-/m0/s1 FMDDQOKGTZCOAA-FQEVSTJZSA-N 352631 (S)-tert-butyl (2-(2- (1-methylpyrrolo[3,4- c]pyrazol-5(1H,4H,6H)- yl)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37T::US9809561, 37T Nuclear receptor ROR-gamma Human 19.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352631&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187253 386393792 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945672 Cn1ccc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)n1 InChI=1S/C27H30F3N5O6S/c1-26(2,3)41-25(37)32-18-8-9-23-22(13-18)35(42(38,39)21-7-5-6-17(12-21)27(28,29)30)16-20(40-23)14-24(36)31-15-19-10-11-34(4)33-19/h5-13,20H,14-16H2,1-4H3,(H,31,36)(H,32,37)/t20-/m0/s1 HXMNXUWPYVRFQE-FQEVSTJZSA-N 352632 (S)-tert-butyl (2-(2- (((1-methyl-1H- pyrazol-3-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37U::US9809561, 37U Nuclear receptor ROR-gamma Human 5.46 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352632&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633124 386393793 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945673 CCn1cc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)cn1 InChI=1S/C28H32F3N5O6S/c1-5-35-16-18(15-33-35)14-32-25(37)13-21-17-36(43(39,40)22-8-6-7-19(11-22)28(29,30)31)23-12-20(9-10-24(23)41-21)34-26(38)42-27(2,3)4/h6-12,15-16,21H,5,13-14,17H2,1-4H3,(H,32,37)(H,34,38)/t21-/m0/s1 GNXKKLZUHJLBAB-NRFANRHFSA-N 352633 (S)-tert-butyl (2- (2-(((1-ethyl-1H- pyrazol-4-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37V::US9809561, 37V Nuclear receptor ROR-gamma Human 6.86 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352633&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633137 386393794 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945674 CCn1ncc(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)c1C InChI=1S/C29H34F3N5O6S/c1-6-36-18(2)19(16-34-36)15-33-26(38)14-22-17-37(44(40,41)23-9-7-8-20(12-23)29(30,31)32)24-13-21(10-11-25(24)42-22)35-27(39)43-28(3,4)5/h7-13,16,22H,6,14-15,17H2,1-5H3,(H,33,38)(H,35,39)/t22-/m0/s1 JOUFEXPZTNEIPI-QFIPXVFZSA-N 352634 (S)-tert-butyl (2-(2- (((1-ethyl-5-methyl- 1H-pyrazol-4-yl) methyl)amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37W::US9809561, 37W Nuclear receptor ROR-gamma Human 9.68 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352634&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633181 386393795 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945675 Cc1c(CNC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)cnn1C InChI=1S/C28H32F3N5O6S/c1-17-18(15-33-35(17)5)14-32-25(37)13-21-16-36(43(39,40)22-8-6-7-19(11-22)28(29,30)31)23-12-20(9-10-24(23)41-21)34-26(38)42-27(2,3)4/h6-12,15,21H,13-14,16H2,1-5H3,(H,32,37)(H,34,38)/t21-/m0/s1 CPMHVCIXMMAKSD-NRFANRHFSA-N 352635 (S)-tert-butyl (2-(2- (((1,5-dimethyl-1H- pyrazol-4-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37X::US9809561, 37X Nuclear receptor ROR-gamma Human 8.03 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352635&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633220 386393796 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945676 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3cnn(Cc4ccccc4)c3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C33H34F3N5O6S/c1-32(2,3)47-31(43)39-25-12-13-29-28(15-25)41(48(44,45)27-11-7-10-24(14-27)33(34,35)36)21-26(46-29)16-30(42)37-17-23-18-38-40(20-23)19-22-8-5-4-6-9-22/h4-15,18,20,26H,16-17,19,21H2,1-3H3,(H,37,42)(H,39,43)/t26-/m0/s1 IUSONESPHWQVAK-SANMLTNESA-N 352636 (S)-tert-butyl (2-(2- (((1-benzyl-1H- pyrazol-4-yl)methyl) amino)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37Y::US9809561, 37Y Nuclear receptor ROR-gamma Human 10.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352636&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633176 386393797 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945677 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCCC(O)=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H28F3N3O8S/c1-24(2,3)39-23(35)30-16-7-8-20-19(12-16)31(14-17(38-20)13-21(32)29-10-9-22(33)34)40(36,37)18-6-4-5-15(11-18)25(26,27)28/h4-8,11-12,17H,9-10,13-14H2,1-3H3,(H,29,32)(H,30,35)(H,33,34)/t17-/m0/s1 HGVUJLMLKDBTQB-KRWDZBQOSA-N 352637 (S)-3-(2-(6-((tert- butoxycarbonyl) amino)-4-((3- (trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-2- yl)acetamido)propanoic acid::US10745364, Example 37Z::US9809561, 37Z Nuclear receptor ROR-gamma Human 6.02 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352637&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122614825 386393798 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945678 COC(=O)CCNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O8S/c1-25(2,3)40-24(35)31-17-8-9-21-20(13-17)32(15-18(39-21)14-22(33)30-11-10-23(34)38-4)41(36,37)19-7-5-6-16(12-19)26(27,28)29/h5-9,12-13,18H,10-11,14-15H2,1-4H3,(H,30,33)(H,31,35)/t18-/m0/s1 KKOICQUJCXUGKK-SFHVURJKSA-N 352638 (S)-methyl 3-(2-(6-((tert- butoxycarbonyl) amino)-4-((3- (trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-2- yl)acetamido) propanoate::US10745364, Example 37AA::US9809561, 37AA Nuclear receptor ROR-gamma Human 2.53 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352638&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122615061 386393799 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945679 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3ccc(cc3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C30H29F6N3O6S/c1-28(2,3)45-27(41)38-21-11-12-25-24(14-21)39(46(42,43)23-6-4-5-20(13-23)30(34,35)36)17-22(44-25)15-26(40)37-16-18-7-9-19(10-8-18)29(31,32)33/h4-14,22H,15-17H2,1-3H3,(H,37,40)(H,38,41)/t22-/m0/s1 VPGRNUMPCILTIV-QFIPXVFZSA-N 352639 (S)-tert-butyl (2-(2-oxo-2-((4- (trifluoromethyl)benzyl) amino)ethyl)-4- ((3-(trifluoromethyl) phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AB::US9809561, 37AB Nuclear receptor ROR-gamma Human 45.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352639&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633182 386393800 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945680 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H30F3N3O6S/c1-28(2,3)41-27(37)34-21-12-13-25-24(15-21)35(42(38,39)23-11-7-10-20(14-23)29(30,31)32)18-22(40-25)16-26(36)33-17-19-8-5-4-6-9-19/h4-15,22H,16-18H2,1-3H3,(H,33,36)(H,34,37)/t22-/m0/s1 FCEAKAOPWWYEJO-QFIPXVFZSA-N 352641 (S)-tert-butyl (2-(2- (benzylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AC::US9809561, 37AC Nuclear receptor ROR-gamma Human 12.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352641&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633180 386393801 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945681 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCC3CC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O6S/c1-25(2,3)38-24(34)31-18-9-10-22-21(12-18)32(15-19(37-22)13-23(33)30-14-16-7-8-16)39(35,36)20-6-4-5-17(11-20)26(27,28)29/h4-6,9-12,16,19H,7-8,13-15H2,1-3H3,(H,30,33)(H,31,34)/t19-/m0/s1 GNVBNBPOEPGWEY-IBGZPJMESA-N 352642 (S)-tert-butyl (2-(2- ((cyclopropylmethyl) amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AD::US9809561, 37AD Nuclear receptor ROR-gamma Human 4.71 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352642&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187462 386393802 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945682 CCCNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O6S/c1-5-11-29-22(32)14-18-15-31(38(34,35)19-8-6-7-16(12-19)25(26,27)28)20-13-17(9-10-21(20)36-18)30-23(33)37-24(2,3)4/h6-10,12-13,18H,5,11,14-15H2,1-4H3,(H,29,32)(H,30,33)/t18-/m0/s1 RZVFLUNWWCCPFS-SFHVURJKSA-N 352643 (S)-tert-butyl (2-(2-oxo-2- (propylamino) ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AE::US9809561, 37AE Nuclear receptor ROR-gamma Human 4.38 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352643&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187451 386393803 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945683 CCNC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O6S/c1-5-28-21(31)13-17-14-30(37(33,34)18-8-6-7-15(11-18)24(25,26)27)19-12-16(9-10-20(19)35-17)29-22(32)36-23(2,3)4/h6-12,17H,5,13-14H2,1-4H3,(H,28,31)(H,29,32)/t17-/m0/s1 MMQXGECCLFZOCX-KRWDZBQOSA-N 352644 (S)-tert-butyl (2-(2-(ethylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AF::US9809561, 37AF Nuclear receptor ROR-gamma Human 4.16 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352644&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187453 386393804 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945684 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)N3CCOC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H28F3N3O7S/c1-24(2,3)38-23(33)29-17-7-8-21-20(12-17)31(14-18(37-21)13-22(32)30-9-10-36-15-30)39(34,35)19-6-4-5-16(11-19)25(26,27)28/h4-8,11-12,18H,9-10,13-15H2,1-3H3,(H,29,33)/t18-/m0/s1 QODOUEHQTFLWPL-SFHVURJKSA-N 352645 (S)-tert-butyl (2-(2- (oxazolidin-3-yl)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AG::US9809561, 37AG Nuclear receptor ROR-gamma Human 2.56 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352645&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 91810297 386393805 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945685 CNC(=O)C[C@H]1CN(c2cc(NC(=O)OCC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O6S/c1-23(2,3)14-35-22(32)29-16-8-9-20-19(11-16)30(13-17(36-20)12-21(31)28-4)37(33,34)18-7-5-6-15(10-18)24(25,26)27/h5-11,17H,12-14H2,1-4H3,(H,28,31)(H,29,32)/t17-/m0/s1 KYTGUTYWMQANRN-KRWDZBQOSA-N 352646 (S)-neopentyl (2-(2- (methylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AH::US9809561, 37AH Nuclear receptor ROR-gamma Human 2.11 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352646&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187466 386393806 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945686 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCc3nn[nH]n3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352647 (S)-tert-butyl (2-(2- (((2H-tetrazol-5- yl)methyl)amino)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37Ai::US9809561, 37Ai Nuclear receptor ROR-gamma Human 13.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352647&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187468 386393807 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945687 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NCCO)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O7S/c1-23(2,3)37-22(33)29-16-7-8-20-19(12-16)30(14-17(36-20)13-21(32)28-9-10-31)38(34,35)18-6-4-5-15(11-18)24(25,26)27/h4-8,11-12,17,31H,9-10,13-14H2,1-3H3,(H,28,32)(H,29,33)/t17-/m0/s1 MFGBKOWCPGDKEP-KRWDZBQOSA-N 352648 (S)-tert-butyl (2-(2-((2- hydroxyethyl)amino)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AJ::US9809561, 37AJ Nuclear receptor ROR-gamma Human 5.73 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352648&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187472 386393808 C04080 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945688 CC(C)(C)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H32F3N3O6S/c1-24(2,3)31-22(33)14-18-15-32(39(35,36)19-9-7-8-16(12-19)26(27,28)29)20-13-17(10-11-21(20)37-18)30-23(34)38-25(4,5)6/h7-13,18H,14-15H2,1-6H3,(H,30,34)(H,31,33)/t18-/m0/s1 JCQIEYJIFYOWBK-SFHVURJKSA-N 352649 (S)-tert-butyl (2-(2- (tert-butylamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AK::US9809561, 37AK Nuclear receptor ROR-gamma Human 12.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352649&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187338 386393809 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945689 CC1CCN1C(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O6S/c1-16-10-11-31(16)23(33)14-19-15-32(39(35,36)20-7-5-6-17(12-20)26(27,28)29)21-13-18(8-9-22(21)37-19)30-24(34)38-25(2,3)4/h5-9,12-13,16,19H,10-11,14-15H2,1-4H3,(H,30,34)/t16?,19-/m0/s1 FVJAUKGEXPZTJY-CVMIBEPCSA-N 352650 US10745364, Example 37AL::US9809561, 37AL::tert-butyl ((2S)-2-(2- (2-methylazetidin-1- yl)-2-oxoethyl)-4-((3- (trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate Nuclear receptor ROR-gamma Human 8.41 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352650&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187344 386393810 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945690 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)N3CC(C3)C#N)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H27F3N4O6S/c1-25(2,3)39-24(35)31-18-7-8-22-21(10-18)33(15-19(38-22)11-23(34)32-13-16(12-30)14-32)40(36,37)20-6-4-5-17(9-20)26(27,28)29/h4-10,16,19H,11,13-15H2,1-3H3,(H,31,35)/t19-/m0/s1 WKCBDFRLFOJBAN-IBGZPJMESA-N 352651 (S)-tert-butyl (2-(2- (3-cyanoazetidin-1- yl)-2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AM::US9809561, 37AM Nuclear receptor ROR-gamma Human 6.15 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352651&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187339 386393811 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945691 COC1CN(C1)C(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O7S/c1-25(2,3)39-24(34)30-17-8-9-22-21(11-17)32(15-18(38-22)12-23(33)31-13-19(14-31)37-4)40(35,36)20-7-5-6-16(10-20)26(27,28)29/h5-11,18-19H,12-15H2,1-4H3,(H,30,34)/t18-/m0/s1 FEGHNBNYKUGWIA-SFHVURJKSA-N 352652 (S)-tert-butyl (2-(2- (3-methoxyazetidin- 1-yl)-2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AN::US9809561, 37AN Nuclear receptor ROR-gamma Human 9.45 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352652&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187341 386393812 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945692 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)N3CCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H28F3N3O6S/c1-24(2,3)37-23(33)29-17-8-9-21-20(13-17)31(15-18(36-21)14-22(32)30-10-5-11-30)38(34,35)19-7-4-6-16(12-19)25(26,27)28/h4,6-9,12-13,18H,5,10-11,14-15H2,1-3H3,(H,29,33)/t18-/m0/s1 QZMCXESQVYRHPM-SFHVURJKSA-N 352653 (S)-tert-butyl (2-(2- (azetidin-1-yl)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37Ao::US9809561, 37Ao Nuclear receptor ROR-gamma Human 5.41 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352653&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187343 386393813 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945693 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)N3CCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H28FN3O6S/c1-24(2,3)34-23(30)26-17-7-10-21-20(13-17)28(35(31,32)19-8-5-16(25)6-9-19)15-18(33-21)14-22(29)27-11-4-12-27/h5-10,13,18H,4,11-12,14-15H2,1-3H3,(H,26,30)/t18-/m0/s1 HVJBFMSVWYUKSN-SFHVURJKSA-N 352654 (S)-tert-butyl (2-(2- (azetidin-1-yl)-2- oxoethyl)-4-((4- fluorophenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AP::US9809561, 37AP Nuclear receptor ROR-gamma Human 9.27 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352654&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187346 386393814 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945694 CC1CN(C1)C(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O6S/c1-16-13-31(14-16)23(33)12-19-15-32(39(35,36)20-7-5-6-17(10-20)26(27,28)29)21-11-18(8-9-22(21)37-19)30-24(34)38-25(2,3)4/h5-11,16,19H,12-15H2,1-4H3,(H,30,34)/t19-/m0/s1 OWUWJJHNIBIKMF-IBGZPJMESA-N 359778 US10221146, Example 37AQ::US10745364, Example 37AQ Nuclear receptor ROR-gamma Human 10.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359778&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633185 386399229 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945695 Cc1nn(cc1S(=O)(=O)N1C[C@H](CC(=O)N2CCC2)Oc2ccc(NC(=O)OCC(C)(C)C)cc12)C(F)F InChI=1S/C24H31F2N5O6S/c1-15-20(13-30(28-15)22(25)26)38(34,35)31-12-17(11-21(32)29-8-5-9-29)37-19-7-6-16(10-18(19)31)27-23(33)36-14-24(2,3)4/h6-7,10,13,17,22H,5,8-9,11-12,14H2,1-4H3,(H,27,33)/t17-/m0/s1 GYWCBCOFLZYAPZ-KRWDZBQOSA-N 352656 (S)-neopentyl (2-(2- (azetidin-1-yl)-2- oxoethyl)-4-((1- (difluoromethyl)-3- methyl-1H-pyrazol- 4-yl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 37AR::US9809561, 37AR Nuclear receptor ROR-gamma Human 17.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352656&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633142 386393816 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945696 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(N)=O InChI=1S/C21H21F4N3O6S/c1-20(2,3)34-19(30)27-11-4-7-16-15(8-11)28(10-17(33-16)18(26)29)35(31,32)12-5-6-14(22)13(9-12)21(23,24)25/h4-9,17H,10H2,1-3H3,(H2,26,29)(H,27,30)/t17-/m1/s1 BVBJASAJTWBIOF-QGZVFWFLSA-N 352657 (R)-tert-butyl (2-carbamoyl-4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 38A::US9809561, 38A Nuclear receptor ROR-gamma Human 4.69 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352657&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187221 386393817 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945697 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(N)=O)C(F)(F)F InChI=1S/C21H18F7N3O6S/c1-19(2,21(26,27)28)37-18(33)30-10-3-6-15-14(7-10)31(9-16(36-15)17(29)32)38(34,35)11-4-5-13(22)12(8-11)20(23,24)25/h3-8,16H,9H2,1-2H3,(H2,29,32)(H,30,33)/t16-/m1/s1 SNUSLWNBJSWFHI-MRXNPFEDSA-N 352658 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (2- carbamoyl-4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 38B::US9809561, 38B Nuclear receptor ROR-gamma Human 6.58 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352658&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187222 386393818 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945698 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(N)=O InChI=1S/C21H24FN3O7S/c1-21(2,3)32-20(27)24-12-5-8-16-15(9-12)25(11-18(31-16)19(23)26)33(28,29)13-6-7-14(22)17(10-13)30-4/h5-10,18H,11H2,1-4H3,(H2,23,26)(H,24,27)/t18-/m1/s1 QOTUHJVZBPMSPE-GOSISDBHSA-N 352659 (R)-tert-butyl (2-carbamoyl-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 38C::US9809561, 38C Nuclear receptor ROR-gamma Human 6.95 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352659&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187228 386393819 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945699 COC(=O)CCNC(=O)[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C24H27ClFN3O8S/c1-24(2,3)37-23(32)28-14-5-8-19-18(11-14)29(38(33,34)15-6-7-17(26)16(25)12-15)13-20(36-19)22(31)27-10-9-21(30)35-4/h5-8,11-12,20H,9-10,13H2,1-4H3,(H,27,31)(H,28,32)/t20-/m1/s1 HZCQHMULXZSRAQ-HXUWFJFHSA-N 352661 (R)-methyl 3-(6-((tert- butoxycarbonyl)amino)-4-((3-chloro-4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazine-2- carboxamido)propanoate::US10745364, Example 38D::US9809561, 38D Nuclear receptor ROR-gamma Human 4.87 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352661&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187217 386393820 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945700 Cc1nn(cc1S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(N)=O)C(F)F InChI=1S/C19H23F2N5O6S/c1-10-15(9-25(24-10)17(20)21)33(29,30)26-8-14(16(22)27)31-13-6-5-11(7-12(13)26)23-18(28)32-19(2,3)4/h5-7,9,14,17H,8H2,1-4H3,(H2,22,27)(H,23,28)/t14-/m1/s1 SRPPDTNCIGFZQX-CQSZACIVSA-N 352662 (R)-tert-butyl (2-carbamoyl-4-((1- (difluoromethyl)-3-methyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 38E::US9809561, 38E Nuclear receptor ROR-gamma Human 50.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352662&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187337 386393821 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945701 CN(C)C(=O)[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cn(nc1C)C(F)F InChI=1S/C21H27F2N5O6S/c1-12-17(11-27(25-12)19(22)23)35(31,32)28-10-16(18(29)26(5)6)33-15-8-7-13(9-14(15)28)24-20(30)34-21(2,3)4/h7-9,11,16,19H,10H2,1-6H3,(H,24,30)/t16-/m1/s1 WNSIUOXCVCRDIM-MRXNPFEDSA-N 352663 (R)-tert-butyl (4-((1-(difluoromethyl)-3- methyl-1H-pyrazol-4-yl)sulfonyl)-2- (dimethylcarbamoyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 38F::US9809561, 38F Nuclear receptor ROR-gamma Human 42.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352663&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187335 386393822 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945702 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)C(=O)NCCC(O)=O InChI=1S/C23H25ClFN3O8S/c1-23(2,3)36-22(32)27-13-4-7-18-17(10-13)28(12-19(35-18)21(31)26-9-8-20(29)30)37(33,34)14-5-6-16(25)15(24)11-14/h4-7,10-11,19H,8-9,12H2,1-3H3,(H,26,31)(H,27,32)(H,29,30)/t19-/m1/s1 XTCMSBCICGGKPW-LJQANCHMSA-N 352664 (R)-3-(6-((tert-butoxycarbonyl)amino)-4- ((3-chloro-4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazine-2- carboxamido)propanoic acid::US10745364, Example 38G::US9809561, 38G Nuclear receptor ROR-gamma Human 12.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352664&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187336 386393823 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945703 CC(C)(C)OC(=O)Nc1ccc2OC(CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(C)(C)C#N InChI=1S/C23H26FN3O5S/c1-22(2,3)32-21(28)26-16-8-11-19-18(12-16)27(13-20(31-19)23(4,5)14-25)33(29,30)17-9-6-15(24)7-10-17/h6-12,20H,13H2,1-5H3,(H,26,28) GXQXRPNAEWOZPY-UHFFFAOYSA-N 352665 US10745364, Example 39::US9809561, 39::tert-butyl (2-(2-cyanopropan-2-yl)-4-((4-fluorophenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 140 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352665&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185285 386393824 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945704 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(C)(C)C(O)=O)C(F)(F)F InChI=1S/C23H24F4N2O7S/c1-21(2,19(30)31)18-12-29(37(33,34)15-8-5-13(24)6-9-15)16-11-14(7-10-17(16)35-18)28-20(32)36-22(3,4)23(25,26)27/h5-11,18H,12H2,1-4H3,(H,28,32)(H,30,31)/t18-/m1/s1 WMGAORNONADGSR-GOSISDBHSA-N 458663 US10745364, Example 40 Nuclear receptor ROR-gamma Human 1136 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458663&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903314 441289930 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945705 Cn1c(n[nH]c1=O)C(C)(C)[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H27F4N5O6S/c1-23(2,20-31-32-21(35)33(20)5)19-13-34(41(37,38)16-9-6-14(26)7-10-16)17-12-15(8-11-18(17)39-19)30-22(36)40-24(3,4)25(27,28)29/h6-12,19H,13H2,1-5H3,(H,30,36)(H,32,35)/t19-/m1/s1 NDHQPAIGUGBBCB-LJQANCHMSA-N 352667 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-(2-(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 41::US9809561, 41 Nuclear receptor ROR-gamma Human 36.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352667&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267871 386393826 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945706 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H23F6N3O8S2/c1-21(2,3)40-20(34)30-14-7-8-18-17(10-14)32(41(35,36)16-6-4-5-13(9-16)22(24,25)26)12-15(39-18)11-19(33)31-42(37,38)23(27,28)29/h4-10,15H,11-12H2,1-3H3,(H,30,34)(H,31,33)/t15-/m0/s1 NJDZGBGNRYHYSN-HNNXBMFYSA-N 352668 (S)-tert-butyl (2-(2-oxo-2-(trifluoromethylsulfonamido)ethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 42::US9809561, 42 Nuclear receptor ROR-gamma Human 19.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352668&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187278 386393827 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945707 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C3CC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O8S2/c1-25(2,3)15-39-24(34)30-17-7-10-22-21(12-17)32(42(37,38)20-6-4-5-16(11-20)26(27,28)29)14-18(40-22)13-23(33)31-41(35,36)19-8-9-19/h4-7,10-12,18-19H,8-9,13-15H2,1-3H3,(H,30,34)(H,31,33)/t18-/m0/s1 OHYPBJDAMVZMOS-SFHVURJKSA-N 352669 (S)-neopentyl (2-(2- (cyclopropanesulfonamido)-2- oxoethyl)-4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin- 6-yl)carbamate::US10745364, Example 43A::US9809561, 43A Nuclear receptor ROR-gamma Human 128 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352669&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187567 386393828 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945708 Cc1nn(cc1S(=O)(=O)N1C[C@H](CC(=O)NS(=O)(=O)C(F)(F)F)Oc2ccc(NC(=O)OCC(C)(C)C)cc12)C(F)F InChI=1S/C22H26F5N5O8S2/c1-12-17(10-31(29-12)19(23)24)41(35,36)32-9-14(8-18(33)30-42(37,38)22(25,26)27)40-16-6-5-13(7-15(16)32)28-20(34)39-11-21(2,3)4/h5-7,10,14,19H,8-9,11H2,1-4H3,(H,28,34)(H,30,33)/t14-/m0/s1 XZXDTFPWBHJCLS-AWEZNQCLSA-N 352670 (S)-neopentyl (4-((1- (difluoromethyl)-3-methyl- 1H-pyrazol-4-yl)sulfonyl)-2-(2- oxo-2-(trifluoromethyl- sulfonamido)ethyl)- 3,4-dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 43B::US9809561, 43B Nuclear receptor ROR-gamma Human 58.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352670&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187573 386393829 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945709 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3nccs3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H25F3N4O8S3/c1-24(2,3)40-22(34)30-16-7-8-20-19(12-16)32(43(37,38)18-6-4-5-15(11-18)25(26,27)28)14-17(39-20)13-21(33)31-42(35,36)23-29-9-10-41-23/h4-12,17H,13-14H2,1-3H3,(H,30,34)(H,31,33)/t17-/m0/s1 XDTCHDKZGUDQIN-KRWDZBQOSA-N 352671 (5)-tert-butyl (2-(2-oxo-2- (thiazole-2-sulfonamido) ethyl)-4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 43C::US9809561, 43C Nuclear receptor ROR-gamma Human 41.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352671&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187581 386393830 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945710 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccncc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H27F3N4O8S2/c1-26(2,3)42-25(36)32-18-7-8-23-22(14-18)34(44(39,40)21-6-4-5-17(13-21)27(28,29)30)16-19(41-23)15-24(35)33-43(37,38)20-9-11-31-12-10-20/h4-14,19H,15-16H2,1-3H3,(H,32,36)(H,33,35)/t19-/m0/s1 AUYIQPKOFXWMQF-IBGZPJMESA-N 352672 (S)-tert-butyl (2-(2-oxo-2- (pyridine-4-sulfonamido)ethyl)- 4-((3-(trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl)carbamate::US10745364, Example 43D::US9809561, 43D Nuclear receptor ROR-gamma Human 35.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352672&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187577 386393831 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945711 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C(C)(C)C)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H32F3N3O8S2/c1-24(2,3)40-23(34)30-17-10-11-21-20(13-17)32(41(35,36)19-9-7-8-16(12-19)26(27,28)29)15-18(39-21)14-22(33)31-42(37,38)25(4,5)6/h7-13,18H,14-15H2,1-6H3,(H,30,34)(H,31,33)/t18-/m0/s1 BLSFCNIMGQMGNI-SFHVURJKSA-N 352673 (S)-tert-buty (2-(2-(1,1- dimethylethylsulfonamido)-2- oxoethyl)-4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin- 6-yl)carbamate::US10745364, Example 43E::US9809561, 43E Nuclear receptor ROR-gamma Human 73.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352673&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187569 386393832 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945712 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccc(cn3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H26F6N4O8S2/c1-26(2,3)46-25(40)36-18-8-9-22-21(12-18)38(48(43,44)20-6-4-5-16(11-20)27(29,30)31)15-19(45-22)13-23(39)37-47(41,42)24-10-7-17(14-35-24)28(32,33)34/h4-12,14,19H,13,15H2,1-3H3,(H,36,40)(H,37,39)/t19-/m0/s1 FYSWSNBAXSTLJN-IBGZPJMESA-N 352674 (S)-tert-butyl (2-(2-oxo-2-(5- (trifluoromethyl)pyridine-2- sulfonamido)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl)carbamate::US10745364, Example 43F::US9809561, 43F Nuclear receptor ROR-gamma Human 50.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352674&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187574 386393833 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945713 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C(F)(F)F)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H25F4N3O8S2/c1-22(2,3)13-37-21(32)28-15-6-9-19-18(10-15)30(39(33,34)17-7-4-14(24)5-8-17)12-16(38-19)11-20(31)29-40(35,36)23(25,26)27/h4-10,16H,11-13H2,1-3H3,(H,28,32)(H,29,31)/t16-/m0/s1 TYKNOHDAOZYIKA-INIZCTEOSA-N 352675 (S)-neopentyl (4-((4- fluorophenyl)sulfonyl)-2- (2-oxo-2-(trifluoromethyl- sulfonamido)ethyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 43G::US9809561, 43G Nuclear receptor ROR-gamma Human 46.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352675&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187366 386393834 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945714 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H27F3N4O8S2/c1-26(2,3)42-25(36)32-18-10-11-22-21(14-18)34(44(39,40)20-8-6-7-17(13-20)27(28,29)30)16-19(41-22)15-23(35)33-43(37,38)24-9-4-5-12-31-24/h4-14,19H,15-16H2,1-3H3,(H,32,36)(H,33,35)/t19-/m0/s1 OFMUWQKNCVHVOF-IBGZPJMESA-N 352676 (S)-tert-butyl (2-(2-oxo-2- (pyridine-2-sulfonamido) ethyl)-4-((3-(trifluoromethyl (phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 43H::US9809561, 43H Nuclear receptor ROR-gamma Human 24.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352676&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187365 386393835 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945715 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3cccnc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H27F3N4O8S2/c1-26(2,3)42-25(36)32-18-9-10-23-22(13-18)34(44(39,40)20-7-4-6-17(12-20)27(28,29)30)16-19(41-23)14-24(35)33-43(37,38)21-8-5-11-31-15-21/h4-13,15,19H,14,16H2,1-3H3,(H,32,36)(H,33,35)/t19-/m0/s1 PZBAIOVLJOIBHQ-IBGZPJMESA-N 352677 (S)-tert-butyl (2-(2-oxo-2- (pyridine-3-sulfonamido) ethyl)-4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 43i::US9809561, 43i Nuclear receptor ROR-gamma Human 27.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352677&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187367 386393836 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945716 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3cc(ccn3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H26F6N4O8S2/c1-26(2,3)46-25(40)36-18-7-8-22-21(13-18)38(48(43,44)20-6-4-5-16(11-20)27(29,30)31)15-19(45-22)14-23(39)37-47(41,42)24-12-17(9-10-35-24)28(32,33)34/h4-13,19H,14-15H2,1-3H3,(H,36,40)(H,37,39)/t19-/m0/s1 IFDHCZDDAVBQQL-IBGZPJMESA-N 352678 (S)-tert-butyl (2-(2-oxo-2-(4- (trifluoromethyl)pyridine-2- sulfonamido)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43J::US9809561, 43J Nuclear receptor ROR-gamma Human 97.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352678&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633088 386393837 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945717 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3cn[nH]c3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352679 (S)-tert-butyl (2-(2-oxo-2- (1H-pyrazole-4- sulfonamido)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43K::US9809561, 43K Nuclear receptor ROR-gamma Human 41.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352679&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187370 386393838 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945718 Cc1ccnc(c1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H29F3N4O8S2/c1-17-10-11-32-25(12-17)44(38,39)34-24(36)15-20-16-35(45(40,41)21-7-5-6-18(13-21)28(29,30)31)22-14-19(8-9-23(22)42-20)33-26(37)43-27(2,3)4/h5-14,20H,15-16H2,1-4H3,(H,33,37)(H,34,36)/t20-/m0/s1 RKSUOXRYMMHQKH-FQEVSTJZSA-N 352680 (S)-tert-butyl (2-(2-(4- methylpyridine-2- sulfonamido)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 43L::US9809561, 43L Nuclear receptor ROR-gamma Human 91.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352680&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187368 386393839 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945719 Cc1ccc(F)c(c1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H29F4N3O8S2/c1-17-8-10-22(30)25(12-17)45(39,40)35-26(37)15-20-16-36(46(41,42)21-7-5-6-18(13-21)29(31,32)33)23-14-19(9-11-24(23)43-20)34-27(38)44-28(2,3)4/h5-14,20H,15-16H2,1-4H3,(H,34,38)(H,35,37)/t20-/m0/s1 VESQJPYUOQGRFG-FQEVSTJZSA-N 352682 (S)-tert-butyl (2-(2-(2- fluoro-5-methylphenyl- sulfonamido)-2-oxoethyl)-4- ((3-(trifluoromethyl(phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43M::US9809561, 43M Nuclear receptor ROR-gamma Human 55.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352682&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187371 386393840 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945720 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccccc3F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H27F4N3O8S2/c1-27(2,3)43-26(37)33-18-11-12-23-22(14-18)35(45(40,41)20-8-6-7-17(13-20)28(30,31)32)16-19(42-23)15-25(36)34-44(38,39)24-10-5-4-9-21(24)29/h4-14,19H,15-16H2,1-3H3,(H,33,37)(H,34,36)/t19-/m0/s1 GTSYXAXNZXZSJI-IBGZPJMESA-N 352683 (S)-tert-butyl (2-(2-(2- fluorophenylsulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43N::US9809561, 43N Nuclear receptor ROR-gamma Human 63.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352683&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633187 386393841 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945721 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccccc3C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H27F6N3O8S2/c1-27(2,3)46-26(40)36-18-11-12-23-22(14-18)38(48(43,44)20-8-6-7-17(13-20)28(30,31)32)16-19(45-23)15-25(39)37-47(41,42)24-10-5-4-9-21(24)29(33,34)35/h4-14,19H,15-16H2,1-3H3,(H,36,40)(H,37,39)/t19-/m0/s1 FFWXUNFRJSEHBT-IBGZPJMESA-N 352684 (S)-tert-butyl (2-(2-oxo-2-(2- (trifluoromethyl)phenyl- sulfonamido)ethyl)- 4-((3-(trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl)carbamate::US10745364, Example 43o::US9809561, 43o Nuclear receptor ROR-gamma Human 110 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352684&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187053 386393842 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945722 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3cccc(c3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H27F6N3O8S2/c1-27(2,3)46-26(40)36-19-10-11-24-23(14-19)38(48(43,44)22-9-5-7-18(13-22)29(33,34)35)16-20(45-24)15-25(39)37-47(41,42)21-8-4-6-17(12-21)28(30,31)32/h4-14,20H,15-16H2,1-3H3,(H,36,40)(H,37,39)/t20-/m0/s1 XTALLDAJPBJPFJ-FQEVSTJZSA-N 352685 (S)-tert-butyl (2-(2-oxo-2-(3- (trifluoromethyl)phenyl- sulfonamido)ethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43P::US9809561, 43P Nuclear receptor ROR-gamma Human 62.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352685&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187058 386393843 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945723 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3cccc(F)c3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H27F4N3O8S2/c1-27(2,3)43-26(37)33-19-10-11-24-23(14-19)35(45(40,41)22-9-4-6-17(12-22)28(30,31)32)16-20(42-24)15-25(36)34-44(38,39)21-8-5-7-18(29)13-21/h4-14,20H,15-16H2,1-3H3,(H,33,37)(H,34,36)/t20-/m0/s1 ZMOYCLWESPPCKF-FQEVSTJZSA-N 352686 (S)-tert-butyl (2-(2- (3-fluorophenyl- sulfonamido)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 43Q::US9809561, 43Q Nuclear receptor ROR-gamma Human 36.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352686&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187054 386393844 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945724 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C3CC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H28F3N3O8S2/c1-24(2,3)39-23(33)29-16-7-10-21-20(12-16)31(41(36,37)19-6-4-5-15(11-19)25(26,27)28)14-17(38-21)13-22(32)30-40(34,35)18-8-9-18/h4-7,10-12,17-18H,8-9,13-14H2,1-3H3,(H,29,33)(H,30,32)/t17-/m0/s1 PNGHHCKNPKBBOI-KRWDZBQOSA-N 352687 (S)-tert-butyl (2-(2- (cyclopropane- sulfonamido)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43R::US9809561, 43R Nuclear receptor ROR-gamma Human 36.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352687&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187049 386393845 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945725 Cc1ccc(cc1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H30F3N3O8S2/c1-18-8-11-22(12-9-18)44(38,39)34-26(36)16-21-17-35(45(40,41)23-7-5-6-19(14-23)29(30,31)32)24-15-20(10-13-25(24)42-21)33-27(37)43-28(2,3)4/h5-15,21H,16-17H2,1-4H3,(H,33,37)(H,34,36)/t21-/m0/s1 VDUPTICSSVRDMT-NRFANRHFSA-N 352688 (S)-tert-butyl (2-(2-(4- methylphenyl- sulfonamido)-2- oxoethyl)-4-((3-(trifluoro- methyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin- 6-yl)carbamate::US10745364, Example 43S::US9809561, 43S Nuclear receptor ROR-gamma Human 31.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352688&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187056 386393846 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945726 CC(C)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O8S2/c1-15(2)40(34,35)30-22(32)13-18-14-31(41(36,37)19-8-6-7-16(11-19)25(26,27)28)20-12-17(9-10-21(20)38-18)29-23(33)39-24(3,4)5/h6-12,15,18H,13-14H2,1-5H3,(H,29,33)(H,30,32)/t18-/m0/s1 ICUFAVLQWMMUCN-SFHVURJKSA-N 352689 (S)-tert-butyl (2-(2-(1- methylethylsulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 43T::US9809561, 43T Nuclear receptor ROR-gamma Human 60.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352689&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187059 386393847 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945727 CCS(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O8S2/c1-5-39(33,34)29-21(31)13-17-14-30(40(35,36)18-8-6-7-15(11-18)24(25,26)27)19-12-16(9-10-20(19)37-17)28-22(32)38-23(2,3)4/h6-12,17H,5,13-14H2,1-4H3,(H,28,32)(H,29,31)/t17-/m0/s1 JAFMHHGZLWDJDB-KRWDZBQOSA-N 352690 (S)-tert-butyl (2-(2- (ethylsulfonamido)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43U::US9809561, 43U Nuclear receptor ROR-gamma Human 47.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352690&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187062 386393848 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945728 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(C)(=O)=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H26F3N3O8S2/c1-22(2,3)37-21(31)27-15-8-9-19-18(11-15)29(13-16(36-19)12-20(30)28-38(4,32)33)39(34,35)17-7-5-6-14(10-17)23(24,25)26/h5-11,16H,12-13H2,1-4H3,(H,27,31)(H,28,30)/t16-/m0/s1 RVGLLDLUXTUTNC-INIZCTEOSA-N 352691 (S)-tert-butyl (2-(2- (methylsulfonamido)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43V::US9809561, 43V Nuclear receptor ROR-gamma Human 33.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352691&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187061 386393849 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945729 Cc1nn(cc1S(=O)(=O)N1C[C@H](CC(=O)NS(=O)(=O)C2CC2)Oc2ccc(NC(=O)OCC(C)(C)C)cc12)C(F)F InChI=1S/C24H31F2N5O8S2/c1-14-20(12-30(28-14)22(25)26)41(36,37)31-11-16(10-21(32)29-40(34,35)17-6-7-17)39-19-8-5-15(9-18(19)31)27-23(33)38-13-24(2,3)4/h5,8-9,12,16-17,22H,6-7,10-11,13H2,1-4H3,(H,27,33)(H,29,32)/t16-/m0/s1 IIBQMHFLWBTXJX-INIZCTEOSA-N 352692 (S-neopentyl (2-(2- (cyclopropane- sulfonamido)-2- oxoethyl)-4-((1- (difluoromethyl)-3- methyl-1H-pyrazol-4- yl)sulfonyl)-3,4- dihydro-2H-benzo [b][1,4]oxazin-6-yl) carbamate::US10745364, Example 43W::US9809561, 43W Nuclear receptor ROR-gamma Human 534 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352692&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187465 386393850 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945730 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C3CCCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H32F3N3O8S2/c1-26(2,3)41-25(35)31-18-11-12-23-22(14-18)33(43(38,39)21-10-6-7-17(13-21)27(28,29)30)16-19(40-23)15-24(34)32-42(36,37)20-8-4-5-9-20/h6-7,10-14,19-20H,4-5,8-9,15-16H2,1-3H3,(H,31,35)(H,32,34)/t19-/m0/s1 RXVOJHJBORTLTC-IBGZPJMESA-N 352693 (S)-tert-butyl (2-(2- (cyclopentane- sulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43X::US9809561, 43X Nuclear receptor ROR-gamma Human 213 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352693&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187470 386393851 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945731 Cc1ccccc1S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H30F3N3O8S2/c1-18-8-5-6-11-25(18)44(38,39)34-26(36)16-21-17-35(45(40,41)22-10-7-9-19(14-22)29(30,31)32)23-15-20(12-13-24(23)42-21)33-27(37)43-28(2,3)4/h5-15,21H,16-17H2,1-4H3,(H,33,37)(H,34,36)/t21-/m0/s1 VLTGCCZSAHWZGS-NRFANRHFSA-N 352694 (S)-tert-butyl (2-(2-(2- methylphenyl- sulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 43Y::US9809561, 43Y Nuclear receptor ROR-gamma Human 73.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352694&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187478 386393852 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945732 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)c3ccc(F)cc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H27F4N3O8S2/c1-27(2,3)43-26(37)33-19-9-12-24-23(14-19)35(45(40,41)22-6-4-5-17(13-22)28(30,31)32)16-20(42-24)15-25(36)34-44(38,39)21-10-7-18(29)8-11-21/h4-14,20H,15-16H2,1-3H3,(H,33,37)(H,34,36)/t20-/m0/s1 YXZKFMZOJBATCC-FQEVSTJZSA-N 352695 (S)-tert-butyl (2-(2-(4- fluorophenyl- sulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6- yl)carbamate::US10745364, Example 43Z::US9809561, 43Z Nuclear receptor ROR-gamma Human 57.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352695&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187469 386393853 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945733 Cc1ccc(C)c(c1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C30H32F3N3O8S2/c1-18-9-10-19(2)26(13-18)45(39,40)35-27(37)16-22-17-36(46(41,42)23-8-6-7-20(14-23)30(31,32)33)24-15-21(11-12-25(24)43-22)34-28(38)44-29(3,4)5/h6-15,22H,16-17H2,1-5H3,(H,34,38)(H,35,37)/t22-/m0/s1 UGUYMKPHWNRSIM-QFIPXVFZSA-N 352696 (S)-tert-butyl (2-(2-(2,5- dimethylphenyl- sulfonamido)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43AA::US9809561, 43AA Nuclear receptor ROR-gamma Human 99.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352696&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187471 386393854 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945734 CCCc1ccc(cc1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C31H34F3N3O8S2/c1-5-7-20-10-13-24(14-11-20)46(40,41)36-28(38)18-23-19-37(47(42,43)25-9-6-8-21(16-25)31(32,33)34)26-17-22(12-15-27(26)44-23)35-29(39)45-30(2,3)4/h6,8-17,23H,5,7,18-19H2,1-4H3,(H,35,39)(H,36,38)/t23-/m0/s1 GYCYTPQGTNMLKA-QHCPKHFHSA-N 352697 (S)-tert-butyl (2-(2-oxo- 2-(4-propylphenyl- sulfonamido)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43AB::US9809561, 43AB Nuclear receptor ROR-gamma Human 85.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352697&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633146 386393855 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945735 Cc1cccc(n1)S(=O)(=O)NC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H29F3N4O8S2/c1-17-7-5-10-25(32-17)44(38,39)34-24(36)15-20-16-35(45(40,41)21-9-6-8-18(13-21)28(29,30)31)22-14-19(11-12-23(22)42-20)33-26(37)43-27(2,3)4/h5-14,20H,15-16H2,1-4H3,(H,33,37)(H,34,36)/t20-/m0/s1 JEEOIHQPJQDZKM-FQEVSTJZSA-N 352698 (S)-tert-butyl (2-(2-(6- methylpyridine-2- sulfonamido)-2-oxoethyl)- 4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo [b][1,4]oxazin-6- yl)carbamate::US10745364, Example 43AC::US9809561, 43AC Nuclear receptor ROR-gamma Human 72.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352698&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187473 386393856 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945736 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CC(=O)NS(=O)(=O)C3CC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H30FN3O8S2/c1-25(2,3)15-36-24(31)27-17-6-11-22-21(12-17)29(39(34,35)20-7-4-16(26)5-8-20)14-18(37-22)13-23(30)28-38(32,33)19-9-10-19/h4-8,11-12,18-19H,9-10,13-15H2,1-3H3,(H,27,31)(H,28,30)/t18-/m0/s1 AORINYVWZKFSRX-SFHVURJKSA-N 352699 (S)-neopentyl (2-(2- (cyclopropane- sulfonamido)- 2-oxoethyl)-4-((4- fluorophenyl)sulfonyl)- 3,4-dihydro-2H-benzo [b][1,4]oxazin-6-yl) carbamate::US10745364, Example 43AD::US9809561, 43AD Nuclear receptor ROR-gamma Human 297 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352699&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187474 386393857 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945737 CONC(=O)C[C@H]1CN(c2cc(NC(O)=O)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C19H18F3N3O7S/c1-31-24-17(26)9-13-10-25(15-8-12(23-18(27)28)5-6-16(15)32-13)33(29,30)14-4-2-3-11(7-14)19(20,21)22/h2-8,13,23H,9-10H2,1H3,(H,24,26)(H,27,28)/t13-/m0/s1 JVNCOYKALIFDAS-ZDUSSCGKSA-N 352700 (S)-(2-(2-(methoxyamino)-2-oxoethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamic Acid::US10745364, Example 44::US9809561, 44 Nuclear receptor ROR-gamma Human 4.07 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352700&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122614982 386393858 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945738 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOc3ccccc3C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H27F6N3O7S/c1-27(2,3)44-26(40)36-18-11-12-24-22(14-18)38(46(41,42)20-8-6-7-17(13-20)28(30,31)32)16-19(43-24)15-25(39)37-45-23-10-5-4-9-21(23)29(33,34)35/h4-14,19H,15-16H2,1-3H3,(H,36,40)(H,37,39)/t19-/m0/s1 SUQDNRQAEUMKJT-IBGZPJMESA-N 352701 (S)-tert-butyl (2-(2-oxo-2- ((2-(trifluoromethyl)phenoxy) amino)ethyl)(trifluoromethyl) phenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl) carbamate::US10745364, Example 45A::US9809561, 45A Nuclear receptor ROR-gamma Human 127 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352701&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633188 386393859 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945739 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOCc3cccnc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H29F3N4O7S/c1-27(2,3)42-26(37)33-20-9-10-24-23(13-20)35(43(38,39)22-8-4-7-19(12-22)28(29,30)31)16-21(41-24)14-25(36)34-40-17-18-6-5-11-32-15-18/h4-13,15,21H,14,16-17H2,1-3H3,(H,33,37)(H,34,36)/t21-/m0/s1 HJRVHTNUVVYBPG-NRFANRHFSA-N 352702 (S)-tert-butyl (2-(2-oxo-2- ((pyridin-3-ylmethoxy)amino) ethyl)-4-((3-(trifluoromethyl) phenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 45B::US9809561, 45B Nuclear receptor ROR-gamma Human 12.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352702&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187104 386393860 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945740 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOCc3ccc(cc3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C30H29F6N3O7S/c1-28(2,3)46-27(41)37-21-11-12-25-24(14-21)39(47(42,43)23-6-4-5-20(13-23)30(34,35)36)16-22(45-25)15-26(40)38-44-17-18-7-9-19(10-8-18)29(31,32)33/h4-14,22H,15-17H2,1-3H3,(H,37,41)(H,38,40)/t22-/m0/s1 JZRKHTXUIFMGAR-QFIPXVFZSA-N 352703 (S)-tert-butyl (2-(2-oxo-2- (((4-(trifluoromethyl)benzyl) oxy)amino)ethyl)-4- ((3-(trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6- yl)carbamate::US10745364, Example 45C::US9809561, 45C Nuclear receptor ROR-gamma Human 43.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352703&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187101 386393861 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945741 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOCc3cccc(c3)C(F)(F)F)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C30H29F6N3O7S/c1-28(2,3)46-27(41)37-21-10-11-25-24(14-21)39(47(42,43)23-9-5-8-20(13-23)30(34,35)36)16-22(45-25)15-26(40)38-44-17-18-6-4-7-19(12-18)29(31,32)33/h4-14,22H,15-17H2,1-3H3,(H,37,41)(H,38,40)/t22-/m0/s1 ZGDFGOFPIZZTPO-QFIPXVFZSA-N 352704 (S)-tert-butyl (2-(2-oxo-2- (((3-(trifluoromethyl)benzyl) oxy)amino)ethyl)-4- ((3-(trifluoromethyl) phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 45D::US9809561, 45D Nuclear receptor ROR-gamma Human 63.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352704&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187109 386393862 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945742 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOc3ccc(F)cc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H27F4N3O7S/c1-27(2,3)41-26(37)33-19-9-12-24-23(14-19)35(43(38,39)22-6-4-5-17(13-22)28(30,31)32)16-21(40-24)15-25(36)34-42-20-10-7-18(29)8-11-20/h4-14,21H,15-16H2,1-3H3,(H,33,37)(H,34,36)/t21-/m0/s1 FVJIMNMSAVDMII-NRFANRHFSA-N 352705 (S)-tert-butyl (2-(2-((4- fluorophenoxy)amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 45E::US9809561, 45E Nuclear receptor ROR-gamma Human 25.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352705&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187102 386393863 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945743 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOC3CCCC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C27H32F3N3O7S/c1-26(2,3)39-25(35)31-18-11-12-23-22(14-18)33(41(36,37)21-10-6-7-17(13-21)27(28,29)30)16-20(38-23)15-24(34)32-40-19-8-4-5-9-19/h6-7,10-14,19-20H,4-5,8-9,15-16H2,1-3H3,(H,31,35)(H,32,34)/t20-/m0/s1 BJNVSRZXVZDAJB-FQEVSTJZSA-N 352706 (S)-tert-butyl (2-(2- ((cyclopentyloxy)amino)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 45F::US9809561, 45F Nuclear receptor ROR-gamma Human 11.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352706&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187125 386393864 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945744 CCONC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O7S/c1-5-35-29-21(31)13-17-14-30(38(33,34)18-8-6-7-15(11-18)24(25,26)27)19-12-16(9-10-20(19)36-17)28-22(32)37-23(2,3)4/h6-12,17H,5,13-14H2,1-4H3,(H,28,32)(H,29,31)/t17-/m0/s1 FTLIVYSLNQXJDB-KRWDZBQOSA-N 352707 (S)-tert-butyl (2-(2- (ethoxyamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 45G::US9809561, 45G Nuclear receptor ROR-gamma Human 5.59 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352707&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187105 386393865 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945745 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CC(=O)NOCc3ccccc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C29H30F3N3O7S/c1-28(2,3)42-27(37)33-21-12-13-25-24(15-21)35(43(38,39)23-11-7-10-20(14-23)29(30,31)32)17-22(41-25)16-26(36)34-40-18-19-8-5-4-6-9-19/h4-15,22H,16-18H2,1-3H3,(H,33,37)(H,34,36)/t22-/m0/s1 PFRUBFQKTGSTNQ-QFIPXVFZSA-N 352709 (S)-tert-butyl (2-(2- ((benzyloxy)amino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 45H::US9809561, 45H Nuclear receptor ROR-gamma Human 14.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352709&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187127 386393866 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945746 Cc1ccc(CONC(=O)C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)cc1 InChI=1S/C30H32F3N3O7S/c1-19-8-10-20(11-9-19)18-41-35-27(37)16-23-17-36(44(39,40)24-7-5-6-21(14-24)30(31,32)33)25-15-22(12-13-26(25)42-23)34-28(38)43-29(2,3)4/h5-15,23H,16-18H2,1-4H3,(H,34,38)(H,35,37)/t23-/m0/s1 QRKVNVVNAJNVSG-QHCPKHFHSA-N 352710 (S)-tert-butyl (2-(2-(((4- methylbenzyl)oxy)amino)- 2-oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 45i::US9809561, 45i Nuclear receptor ROR-gamma Human 17.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352710&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187110 386393867 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945747 CC(C)ONC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O7S/c1-15(2)38-30-22(32)13-18-14-31(39(34,35)19-8-6-7-16(11-19)25(26,27)28)20-12-17(9-10-21(20)36-18)29-23(33)37-24(3,4)5/h6-12,15,18H,13-14H2,1-5H3,(H,29,33)(H,30,32)/t18-/m0/s1 UOOYBGXBIRJLBP-SFHVURJKSA-N 352711 (S)-tert-butyl (2-(2- (isopropoxyamino)-2- oxoethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b] [1,4]oxazin-6-yl)carbamate::US10745364, Example 45J::US9809561, 45J Nuclear receptor ROR-gamma Human 6.85 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352711&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633091 386393868 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945748 CCCONC(=O)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O7S/c1-5-11-36-30-22(32)14-18-15-31(39(34,35)19-8-6-7-16(12-19)25(26,27)28)20-13-17(9-10-21(20)37-18)29-23(33)38-24(2,3)4/h6-10,12-13,18H,5,11,14-15H2,1-4H3,(H,29,33)(H,30,32)/t18-/m0/s1 KCYOZXAHJSCDKK-SFHVURJKSA-N 352712 (S)-tert-butyl (2-(2-oxo-2- (propoxyamino)ethyl)-4-((3- (trifluoromethyl)phenyl) sulfonyl)-3,4- dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 45K::US9809561, 45K Nuclear receptor ROR-gamma Human 6.30 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352712&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185356 386393869 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945749 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)c1n[nH]c(=O)o1 InChI=1S/C21H21FN4O7S/c1-21(2,3)33-19(27)23-13-6-9-16-15(10-13)26(11-17(31-16)18-24-25-20(28)32-18)34(29,30)14-7-4-12(22)5-8-14/h4-10,17H,11H2,1-3H3,(H,23,27)(H,25,28)/t17-/m1/s1 KOWSAMRBUAMUEF-QGZVFWFLSA-N 352713 (R)-tert-butyl (4-((4-fluorophenyl)sulfonyl)-2-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 46::US9809561, 46 Nuclear receptor ROR-gamma Human 12.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352713&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187458 386393870 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945750 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)c1n[nH]c(=O)o1)C(F)(F)F 352714 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (4- ((4-fluorophenyl)sulfonyl)-2-(5-oxo-4,5- dihydro-1,3,4-oxadiazol-2-yl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 47A::US9809561, 47A Nuclear receptor ROR-gamma Human 12.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352714&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187243 386393871 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945751 Cc1nn(cc1S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C)cc12)c1n[nH]c(=O)o1)C(F)F 352715 (R)-tert-butyl (4-((1-(difluoromethyl)-3- methyl-1H-pyrazol-4-yl)sulfonyl)-2-(5- oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 47B::US9809561, 47B Nuclear receptor ROR-gamma Human 8.83 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352715&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187491 386393872 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945752 Cc1nn(cc1S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)c1n[nH]c(=O)o1)C(F)F 352717 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (4- ((1-(difluoromethyl)-3-methyl-1H-pyrazol- 4-yl)sulfonyl)-2-(5-oxo-4,5-dihydro-1,3,4- oxadiazol-2-yl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 47C::US9809561, 47C Nuclear receptor ROR-gamma Human 5.71 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352717&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187486 386393873 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945753 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(Cl)c1)c1n[nH]c(=O)o1 352718 (R)-tert-butyl (4-((3-chloro-4- fluorophenyl)sulfonyl)-2-(5-oxo-4,5- dihydro-1,3,4-oxadiazol-2-yl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 47D::US9809561, 47D Nuclear receptor ROR-gamma Human 5.98 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352718&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187488 386393874 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945754 CC(C)(C)OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)c1n[nH]c(=O)o1 352720 (R)-tert-butyl (4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-2-(5- oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 47E::US9809561, 47E Nuclear receptor ROR-gamma Human 5.95 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352720&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187499 386393875 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945755 Cn1nc(C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2ccc(F)cc2)oc1=O InChI=1S/C23H25FN4O7S/c1-23(2,3)35-21(29)25-15-7-10-19-18(11-15)28(36(31,32)17-8-5-14(24)6-9-17)13-16(33-19)12-20-26-27(4)22(30)34-20/h5-11,16H,12-13H2,1-4H3,(H,25,29)/t16-/m0/s1 FOFMWSZYNQFIAD-INIZCTEOSA-N 352721 (S)-tert-butyl (4-((4- fluorophenyl)sulfonyl)-2-((4-methyl-5- oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl) methyl)-3,4-dihydro-2H-benzo[b][1,4] oxazin-6-yl)carbamate::US10745364, Example 47F::US9809561, 47F Nuclear receptor ROR-gamma Human 27.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352721&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187492 386393876 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945756 Cc1nn(cc1S(=O)(=O)N1C[C@H](Cc2nn(C)c(=O)o2)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C22H26F2N6O7S/c1-12-17(11-29(26-12)19(23)24)38(33,34)30-10-14(9-18-27-28(5)21(32)36-18)35-16-7-6-13(8-15(16)30)25-20(31)37-22(2,3)4/h6-8,11,14,19H,9-10H2,1-5H3,(H,25,31)/t14-/m0/s1 MIBDMNIKCLLVCD-AWEZNQCLSA-N 352722 (S)-tert-butyl (4-((1-(difluoromethyl)-3- methyl-1H-pyrazol-4-yl)sulfonyl)-2-((4- methyl-5-oxo-4,5-dihydro-1,3,4-oxadiazol- 2-yl)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 47G::US9809561, 47G Nuclear receptor ROR-gamma Human 26.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352722&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187501 386393877 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945757 Cn1nc(C[C@H]2CN(c3cc(NC(=O)OC(C)(C)C)ccc3O2)S(=O)(=O)c2cccc(c2)C(F)(F)F)oc1=O InChI=1S/C24H25F3N4O7S/c1-23(2,3)38-21(32)28-15-8-9-19-18(11-15)31(13-16(36-19)12-20-29-30(4)22(33)37-20)39(34,35)17-7-5-6-14(10-17)24(25,26)27/h5-11,16H,12-13H2,1-4H3,(H,28,32)/t16-/m0/s1 LNABCAPCPKHGHF-INIZCTEOSA-N 352723 (S)-tert-butyl (2-((4-methyl-5-oxo-4,5- dihydro-1,3,4-oxadiazol-2-yl)methyl)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 47H::US9809561, 47H Nuclear receptor ROR-gamma Human 5.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352723&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633189 386393878 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945758 Cn1c(n[nH]c1=O)[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H24FN5O6S/c1-22(2,3)34-21(30)24-14-7-10-17-16(11-14)28(35(31,32)15-8-5-13(23)6-9-15)12-18(33-17)19-25-26-20(29)27(19)4/h5-11,18H,12H2,1-4H3,(H,24,30)(H,26,29)/t18-/m1/s1 UEWDBESVFNIACL-GOSISDBHSA-N 352724 (R)-tert-butyl (4-((4-fluorophenyl)sulfonyl)-2-(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 48::US9809561, 48 Nuclear receptor ROR-gamma Human 5.72 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352724&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187128 386393879 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945759 CC(C)(C)OC(=O)Nc1ccc2OC(CC#N)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H22F3N3O5S/c1-21(2,3)33-20(29)27-15-7-8-19-18(12-15)28(13-16(32-19)9-10-26)34(30,31)17-6-4-5-14(11-17)22(23,24)25/h4-8,11-12,16H,9,13H2,1-3H3,(H,27,29) GTWAKCHBAJXRGM-UHFFFAOYSA-N 352725 US10745364, Example 49::US9809561, 49::tert-butyl (2-(cyanomethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 2.46 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352725&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187280 386393880 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945760 CC(O)CC1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H27F3N2O6S/c1-14(29)10-17-13-28(35(31,32)18-7-5-6-15(11-18)23(24,25)26)19-12-16(8-9-20(19)33-17)27-21(30)34-22(2,3)4/h5-9,11-12,14,17,29H,10,13H2,1-4H3,(H,27,30) ZYNWSKDEUMVEGL-UHFFFAOYSA-N 352726 US10745364, Example 50::US9809561, 50::tert-butyl (2-(2-hydroxypropyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 4.83 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352726&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187098 386393881 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945761 CC(C)(N)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H30F3N3O5S/c1-22(2,3)35-21(31)29-16-9-10-20-19(12-16)30(14-17(34-20)13-23(4,5)28)36(32,33)18-8-6-7-15(11-18)24(25,26)27/h6-12,17H,13-14,28H2,1-5H3,(H,29,31)/t17-/m0/s1 FLSBAPZEAMFIQH-KRWDZBQOSA-N 352727 (S)-tert-butyl (2-(2-amino-2-methylpropyl)-4-((3-(trifluoromethyl)phenyl) sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 51::US9809561, 51 Nuclear receptor ROR-gamma Human 42.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352727&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187586 386393882 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945762 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H32F3N3O6S/c1-16(33)31-25(5,6)14-19-15-32(39(35,36)20-9-7-8-17(12-20)26(27,28)29)21-13-18(10-11-22(21)37-19)30-23(34)38-24(2,3)4/h7-13,19H,14-15H2,1-6H3,(H,30,34)(H,31,33)/t19-/m0/s1 AKKPTEWPNWKNQT-IBGZPJMESA-N 352728 (S)-tert-butyl (2-(2-acetamido-2-methylpropyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 52::US9809561, 52 Nuclear receptor ROR-gamma Human 6.14 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352728&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187378 386393883 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945763 CCC(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O6S/c1-5-22(32)29-12-11-18-15-31(38(34,35)19-8-6-7-16(13-19)25(26,27)28)20-14-17(9-10-21(20)36-18)30-23(33)37-24(2,3)4/h6-10,13-14,18H,5,11-12,15H2,1-4H3,(H,29,32)(H,30,33)/t18-/m0/s1 KNMXAONVZCRUQS-SFHVURJKSA-N 352729 (S)-tert-butyl (2-(2-propionamidoethyl)-4- ((3-(trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53A::US9809561, 53A Nuclear receptor ROR-gamma Human 4.07 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352729&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187250 386393884 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945764 CC(O)C(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O7S/c1-15(32)22(33)29-11-10-18-14-31(39(35,36)19-7-5-6-16(12-19)25(26,27)28)20-13-17(8-9-21(20)37-18)30-23(34)38-24(2,3)4/h5-9,12-13,15,18,32H,10-11,14H2,1-4H3,(H,29,33)(H,30,34)/t15?,18-/m0/s1 XJZPDYGXDDQROX-PKHIMPSTSA-N 352730 US10745364, Example 53B::US9809561, 53B::tert-butyl ((2S)-2-(2-(2- hydroxypropanamido)ethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate Nuclear receptor ROR-gamma Human 6.26 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352730&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187268 386393885 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945765 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CCNC(=O)C3COC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O7S/c1-25(2,3)39-24(34)31-18-7-8-22-21(12-18)32(13-19(38-22)9-10-30-23(33)16-14-37-15-16)40(35,36)20-6-4-5-17(11-20)26(27,28)29/h4-8,11-12,16,19H,9-10,13-15H2,1-3H3,(H,30,33)(H,31,34)/t19-/m0/s1 OTKRMSOYHGTSAV-IBGZPJMESA-N 352731 (S)-tert-butyl (2-(2-(oxetane-3- carboxamido)ethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53C::US9809561, 53C Nuclear receptor ROR-gamma Human 4.88 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352731&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187252 386393886 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945766 CC(C)C(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H32F3N3O6S/c1-16(2)23(33)30-12-11-19-15-32(39(35,36)20-8-6-7-17(13-20)26(27,28)29)21-14-18(9-10-22(21)37-19)31-24(34)38-25(3,4)5/h6-10,13-14,16,19H,11-12,15H2,1-5H3,(H,30,33)(H,31,34)/t19-/m0/s1 GSMSUHIKWVICMJ-IBGZPJMESA-N 352732 (S)-tert-butyl (2-(2-isobutyramidoethyl)- 4-((3-(trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53D::US9809561, 53D Nuclear receptor ROR-gamma Human 5.51 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352732&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187260 386393887 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945767 CC(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O6S/c1-15(31)28-11-10-18-14-30(37(33,34)19-7-5-6-16(12-19)24(25,26)27)20-13-17(8-9-21(20)35-18)29-22(32)36-23(2,3)4/h5-9,12-13,18H,10-11,14H2,1-4H3,(H,28,31)(H,29,32)/t18-/m0/s1 FPGBRINMZKYMLW-SFHVURJKSA-N 352733 (S)-tert-butyl (2-(2-acetamidoethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53E::US9809561, 53E Nuclear receptor ROR-gamma Human 4.38 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352733&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187281 386393888 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945768 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CCNC(=O)C3CC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H30F3N3O6S/c1-25(2,3)38-24(34)31-18-9-10-22-21(14-18)32(15-19(37-22)11-12-30-23(33)16-7-8-16)39(35,36)20-6-4-5-17(13-20)26(27,28)29/h4-6,9-10,13-14,16,19H,7-8,11-12,15H2,1-3H3,(H,30,33)(H,31,34)/t19-/m0/s1 CCJHPLJQLNXWBU-IBGZPJMESA-N 352734 (S)-tert-butyl (2-(2- (cyclopropanecarboxamido)ethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53F::US9809561, 53F Nuclear receptor ROR-gamma Human 6.14 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352734&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187592 386393889 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945769 CCC(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H30FN3O6S/c1-5-22(29)26-13-12-18-15-28(35(31,32)19-9-6-16(25)7-10-19)20-14-17(8-11-21(20)33-18)27-23(30)34-24(2,3)4/h6-11,14,18H,5,12-13,15H2,1-4H3,(H,26,29)(H,27,30)/t18-/m0/s1 OERGCJMAFWFCFL-SFHVURJKSA-N 352735 (S)-tert-butyl (4-((4- fluorophenyl)sulfonyl)-2-(2- propionamidoethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53G::US9809561, 53G Nuclear receptor ROR-gamma Human 7.73 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352735&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187593 386393890 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945770 CC(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C23H28FN3O6S/c1-15(28)25-12-11-18-14-27(34(30,31)19-8-5-16(24)6-9-19)20-13-17(7-10-21(20)32-18)26-22(29)33-23(2,3)4/h5-10,13,18H,11-12,14H2,1-4H3,(H,25,28)(H,26,29)/t18-/m0/s1 OKPVDARNDVGIIA-SFHVURJKSA-N 352736 (S)-tert-butyl (2-(2-acetamidoethyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53H::US9809561, 53H Nuclear receptor ROR-gamma Human 6.77 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352736&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187594 386393891 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945771 CC(O)C(=O)NCC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H30FN3O7S/c1-15(29)22(30)26-12-11-18-14-28(36(32,33)19-8-5-16(25)6-9-19)20-13-17(7-10-21(20)34-18)27-23(31)35-24(2,3)4/h5-10,13,15,18,29H,11-12,14H2,1-4H3,(H,26,30)(H,27,31)/t15?,18-/m0/s1 HPZIGPPRWZIOPL-PKHIMPSTSA-N 352737 US10745364, Example 53i::US9809561, 53i::tert-butyl ((2S)-4-((4- fluorophenyl)sulfonyl)-2-(2-(2- hydroxypropanamido)ethyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 4.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352737&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187589 386393892 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945772 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CCNC(=O)C3CC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H30FN3O6S/c1-25(2,3)35-24(31)28-18-8-11-22-21(14-18)29(36(32,33)20-9-6-17(26)7-10-20)15-19(34-22)12-13-27-23(30)16-4-5-16/h6-11,14,16,19H,4-5,12-13,15H2,1-3H3,(H,27,30)(H,28,31)/t19-/m0/s1 FWEWHTFEDNRTJL-IBGZPJMESA-N 352738 (S)-tert-butyl (2-(2- (cyclopropanecarboxamido)ethyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53J::US9809561, 53J Nuclear receptor ROR-gamma Human 6.37 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352738&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187584 386393893 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945773 CCC(=O)NCC[C@H]1CN(c2cc(NC(=O)OCC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H32FN3O6S/c1-5-23(30)27-13-12-19-15-29(36(32,33)20-9-6-17(26)7-10-20)21-14-18(8-11-22(21)35-19)28-24(31)34-16-25(2,3)4/h6-11,14,19H,5,12-13,15-16H2,1-4H3,(H,27,30)(H,28,31)/t19-/m0/s1 ARCXQZKQNVTKDK-IBGZPJMESA-N 352739 (S)-neopentyl (4-((4- fluorophenyl)sulfonyl)-2-(2- propionamidoethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53K::US9809561, 53K Nuclear receptor ROR-gamma Human 10.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352739&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187585 386393894 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945774 CC(=O)NCC[C@H]1CN(c2cc(NC(=O)OCC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H30FN3O6S/c1-16(29)26-12-11-19-14-28(35(31,32)20-8-5-17(25)6-9-20)21-13-18(7-10-22(21)34-19)27-23(30)33-15-24(2,3)4/h5-10,13,19H,11-12,14-15H2,1-4H3,(H,26,29)(H,27,30)/t19-/m0/s1 YDUYQUIWTWZWEL-IBGZPJMESA-N 352740 (S)-neopentyl (2-(2-acetamidoethyl)-4- ((4-fluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53L::US9809561, 53L Nuclear receptor ROR-gamma Human 5.99 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352740&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118188240 386393895 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945775 CC(C)(C)COC(=O)Nc1ccc2O[C@@H](CCNC(=O)C3CC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C26H32FN3O6S/c1-26(2,3)16-35-25(32)29-19-8-11-23-22(14-19)30(37(33,34)21-9-6-18(27)7-10-21)15-20(36-23)12-13-28-24(31)17-4-5-17/h6-11,14,17,20H,4-5,12-13,15-16H2,1-3H3,(H,28,31)(H,29,32)/t20-/m0/s1 WYTAZUDGFIRLQY-FQEVSTJZSA-N 352741 (S)-neopentyl (2-(2- (cyclopropanecarboxamido)ethyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 53M::US9809561, 53M Nuclear receptor ROR-gamma Human 15.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352741&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633190 386393896 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945776 CC(C)(N)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C23H26ClF4N3O5S/c1-21(2,29)11-14-12-31(37(33,34)15-6-7-17(25)16(24)10-15)18-9-13(5-8-19(18)35-14)30-20(32)36-22(3,4)23(26,27)28/h5-10,14H,11-12,29H2,1-4H3,(H,30,32)/t14-/m0/s1 GBVXBFVXRYGVGU-AWEZNQCLSA-N 352742 (S)-1,1,l-trifluoro-2-methylpropan-2-yl (2-(2-amino-2-methylpropyl)-4-((3- chloro-4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53N::US9809561, 53N Nuclear receptor ROR-gamma Human 68.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352742&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633191 386393897 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945777 CC(C)(N)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H27F6N3O5S/c1-21(2,31)12-16-13-33(39(35,36)17-7-5-6-14(10-17)23(25,26)27)18-11-15(8-9-19(18)37-16)32-20(34)38-22(3,4)24(28,29)30/h5-11,16H,12-13,31H2,1-4H3,(H,32,34)/t16-/m0/s1 GQKBLSZTHBFVTN-INIZCTEOSA-N 352743 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-amino-2-methylpropyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53o::US9809561, 53o Nuclear receptor ROR-gamma Human 53.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352743&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633147 386393898 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945778 CC(C)(OC(=O)Nc1ccc2O[C@H](CCN3CCCC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C26H27F6N3O6S/c1-24(2,26(30,31)32)41-23(37)33-17-8-9-21-20(14-17)35(15-18(40-21)10-12-34-11-4-7-22(34)36)42(38,39)19-6-3-5-16(13-19)25(27,28)29/h3,5-6,8-9,13-14,18H,4,7,10-12,15H2,1-2H3,(H,33,37)/t18-/m1/s1 LNPJUZHJUCJWDB-GOSISDBHSA-N 352744 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(2-oxopyrrolidin-1-yl)ethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53P::US9809561, 53P Nuclear receptor ROR-gamma Human 3.42 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352744&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633148 386393899 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945779 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCN3CCCC3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C26H27F6N3O6S/c1-24(2,26(30,31)32)41-23(37)33-17-8-9-21-20(14-17)35(15-18(40-21)10-12-34-11-4-7-22(34)36)42(38,39)19-6-3-5-16(13-19)25(27,28)29/h3,5-6,8-9,13-14,18H,4,7,10-12,15H2,1-2H3,(H,33,37)/t18-/m0/s1 LNPJUZHJUCJWDB-SFHVURJKSA-N 352745 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(2-oxopyrrolidin-1-yl)ethyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 53Q::US9809561, 53Q Nuclear receptor ROR-gamma Human 10.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352745&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633192 386393900 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945780 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C25H31ClFN3O6S/c1-15(31)29-25(5,6)13-17-14-30(37(33,34)18-8-9-20(27)19(26)12-18)21-11-16(7-10-22(21)35-17)28-23(32)36-24(2,3)4/h7-12,17H,13-14H2,1-6H3,(H,28,32)(H,29,31)/t17-/m0/s1 ZANMIBQYAXTITB-KRWDZBQOSA-N 352746 (S)-tert-butyl (2-(2-acetamido-2-methylpropyl)-4-((3-chloro-4-fluorophenyl) sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 54::US9809561, 54 Nuclear receptor ROR-gamma Human 3.49 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352746&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187583 386393901 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945781 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)c(F)c1 InChI=1S/C25H31F2N3O6S/c1-15(31)29-25(5,6)13-17-14-30(37(33,34)18-8-9-19(26)20(27)12-18)21-11-16(7-10-22(21)35-17)28-23(32)36-24(2,3)4/h7-12,17H,13-14H2,1-6H3,(H,28,32)(H,29,31)/t17-/m0/s1 REWWMAQRKPZZTO-KRWDZBQOSA-N 352748 (S)-tert-butyl (2-(2-acetamido-2- methylpropyl)-4-((3,4- difluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 55A::US9809561, 55A Nuclear receptor ROR-gamma Human 3.13 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352748&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187373 386393902 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945782 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cn(nc1C)C(F)F InChI=1S/C24H33F2N5O6S/c1-14-20(13-30(29-14)21(25)26)38(34,35)31-12-17(11-24(6,7)28-15(2)32)36-19-9-8-16(10-18(19)31)27-22(33)37-23(3,4)5/h8-10,13,17,21H,11-12H2,1-7H3,(H,27,33)(H,28,32)/t17-/m0/s1 LWRUHBUUGLUXCW-KRWDZBQOSA-N 352749 (S)-tert-butyl (2-(2-acetamido-2- methylpropyl)-4-((1-(difluoromethyl)-3- methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 55B::US9809561, 55B Nuclear receptor ROR-gamma Human 7.85 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352749&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187372 386393903 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945783 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cnn(C(F)F)c1C InChI=1S/C24H33F2N5O6S/c1-14-20(12-27-31(14)21(25)26)38(34,35)30-13-17(11-24(6,7)29-15(2)32)36-19-9-8-16(10-18(19)30)28-22(33)37-23(3,4)5/h8-10,12,17,21H,11,13H2,1-7H3,(H,28,33)(H,29,32)/t17-/m0/s1 YHBLRKFLTHFEDQ-KRWDZBQOSA-N 352750 (S)-tert-butyl (2-(2-acetamido-2- methylpropyl)-4-((1-(difluoromethyl)-5- methyl-1H-pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 55C::US9809561, 55C Nuclear receptor ROR-gamma Human 8.62 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352750&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187375 386393904 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945784 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H32FN3O6S/c1-16(30)28-25(5,6)14-19-15-29(36(32,33)20-10-7-17(26)8-11-20)21-13-18(9-12-22(21)34-19)27-23(31)35-24(2,3)4/h7-13,19H,14-15H2,1-6H3,(H,27,31)(H,28,30)/t19-/m0/s1 ZKEGSZFSCYUSAP-IBGZPJMESA-N 352751 (S)-tert-butyl (2-(2-acetamido-2- methylpropyl)-4-((4-fluorophenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 55D::US9809561, 55D Nuclear receptor ROR-gamma Human 136 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352751&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187376 386393905 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945785 CC(=O)NC(C)(C)C[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H32FN3O6S/c1-16(30)28-25(5,6)14-19-15-29(36(32,33)20-10-7-17(26)8-11-20)21-13-18(9-12-22(21)34-19)27-23(31)35-24(2,3)4/h7-13,19H,14-15H2,1-6H3,(H,27,31)(H,28,30)/t19-/m1/s1 ZKEGSZFSCYUSAP-LJQANCHMSA-N 352752 (R)-tert-butyl (2-(2-acetamido-2- methylpropyl)-4-((4-fluorophenyl)sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 55E::US9809561, 55E Nuclear receptor ROR-gamma Human 4.09 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352752&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187374 386393906 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945786 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H29F6N3O6S/c1-15(36)34-23(2,3)13-18-14-35(42(38,39)19-8-6-7-16(11-19)25(27,28)29)20-12-17(9-10-21(20)40-18)33-22(37)41-24(4,5)26(30,31)32/h6-12,18H,13-14H2,1-5H3,(H,33,37)(H,34,36)/t18-/m0/s1 NIBUZCWTRSYBCH-SFHVURJKSA-N 352753 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 56::US9809561, 56 Nuclear receptor ROR-gamma Human 4.92 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352753&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185286 386393907 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945787 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C25H29F4N3O6S/c1-15(33)31-23(2,3)13-18-14-32(39(35,36)19-9-6-16(26)7-10-19)20-12-17(8-11-21(20)37-18)30-22(34)38-24(4,5)25(27,28)29/h6-12,18H,13-14H2,1-5H3,(H,30,34)(H,31,33)/t18-/m0/s1 RZPAUZCJQUWAQN-SFHVURJKSA-N 352754 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57A::US9809561, 57A Nuclear receptor ROR-gamma Human 5.67 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352754&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187399 386393908 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945788 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1 InChI=1S/C25H28ClF4N3O6S/c1-14(34)32-23(2,3)12-16-13-33(40(36,37)17-7-8-19(27)18(26)11-17)20-10-15(6-9-21(20)38-16)31-22(35)39-24(4,5)25(28,29)30/h6-11,16H,12-13H2,1-5H3,(H,31,35)(H,32,34)/t16-/m0/s1 KVZCIWGLCZGPKO-INIZCTEOSA-N 352755 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((3- chloro-4-fluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57B::US9809561, 57B Nuclear receptor ROR-gamma Human 3.99 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352755&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187307 386393909 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945789 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cn(nc1C)C(F)F InChI=1S/C24H30F5N5O6S/c1-13-19(12-33(32-13)20(25)26)41(37,38)34-11-16(10-22(3,4)31-14(2)35)39-18-8-7-15(9-17(18)34)30-21(36)40-23(5,6)24(27,28)29/h7-9,12,16,20H,10-11H2,1-6H3,(H,30,36)(H,31,35)/t16-/m0/s1 MRLASIHSFJWBNZ-INIZCTEOSA-N 352756 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((1- (difluoromethyl)-3-methyl-1H-pyrazol- 4-yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57C::US9809561, 57C Nuclear receptor ROR-gamma Human 6.44 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352756&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187314 386393910 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945790 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1)NS(C)(=O)=O InChI=1S/C24H29F4N3O7S2/c1-22(2,30-39(5,33)34)13-17-14-31(40(35,36)18-9-6-15(25)7-10-18)19-12-16(8-11-20(19)37-17)29-21(32)38-23(3,4)24(26,27)28/h6-12,17,30H,13-14H2,1-5H3,(H,29,32)/t17-/m0/s1 VFQVOGKHNRMHIC-KRWDZBQOSA-N 352757 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((4-fluorophenyl)sulfonyl)-2-(2- methyl-2-(methylsulfonamido)propyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57D::US9809561, 57D Nuclear receptor ROR-gamma Human 4.52 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352757&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187295 386393911 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945791 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(F)c1 InChI=1S/C25H28F5N3O6S/c1-14(34)32-23(2,3)12-16-13-33(40(36,37)17-7-8-18(26)19(27)11-17)20-10-15(6-9-21(20)38-16)31-22(35)39-24(4,5)25(28,29)30/h6-11,16H,12-13H2,1-5H3,(H,31,35)(H,32,34)/t16-/m0/s1 PWDWALSZMPZRHO-INIZCTEOSA-N 352758 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4- ((3,4-difluorophenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57E::US9809561, 57E Nuclear receptor ROR-gamma Human 4.17 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352758&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187305 386393912 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945792 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(Cl)c1)NS(C)(=O)=O InChI=1S/C24H28ClF4N3O7S2/c1-22(2,31-40(5,34)35)12-15-13-32(41(36,37)16-7-8-18(26)17(25)11-16)19-10-14(6-9-20(19)38-15)30-21(33)39-23(3,4)24(27,28)29/h6-11,15,31H,12-13H2,1-5H3,(H,30,33)/t15-/m0/s1 UAABOBAIEYGUOK-HNNXBMFYSA-N 352760 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)- 2-(2-methyl-2- (methylsulfonamido)propyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57F::US9809561, 57F Nuclear receptor ROR-gamma Human 7.50 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352760&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187296 386393913 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945793 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(F)c1)NS(C)(=O)=O InChI=1S/C24H28F5N3O7S2/c1-22(2,31-40(5,34)35)12-15-13-32(41(36,37)16-7-8-17(25)18(26)11-16)19-10-14(6-9-20(19)38-15)30-21(33)39-23(3,4)24(27,28)29/h6-11,15,31H,12-13H2,1-5H3,(H,30,33)/t15-/m0/s1 NNTAQTNJIUKJTA-HNNXBMFYSA-N 352761 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3,4-difluorophenyl)sulfonyl)-2-(2- methyl-2-(methylsulfonamido)propyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57G::US9809561, 57G Nuclear receptor ROR-gamma Human 5.76 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352761&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187316 386393914 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945794 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(F)c1)NS(=O)(=O)C1CC1 InChI=1S/C26H30F5N3O7S2/c1-24(2,33-42(36,37)17-6-7-17)13-16-14-34(43(38,39)18-8-9-19(27)20(28)12-18)21-11-15(5-10-22(21)40-16)32-23(35)41-25(3,4)26(29,30)31/h5,8-12,16-17,33H,6-7,13-14H2,1-4H3,(H,32,35)/t16-/m0/s1 NZQFDXKPMWQXHV-INIZCTEOSA-N 352762 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(cyclopropanesulfonamido)-2- methylpropyl)-4-((3,4- difluorophenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57H::US9809561, 57H Nuclear receptor ROR-gamma Human 10.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352762&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187293 386393915 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945795 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F)NS(C)(=O)=O InChI=1S/C25H29F6N3O7S2/c1-22(2,33-42(5,36)37)13-17-14-34(43(38,39)18-8-6-7-15(11-18)24(26,27)28)19-12-16(9-10-20(19)40-17)32-21(35)41-23(3,4)25(29,30)31/h6-12,17,33H,13-14H2,1-5H3,(H,32,35)/t17-/m0/s1 GSNPHJAXPRMTOF-KRWDZBQOSA-N 352763 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-methyl-2- (methylsulfonamido)propyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57i::US9809561, 57i Nuclear receptor ROR-gamma Human 8.27 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352763&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187298 386393916 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945796 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F)NS(=O)(=O)C1CC1 InChI=1S/C27H31F6N3O7S2/c1-24(2,35-44(38,39)19-9-10-19)14-18-15-36(45(40,41)20-7-5-6-16(12-20)26(28,29)30)21-13-17(8-11-22(21)42-18)34-23(37)43-25(3,4)27(31,32)33/h5-8,11-13,18-19,35H,9-10,14-15H2,1-4H3,(H,34,37)/t18-/m0/s1 GJWCWIZWEHNGLM-SFHVURJKSA-N 352764 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(cyclopropanesulfonamido)-2- methylpropyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57J::US9809561, 57J Nuclear receptor ROR-gamma Human 12.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352764&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185303 386393917 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945797 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)NS(=O)(=O)C1CC1 InChI=1S/C27H30F7N3O7S2/c1-24(2,36-45(39,40)17-6-7-17)13-16-14-37(46(41,42)18-8-9-20(28)19(12-18)26(29,30)31)21-11-15(5-10-22(21)43-16)35-23(38)44-25(3,4)27(32,33)34/h5,8-12,16-17,36H,6-7,13-14H2,1-4H3,(H,35,38)/t16-/m0/s1 WYWKRMWYUYHGNA-INIZCTEOSA-N 458756 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4-((3-chloro-4-fluorophenyl)sulfonyl)-2- (2-methyl-2-(methylsulfonamido)propyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57K Nuclear receptor ROR-gamma Human 11.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458756&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139524609 441290021 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945798 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1)NS(=O)(=O)C1CC1 InChI=1S/C26H31F4N3O7S2/c1-24(2,32-41(35,36)19-10-11-19)14-18-15-33(42(37,38)20-8-5-16(27)6-9-20)21-13-17(7-12-22(21)39-18)31-23(34)40-25(3,4)26(28,29)30/h5-9,12-13,18-19,32H,10-11,14-15H2,1-4H3,(H,31,34)/t18-/m0/s1 HRVZSSDPUOOUNC-SFHVURJKSA-N 352766 (S)-1,1,1-trifluoro-2-mrthylpropan-2-yl (2-(2-(cyclopropanrsulfonamido)-2- methylpropyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57L::US9809561, 57L Nuclear receptor ROR-gamma Human 12.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352766&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185304 386393919 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945799 CC(C)(C[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1)NS(=O)(=O)C1CC1 InChI=1S/C26H31F4N3O7S2/c1-24(2,32-41(35,36)19-10-11-19)14-18-15-33(42(37,38)20-8-5-16(27)6-9-20)21-13-17(7-12-22(21)39-18)31-23(34)40-25(3,4)26(28,29)30/h5-9,12-13,18-19,32H,10-11,14-15H2,1-4H3,(H,31,34)/t18-/m1/s1 HRVZSSDPUOOUNC-GOSISDBHSA-N 352767 (R)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(cyclopropanesulfonamido)-2- methylpropyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57M::US9809561, 57M Nuclear receptor ROR-gamma Human 394 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352767&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185300 386393920 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945800 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F)NS(=O)(=O)C(F)(F)F InChI=1S/C25H26F9N3O7S2/c1-21(2,36-46(41,42)25(32,33)34)12-16-13-37(45(39,40)17-7-5-6-14(10-17)23(26,27)28)18-11-15(8-9-19(18)43-16)35-20(38)44-22(3,4)24(29,30)31/h5-11,16,36H,12-13H2,1-4H3,(H,35,38)/t16-/m0/s1 IXAMFFWGAJBKGR-INIZCTEOSA-N 352768 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-methyl-2- (trifluoromethylsulfonamido)propyl)-4- ((3-(trifluoromethyl(phenyl(sulfonyl)- 3,4-dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57N::US9809561, 57N Nuclear receptor ROR-gamma Human 30.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352768&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185305 386393921 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945801 CN(C)C(=O)C(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C28H32F6N4O7S/c1-25(2,36-22(39)23(40)37(5)6)14-18-15-38(46(42,43)19-9-7-8-16(12-19)27(29,30)31)20-13-17(10-11-21(20)44-18)35-24(41)45-26(3,4)28(32,33)34/h7-13,18H,14-15H2,1-6H3,(H,35,41)(H,36,39)/t18-/m0/s1 PKKKLFLEGCWLGE-SFHVURJKSA-N 352769 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-(2-(dimethylamino)-2- oxoacetamido)-2-methylpropyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 57o::US9809561, 57o Nuclear receptor ROR-gamma Human 12.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352769&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185302 386393922 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945802 CC(=O)NC(C)(C)C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C26H28F7N3O6S/c1-14(37)35-23(2,3)12-16-13-36(43(39,40)17-7-8-19(27)18(11-17)25(28,29)30)20-10-15(6-9-21(20)41-16)34-22(38)42-24(4,5)26(31,32)33/h6-11,16H,12-13H2,1-5H3,(H,34,38)(H,35,37)/t16-/m0/s1 QUKAWACVHFVXAI-INIZCTEOSA-N 352770 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((4- fluoro-3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- carbamate::US10745364, Example 57P::US9809561, 57P Nuclear receptor ROR-gamma Human 11.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352770&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185301 386393923 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945803 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)NC(C)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H31ClF3N5O6S/c1-7-32-13-19(20(25)31-32)40(36,37)33-12-16(11-22(3,4)30-14(2)34)38-18-9-8-15(10-17(18)33)29-21(35)39-23(5,6)24(26,27)28/h8-10,13,16H,7,11-12H2,1-6H3,(H,29,35)(H,30,34)/t16-/m0/s1 XMNKJHNVGVEDJK-INIZCTEOSA-N 352771 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57Q::US9809561, 57Q Nuclear receptor ROR-gamma Human 7.38 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352771&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118185307 386393924 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945804 COc1nn(C)c(C)c1S(=O)(=O)N1C[C@H](CC(C)(C)NC(C)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H34F3N5O7S/c1-14-20(21(38-8)31-32(14)7)41(36,37)33-13-17(12-23(3,4)30-15(2)34)39-19-10-9-16(11-18(19)33)29-22(35)40-24(5,6)25(26,27)28/h9-11,17H,12-13H2,1-8H3,(H,29,35)(H,30,34)/t17-/m0/s1 MWHVXUKHCKADNY-KRWDZBQOSA-N 359888 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((3- methoxy-1,5-dimethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10221146, Example 57R::US10745364, Example 57R Nuclear receptor ROR-gamma Human 13.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359888&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187487 386399333 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945805 CCOc1nn(cc1S(=O)(=O)N1C[C@H](CC(C)(C)NC(C)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)C(F)F InChI=1S/C25H32F5N5O7S/c1-7-40-20-19(13-34(33-20)21(26)27)43(38,39)35-12-16(11-23(3,4)32-14(2)36)41-18-9-8-15(10-17(18)35)31-22(37)42-24(5,6)25(28,29)30/h8-10,13,16,21H,7,11-12H2,1-6H3,(H,31,37)(H,32,36)/t16-/m0/s1 WEZDHOFLIAAINU-INIZCTEOSA-N 352773 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((1- (difluoromethyl)-3-ethoxy-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57S::US9809561, 57S Nuclear receptor ROR-gamma Human 14.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352773&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187494 386393926 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945806 CCn1cc(c(OC(F)F)n1)S(=O)(=O)N1C[C@H](CC(C)(C)NC(C)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H32F5N5O7S/c1-7-34-13-19(20(33-34)41-21(26)27)43(38,39)35-12-16(11-23(3,4)32-14(2)36)40-18-9-8-15(10-17(18)35)31-22(37)42-24(5,6)25(28,29)30/h8-10,13,16,21H,7,11-12H2,1-6H3,(H,31,37)(H,32,36)/t16-/m0/s1 WLRFYRRRNXHMOV-INIZCTEOSA-N 352774 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2-(2-acetamido-2-methylpropyl)-4-((3- (difluoromethoxy)-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 57T::US9809561, 57T Nuclear receptor ROR-gamma Human 12.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352774&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187490 386393927 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945807 CC(C)(C)OC(=O)Nc1ccc2OC(CCO)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H25F3N2O6S/c1-21(2,3)33-20(29)26-15-7-8-19-18(12-15)27(13-16(32-19)9-10-28)34(30,31)17-6-4-5-14(11-17)22(23,24)25/h4-8,11-12,16,28H,9-10,13H2,1-3H3,(H,26,29) GHRHQYOXAHUXRY-UHFFFAOYSA-N 352775 US10745364, Example 58::US9809561, 58::tert-butyl (2-(2-hydroxyethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 3.56 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352775&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187369 386393928 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945808 CC(C)(C)OC(=O)Nc1ccc2OC(Cc3ncc[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F 352776 US10745364, Example 59::US9809561, 59::tert-butyl (2-((1H-imidazol-2-yl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 4.77 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352776&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187274 386393929 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945809 Cn1ccnc1CC1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H27F3N4O5S/c1-24(2,3)37-23(33)30-17-8-9-21-20(13-17)32(15-18(36-21)14-22-29-10-11-31(22)4)38(34,35)19-7-5-6-16(12-19)25(26,27)28/h5-13,18H,14-15H2,1-4H3,(H,30,33) ADKNKXMFNYGGST-UHFFFAOYSA-N 352777 US10745364, Example 60::US9809561, 60::tert-butyl (2-((1-methyl-1H-imidazol-2-yl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 5.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352777&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187259 386393930 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945810 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CN3CCCC3=O)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H28FN3O6S/c1-24(2,3)34-23(30)26-17-8-11-21-20(13-17)28(35(31,32)19-9-6-16(25)7-10-19)15-18(33-21)14-27-12-4-5-22(27)29/h6-11,13,18H,4-5,12,14-15H2,1-3H3,(H,26,30)/t18-/m0/s1 GUZMDXFKVQGQCN-SFHVURJKSA-N 352778 (S)-tert-butyl (4-((4-fluorophenyl)sulfonyl)-2-((2-oxopyrrolidin-1-yl)methyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 61::US9809561, 61 Nuclear receptor ROR-gamma Human 14.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352778&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187600 386393931 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945811 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3cccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H25F3N4O5S/c1-23(2,3)36-22(32)29-17-8-9-21-20(13-17)31(15-18(35-21)14-30-11-5-10-28-30)37(33,34)19-7-4-6-16(12-19)24(25,26)27/h4-13,18H,14-15H2,1-3H3,(H,29,32)/t18-/m0/s1 LWQRNQSIGYXDHB-SFHVURJKSA-N 352779 (S)-tert-butyl (2-((1H-pyrazol-1-yl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 62::US9809561, 62 Nuclear receptor ROR-gamma Human 8.87 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352779&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187597 386393932 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945812 Cc1nn(cc1S(=O)(=O)N1C[C@H](Cn2nccn2)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C21H25F2N7O5S/c1-13-18(12-28(27-13)19(22)23)36(32,33)29-10-15(11-30-24-7-8-25-30)34-17-6-5-14(9-16(17)29)26-20(31)35-21(2,3)4/h5-9,12,15,19H,10-11H2,1-4H3,(H,26,31)/t15-/m1/s1 HPAXIADABIDSRU-OAHLLOKOSA-N 352780 (S)-tert-butyl (2-((2H-1,2,3-triazol-2- yl)methyl-4-((1-(difluoromethyl)-3-methyl- 1H-pyrazol-4-yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 63A::US9809561, 63A Nuclear receptor ROR-gamma Human 21.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352780&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187482 386393933 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945813 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3cnnc3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H24F3N5O5S/c1-22(2,3)36-21(32)29-16-7-8-20-19(10-16)31(12-17(35-20)11-30-13-27-28-14-30)37(33,34)18-6-4-5-15(9-18)23(24,25)26/h4-10,13-14,17H,11-12H2,1-3H3,(H,29,32)/t17-/m0/s1 IPUUMYCVDZPJHI-KRWDZBQOSA-N 352781 (S)-tert-butyl (2-((4H-1,2,4-triazol-4- yl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63B::US9809561, 63B Nuclear receptor ROR-gamma Human 9.75 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352781&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187483 386393934 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945814 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3cncn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H24F3N5O5S/c1-22(2,3)36-21(32)29-16-7-8-20-19(10-16)31(12-17(35-20)11-30-14-27-13-28-30)37(33,34)18-6-4-5-15(9-18)23(24,25)26/h4-10,13-14,17H,11-12H2,1-3H3,(H,29,32)/t17-/m0/s1 BHFJABVHVFQANJ-KRWDZBQOSA-N 352782 (S)-tert-butyl (2-((1H-1,2,4-triazol-1- yl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63C::US9809561, 63C Nuclear receptor ROR-gamma Human 3.04 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352782&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187603 386393935 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945815 Cc1nn(cc1S(=O)(=O)N1C[C@H](Cn2ccnn2)Oc2ccc(NC(=O)OC(C)(C)C)cc12)C(F)F InChI=1S/C21H25F2N7O5S/c1-13-18(12-29(26-13)19(22)23)36(32,33)30-11-15(10-28-8-7-24-27-28)34-17-6-5-14(9-16(17)30)25-20(31)35-21(2,3)4/h5-9,12,15,19H,10-11H2,1-4H3,(H,25,31)/t15-/m0/s1 KBAYNHUYIISUMH-HNNXBMFYSA-N 352783 (S)-tert-butyl (2-((1H-1,2,3-triazol-1- yl)methyl)-4-((1-(difluoromethyl)-3-methyl- 1H-pyrazol-4-yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 63D::US9809561, 63D Nuclear receptor ROR-gamma Human 37.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352783&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187599 386393936 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945816 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3ccnn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H24F3N5O5S/c1-22(2,3)36-21(32)28-16-7-8-20-19(12-16)31(14-17(35-20)13-30-10-9-27-29-30)37(33,34)18-6-4-5-15(11-18)23(24,25)26/h4-12,17H,13-14H2,1-3H3,(H,28,32)/t17-/m0/s1 MWLIBOBSHQPJFY-KRWDZBQOSA-N 352784 (S)-tert-butyl (2-((1H-1,2,3-triazol-1- yl)methyl)-4-((3- (trifluoromethyl(phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63E::US9809561, 63E Nuclear receptor ROR-gamma Human 2.80 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352784&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187604 386393937 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945817 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3nccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H24F3N5O5S/c1-22(2,3)36-21(32)29-16-7-8-20-19(12-16)30(13-17(35-20)14-31-27-9-10-28-31)37(33,34)18-6-4-5-15(11-18)23(24,25)26/h4-12,17H,13-14H2,1-3H3,(H,29,32)/t17-/m1/s1 BTXYHMUNXNUQSY-QGZVFWFLSA-N 352785 (S)-tert-butyl (2-((2H-1,2,3-triazol-2- yl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63F::US9809561, 63F Nuclear receptor ROR-gamma Human 2.78 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352785&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187605 386393938 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945818 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](COc3ccccn3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H26F3N3O6S/c1-25(2,3)38-24(33)31-18-10-11-22-21(14-18)32(15-19(37-22)16-36-23-9-4-5-12-30-23)39(34,35)20-8-6-7-17(13-20)26(27,28)29/h4-14,19H,15-16H2,1-3H3,(H,31,33)/t19-/m1/s1 DKSMXHQZSOKDSL-LJQANCHMSA-N 352786 (R)-tert-butyl (2-((pyridin-2-yloxy(methyl)- 4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63G::US9809561, 63G Nuclear receptor ROR-gamma Human 5.59 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352786&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187596 386393939 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945819 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cn3ccccc3=O)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C26H26F3N3O6S/c1-25(2,3)38-24(34)30-18-10-11-22-21(14-18)32(16-19(37-22)15-31-12-5-4-9-23(31)33)39(35,36)20-8-6-7-17(13-20)26(27,28)29/h4-14,19H,15-16H2,1-3H3,(H,30,34)/t19-/m0/s1 FKBYKTLEQFJEMS-IBGZPJMESA-N 352787 (S)-tert-butyl (2-((2-oxopyridin-1(2H)- yl)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 63H::US9809561, 63H Nuclear receptor ROR-gamma Human 8.44 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352787&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633202 386393940 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945820 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](Cc3nc(=O)o[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C23H23F3N4O7S/c1-22(2,3)36-20(31)27-14-7-8-18-17(10-14)30(12-15(35-18)11-19-28-21(32)37-29-19)38(33,34)16-6-4-5-13(9-16)23(24,25)26/h4-10,15H,11-12H2,1-3H3,(H,27,31)(H,28,29,32)/t15-/m0/s1 WFJVERZRIBPHAM-HNNXBMFYSA-N 352788 (S)-tert-butyl (2-((5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 64::US9809561, 64 Nuclear receptor ROR-gamma Human 16.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352788&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267872 386393941 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945821 CC(C)(O)CC1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H29F3N2O6S/c1-22(2,3)35-21(30)28-16-9-10-20-19(12-16)29(14-17(34-20)13-23(4,5)31)36(32,33)18-8-6-7-15(11-18)24(25,26)27/h6-12,17,31H,13-14H2,1-5H3,(H,28,30) IWSVLAVVPUBLKG-UHFFFAOYSA-N 352789 tert-butyl (2-(2-hydroxy-2-methylpropyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate ::US10745364, Example 65::US9809561, 65 Nuclear receptor ROR-gamma Human 4.57 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352789&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 123877115 386393942 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945822 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CN3CC(O)C3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H28F3N3O6S/c1-23(2,3)36-22(32)28-16-7-8-21-20(10-16)30(14-18(35-21)13-29-11-17(31)12-29)37(33,34)19-6-4-5-15(9-19)24(25,26)27/h4-10,17-18,31H,11-14H2,1-3H3,(H,28,32)/t18-/m0/s1 NWKVAAPSLPNUFA-SFHVURJKSA-N 352790 (S)-tert-butyl (2-((3-hydroxyazetidin-1-yl)methyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 66::US9809561, 66 Nuclear receptor ROR-gamma Human 6.85 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352790&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633106 386393943 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945823 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CNC3(C)COC3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C25H30F3N3O6S/c1-23(2,3)37-22(32)30-17-8-9-21-20(11-17)31(13-18(36-21)12-29-24(4)14-35-15-24)38(33,34)19-7-5-6-16(10-19)25(26,27)28/h5-11,18,29H,12-15H2,1-4H3,(H,30,32)/t18-/m0/s1 OFBDIAPHNLVVMK-SFHVURJKSA-N 352791 (S)-tert-butyl (2-(((3-methyloxetan-3- yl)amino)methyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 67A::US9809561, 67A Nuclear receptor ROR-gamma Human 4.90 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352791&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187510 386393944 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945824 CC(NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C24H27F6N3O5S/c1-14(23(25,26)27)31-12-17-13-33(39(35,36)18-7-5-6-15(10-18)24(28,29)30)19-11-16(8-9-20(19)37-17)32-21(34)38-22(2,3)4/h5-11,14,17,31H,12-13H2,1-4H3,(H,32,34)/t14?,17-/m0/s1 JMONAKLAOLBPIY-JRZJBTRGSA-N 352792 US10745364, Example 67B::US9809561, 67B::tert-butyl ((2S)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-2- (((1,1,1-trifluoropropan-2- yl)amino)methyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate Nuclear receptor ROR-gamma Human 5.79 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352792&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187511 386393945 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945825 CC1CCN1C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C24H27F4N3O5S/c1-15-10-11-30(15)13-18-14-31(37(33,34)19-7-4-16(25)5-8-19)20-12-17(6-9-21(20)35-18)29-22(32)36-23(2,3)24(26,27)28/h4-9,12,15,18H,10-11,13-14H2,1-3H3,(H,29,32)/t15?,18-/m0/s1 XNQNJQKFAUAEFD-PKHIMPSTSA-N 352793 1,1,1-trifluoro-2-methylpropan-2-yl ((2S)- 4-((4-fluorophenyl)sulfonyl)-2-((2- methylazetidin-1-yl)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 67C::US9809561, 67C Nuclear receptor ROR-gamma Human 23.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352793&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187512 386393946 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945826 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN3CC(O)C3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C23H25F4N3O6S/c1-22(2,23(25,26)27)36-21(32)28-15-5-8-20-19(9-15)30(13-17(35-20)12-29-10-16(31)11-29)37(33,34)18-6-3-14(24)4-7-18/h3-9,16-17,31H,10-13H2,1-2H3,(H,28,32)/t17-/m0/s1 HPDCUBKOWYUHMS-KRWDZBQOSA-N 352794 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (4- ((4-fluorophenyl)sulfonyl)-2-((3- hydroxyazetidin-1-yl)methyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 67D::US9809561, 67D Nuclear receptor ROR-gamma Human 21.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352794&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187509 386393947 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945827 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN3CCC3)CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C23H25F4N3O5S/c1-22(2,23(25,26)27)35-21(31)28-16-6-9-20-19(12-16)30(14-17(34-20)13-29-10-3-11-29)36(32,33)18-7-4-15(24)5-8-18/h4-9,12,17H,3,10-11,13-14H2,1-2H3,(H,28,31)/t17-/m0/s1 NQKPFZFZLYYOHW-KRWDZBQOSA-N 352795 (S)-1,1,1-trifluoro-2-methylpropan-2-yl (2- (azetidin-1-ylmethyl)-4-((4- fluorophenyl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 67E::US9809561, 67E Nuclear receptor ROR-gamma Human 38.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352795&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187513 386393948 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945828 C[C@H]1CCc2ncc(NC(=O)OC(C)(C)C)cc2N1S(=O)(=O)c1ccc(F)cc1 InChI=1S/C20H24FN3O4S/c1-13-5-10-17-18(11-15(12-22-17)23-19(25)28-20(2,3)4)24(13)29(26,27)16-8-6-14(21)7-9-16/h6-9,11-13H,5,10H2,1-4H3,(H,23,25)/t13-/m0/s1 QBJGIKFOMNFKTK-ZDUSSCGKSA-N 352796 (S)-tert-butyl (5-((4-fluorophenyl)sulfonyl)-6-methyl-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate::US10745364, Example 72::US9809561, 72 Nuclear receptor ROR-gamma Human 314 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352796&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267873 386393949 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945829 CC(C)(C)OC(=O)Nc1cnc2C[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)NC(=O)OCc1ccccc1 InChI=1S/C27H29FN4O6S/c1-27(2,3)38-26(34)30-20-14-24-23(29-15-20)13-21(31-25(33)37-17-18-7-5-4-6-8-18)16-32(24)39(35,36)22-11-9-19(28)10-12-22/h4-12,14-15,21H,13,16-17H2,1-3H3,(H,30,34)(H,31,33)/t21-/m0/s1 UCYYEVUWBOGVOA-NRFANRHFSA-N 352797 (S)-benzyl tert-butyl (1-((4-fluorophenyl)sulfonyl)-1,2,3,4-tetrahydro-1,5-naphthyridine-3,7-diyl)dicarbamate::US10745364, Example 73::US9809561, 73 Nuclear receptor ROR-gamma Human 904 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352797&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267874 386393950 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945830 CC(C)(C)OC(=O)Nc1cnc2CC(CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)NC(=O)OCc1ccccc1 InChI=1S/C28H29F3N4O6S/c1-27(2,3)41-26(37)33-20-14-24-23(32-15-20)13-21(34-25(36)40-17-18-8-5-4-6-9-18)16-35(24)42(38,39)22-11-7-10-19(12-22)28(29,30)31/h4-12,14-15,21H,13,16-17H2,1-3H3,(H,33,37)(H,34,36) KORSRAKOYPSPKA-UHFFFAOYSA-N 458789 US10745364, Example 74A::benzyl tert-butyl (1-((3- (trifluoromethyl)phenyl)sulfonyl)-1,2,3,4- tetrahydro-1,5-naphthyridine-3,7- diyl)dicarbamate Nuclear receptor ROR-gamma Human 195 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458789&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 140747585 441290053 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945831 CC(C)(C)OC(=O)NC1CN(c2cc(NC(=O)OCc3ccccc3)cnc2C1)S(=O)(=O)c1cccc(c1)C#N InChI=1S/C28H29N5O6S/c1-28(2,3)39-27(35)32-22-13-24-25(33(17-22)40(36,37)23-11-7-10-20(12-23)15-29)14-21(16-30-24)31-26(34)38-18-19-8-5-4-6-9-19/h4-12,14,16,22H,13,17-18H2,1-3H3,(H,31,34)(H,32,35) CTNVISJMAJLYOS-UHFFFAOYSA-N 352799 US10745364, Example 74B::US9809561, 74B::benzyl tert-butyl (1-((3- cyanophenyl)sulfonyl)-1,2,3,4-tetrahydro- 1,5-naphthyridine-3,7-diyl)dicarbamate Nuclear receptor ROR-gamma Human 902 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352799&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186254 386393952 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945832 Cc1nn(cc1S(=O)(=O)N1CC(Cc2ncc(NC(=O)OCc3ccccc3)cc12)NC(=O)OC(C)(C)C)C(F)F InChI=1S/C26H30F2N6O6S/c1-16-22(14-33(32-16)23(27)28)41(37,38)34-13-19(31-25(36)40-26(2,3)4)10-20-21(34)11-18(12-29-20)30-24(35)39-15-17-8-6-5-7-9-17/h5-9,11-12,14,19,23H,10,13,15H2,1-4H3,(H,30,35)(H,31,36) DGCOFHBXVLZHIU-UHFFFAOYSA-N 352800 US10745364, Example 74C::US9809561, 74C::benzyl tert-butyl (1-((1-(difluoromethyl)-3- methyl-1H-pyrazol-4-yl)sulfonyl)-1,2,3,4- tetrahydro-1,5-naphthyridine-3,7- diyl)dicarbamate Nuclear receptor ROR-gamma Human 4955 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352800&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118186256 386393953 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945833 Fc1ccc(cc1)S(=O)(=O)N1C[C@H](Cc2ncc(NC(=O)OCc3ccccc3)cc12)N1CCCC1=O InChI=1S/C26H25FN4O5S/c27-19-8-10-22(11-9-19)37(34,35)31-16-21(30-12-4-7-25(30)32)14-23-24(31)13-20(15-28-23)29-26(33)36-17-18-5-2-1-3-6-18/h1-3,5-6,8-11,13,15,21H,4,7,12,14,16-17H2,(H,29,33)/t21-/m0/s1 RGSRHUFLURDVBE-NRFANRHFSA-N 352801 (S)-benzyl (5-((4-fluorophenyl)sulfonyl)-7-(2-oxopyrrolidin-1-yl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate ::US10745364, Example 75::US9809561, 75 Nuclear receptor ROR-gamma Human 1923 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352801&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187415 386393954 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945834 CC(C)(C)COC(=O)Nc1cnc2C[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)N1CCCC1=O InChI=1S/C24H29FN4O5S/c1-24(2,3)15-34-23(31)27-17-11-21-20(26-13-17)12-18(28-10-4-5-22(28)30)14-29(21)35(32,33)19-8-6-16(25)7-9-19/h6-9,11,13,18H,4-5,10,12,14-15H2,1-3H3,(H,27,31)/t18-/m0/s1 LCKUWBABSVDUCU-SFHVURJKSA-N 352802 (S)-neopentyl (5-((4-fluorophenyl)sulfonyl)-7-(2-oxopyrrolidin-1-yl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate::US10745364, Example 76A::US9809561, 76A Nuclear receptor ROR-gamma Human 3309 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352802&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187283 386393955 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945835 CC(C)(C)COC(=O)Nc1cnc2C[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)N1CCCC1=O InChI=1S/C24H29FN4O5S/c1-24(2,3)15-34-23(31)27-17-11-21-20(26-13-17)12-18(28-10-4-5-22(28)30)14-29(21)35(32,33)19-8-6-16(25)7-9-19/h6-9,11,13,18H,4-5,10,12,14-15H2,1-3H3,(H,27,31)/t18-/m1/s1 LCKUWBABSVDUCU-GOSISDBHSA-N 352803 (R)-neopentyl (5-((4-fluorophenyl)sulfonyl)-7-(2-oxopyrrolidin-1-yl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate ::US10745364, Example 76B::US9809561, 76B Nuclear receptor ROR-gamma Human 270 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352803&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267875 386393956 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945836 CC(C)(C)OC(=O)Nc1cnc2CC(O)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C19H22FN3O5S/c1-19(2,3)28-18(25)22-13-8-17-16(21-10-13)9-14(24)11-23(17)29(26,27)15-6-4-12(20)5-7-15/h4-8,10,14,24H,9,11H2,1-3H3,(H,22,25) AEOIIKJFSJEZFP-UHFFFAOYSA-N 352804 US10745364, Example 77::US9809561, 77::tert-butyl (5-((4-fluorophenyl)sulfonyl)-7-hydroxy-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate Nuclear receptor ROR-gamma Human 192 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352804&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187205 386393957 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945837 Cc1nn(cc1S(=O)(=O)N1C[C@@H](CO)Cc2ncc(NC(=O)OCC(C)(C)C)cc12)C(F)F InChI=1S/C20H27F2N5O5S/c1-12-17(9-26(25-12)18(21)22)33(30,31)27-8-13(10-28)5-15-16(27)6-14(7-23-15)24-19(29)32-11-20(2,3)4/h6-7,9,13,18,28H,5,8,10-11H2,1-4H3,(H,24,29)/t13-/m0/s1 PLFMPJKYUDQRIL-ZDUSSCGKSA-N 352806 (S)-neopentyl (5-((1-(difluoromethyl)-3-methyl-1H-pyrazol-4-yl)sulfonyl)-7-(hydroxymethyl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate::US10745364, Example 78A::US9809561, 78B Nuclear receptor ROR-gamma Human 830 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352806&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633114 386393959 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945838 Cc1nn(cc1S(=O)(=O)N1C[C@H](CO)Cc2ncc(NC(=O)OCC(C)(C)C)cc12)C(F)F InChI=1S/C20H27F2N5O5S/c1-12-17(9-26(25-12)18(21)22)33(30,31)27-8-13(10-28)5-15-16(27)6-14(7-23-15)24-19(29)32-11-20(2,3)4/h6-7,9,13,18,28H,5,8,10-11H2,1-4H3,(H,24,29)/t13-/m1/s1 PLFMPJKYUDQRIL-CYBMUJFWSA-N 352805 (R)-neopentyl (5-((1-(difluoromethyl)-3-methyl-1H-pyrazol-4-yl)sulfonyl)-7-(hydroxymethyl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate::US10745364, Example 78B::US9809561, 78A Nuclear receptor ROR-gamma Human 313 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352805&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187425 386393958 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945839 Cc1cccc(c1)S(=O)(=O)N1CC(CO)Cc2ncc(NC(=O)OC(C)(C)C)cc12 InChI=1S/C21H27N3O5S/c1-14-6-5-7-17(8-14)30(27,28)24-12-15(13-25)9-18-19(24)10-16(11-22-18)23-20(26)29-21(2,3)4/h5-8,10-11,15,25H,9,12-13H2,1-4H3,(H,23,26) ZAPUMBTZGCGDMX-UHFFFAOYSA-N 352807 US10745364, Example 79A::US9809561, 79A::tert-butyl (7-(hydroxymethyl)-5-(m- tolylsulfonyl)-5,6,7,8-tetrahydro-1,5- naphthyridin-3-yl)carbamate Nuclear receptor ROR-gamma Human 63.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352807&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187218 386393960 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945840 CC(C)(C)OC(=O)Nc1cnc2CC(CO)CN(c2c1)S(=O)(=O)c1ccc(F)c(F)c1 InChI=1S/C20H23F2N3O5S/c1-20(2,3)30-19(27)24-13-7-18-17(23-9-13)6-12(11-26)10-25(18)31(28,29)14-4-5-15(21)16(22)8-14/h4-5,7-9,12,26H,6,10-11H2,1-3H3,(H,24,27) SQVLYEPZMKXNHE-UHFFFAOYSA-N 352808 US10745364, Example 79B::US9809561, 79B::tert-butyl (5-((3,4-difluorophenyl)sulfonyl)-7- (hydroxymethyl)-5,6,7,8-tetrahydro-1,5- naphthyridin-3-yl)carbamate Nuclear receptor ROR-gamma Human 130 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352808&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187216 386393961 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945841 CC(C)(C)COC(=O)Nc1cnc2C[C@@H](CO)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C21H26FN3O5S/c1-21(2,3)13-30-20(27)24-16-9-19-18(23-10-16)8-14(12-26)11-25(19)31(28,29)17-6-4-15(22)5-7-17/h4-7,9-10,14,26H,8,11-13H2,1-3H3,(H,24,27)/t14-/m1/s1 ZZIMAUFKJSEXAI-CQSZACIVSA-N 352809 (R or S)-neopentyl (5-((4- fluorophenyl)sulfonyl)-7-(hydroxymethyl)- 5,6,7,8-tetrahydro-1,5-naphthyridin-3- yl)carbamate::US10745364, Example 79C::US9809561, 79C Nuclear receptor ROR-gamma Human 603 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352809&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187459 386393962 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945842 CC(C)(C)COC(=O)Nc1cnc2C[C@H](CO)CN(c2c1)S(=O)(=O)c1ccc(F)cc1 InChI=1S/C21H26FN3O5S/c1-21(2,3)13-30-20(27)24-16-9-19-18(23-10-16)8-14(12-26)11-25(19)31(28,29)17-6-4-15(22)5-7-17/h4-7,9-10,14,26H,8,11-13H2,1-3H3,(H,24,27)/t14-/m0/s1 ZZIMAUFKJSEXAI-AWEZNQCLSA-N 352810 (S or R)-neopentyl (5-((4- fluorophenyl)sulfonyl)-7-(hydroxymethyl)- 5,6,7,8-tetrahydro-1,5-naphthyridin-3- yl)carbamate::US10745364, Example 79D::US9809561, 79D Nuclear receptor ROR-gamma Human 190 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352810&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187455 386393963 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945843 Cc1nn(cc1S(=O)(=O)N1C[C@H](CN2CC[C@@H](O)C2)Cc2ncc(NC([O-])=O)cc12)C(F)F InChI=1S/C19H24F2N6O5S/c1-11-17(10-26(24-11)18(20)21)33(31,32)27-8-12(7-25-3-2-14(28)9-25)4-15-16(27)5-13(6-22-15)23-19(29)30/h5-6,10,12,14,18,23,28H,2-4,7-9H2,1H3,(H,29,30)/p-1/t12-,14+/m0/s1 ABDIUTMOYKUVRI-GXTWGEPZSA-M 352811 ((S)-5-((1-(difluoromethyl)-3-methyl-1H-pyrazol-4-yl)sulfonyl)-7-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate::US10745364, Example 80::US9809561, 80 Nuclear receptor ROR-gamma Human 330 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352811&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267876 386393964 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945844 CC(C)(OC(=O)Nc1ccc2OC(CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(=O)C(F)(F)F)C(F)(F)F InChI=1S/C21H17F7N2O6S/c1-19(2,21(26,27)28)36-18(32)29-12-5-8-15-14(9-12)30(10-16(35-15)17(31)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16H,10H2,1-2H3,(H,29,32) WIXINMPJYAIFJE-UHFFFAOYSA-N 352812 (R and S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((4- fluorophenyl)sulfonyl)-2-(2,2,2- trifluoroacetyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 6B::US9809561, 6B Nuclear receptor ROR-gamma Human 40.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352812&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118181162 386393965 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945845 CNS(=O)(=O)NC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cn(nc1OCCO)C(F)F InChI=1S/C21H27F5N6O9S2/c1-20(2,21(24,25)26)41-19(34)29-12-4-5-15-14(8-12)32(10-13(40-15)9-28-43(37,38)27-3)42(35,36)16-11-31(18(22)23)30-17(16)39-7-6-33/h4-5,8,11,13,18,27-28,33H,6-7,9-10H2,1-3H3,(H,29,34)/t13-/m0/s1 MZQPZSIDBBNOCH-ZDUSSCGKSA-N 352813 2,2,2-trifluoro-1,1-dimethylethyl [(2S)-4- {[1-(difluoromethyl)-3-(2- hydroxyethoxy)-1H-pyrazol-4- yl]sulfonyl}-2- {[(methylsulfamoyl)amino]methyl}- 3,4-dihydro-2H-1,4-benzoxazin-6- yl]carbamate::US10745364, Example 13AG::US9809561, 13AG Nuclear receptor ROR-gamma Human 5.84 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352813&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633154 386393966 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945846 CCn1cc(c(OCCO)n1)S(=O)(=O)N1C[C@H](CC(C)(C)NC(C)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H36F3N5O8S/c1-7-33-15-21(22(32-33)40-11-10-35)43(38,39)34-14-18(13-24(3,4)31-16(2)36)41-20-9-8-17(12-19(20)34)30-23(37)42-25(5,6)26(27,28)29/h8-9,12,15,18,35H,7,10-11,13-14H2,1-6H3,(H,30,37)(H,31,36)/t18-/m0/s1 PDAVGYXMNQEOCD-SFHVURJKSA-N 352815 2,2,2-trifluoro-1,1-dimethylethyl [(2S)-2- [2-(acetylamino)-2-methylpropyl]-4-{[l- ethyl-3-(2-hydroxyethoxy)-1H-pyrazol-4- yl]sulfonyl}-3,4-dihydro-2H-1,4- benzoxazin-6-yl]carbamate::US10745364, Example 57U::US9809561, 57U Nuclear receptor ROR-gamma Human 19.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352815&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187481 386393967 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945847 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(F)c1)[C@H](O)C(F)(F)F)C(F)(F)F InChI=1S/C21H18F8N2O6S/c1-19(2,21(27,28)29)37-18(33)30-10-3-6-15-14(7-10)31(9-16(36-15)17(32)20(24,25)26)38(34,35)11-4-5-12(22)13(23)8-11/h3-8,16-17,32H,9H2,1-2H3,(H,30,33)/t16-,17+/m1/s1 SQRPLJJABYHOSH-SJORKVTESA-N 352816 US10745364, Example 81A::US9809561, 81A Nuclear receptor ROR-gamma Human 99.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352816&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267877 386393968 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945848 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(F)c1)[C@H](O)C(F)(F)F)C(F)(F)F InChI=1S/C21H18F8N2O6S/c1-19(2,21(27,28)29)37-18(33)30-10-3-6-15-14(7-10)31(9-16(36-15)17(32)20(24,25)26)38(34,35)11-4-5-12(22)13(23)8-11/h3-8,16-17,32H,9H2,1-2H3,(H,30,33)/t16-,17-/m0/s1 SQRPLJJABYHOSH-IRXDYDNUSA-N 352818 US10745364, Example 81B::US9809561, 81C Nuclear receptor ROR-gamma Human 28.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352818&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267879 386393970 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945849 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)c(F)c1)[C@@H](O)C(F)(F)F)C(F)(F)F InChI=1S/C21H18F8N2O6S/c1-19(2,21(27,28)29)37-18(33)30-10-3-6-15-14(7-10)31(9-16(36-15)17(32)20(24,25)26)38(34,35)11-4-5-12(22)13(23)8-11/h3-8,16-17,32H,9H2,1-2H3,(H,30,33)/t16-,17-/m1/s1 SQRPLJJABYHOSH-IAGOWNOFSA-N 458894 US10745364, Example 81C Nuclear receptor ROR-gamma Human 5.14 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458894&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 140747590 441290158 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945850 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)[C@H](O)C(F)(F)F InChI=1S/C20H21ClF6N4O6S/c1-4-30-9-14(16(21)29-30)38(34,35)31-8-13(15(32)19(22,23)24)36-12-6-5-10(7-11(12)31)28-17(33)37-18(2,3)20(25,26)27/h5-7,9,13,15,32H,4,8H2,1-3H3,(H,28,33)/t13-,15+/m1/s1 RNWFUCOEQSFFSU-HIFRSBDPSA-N 352819 1,1,1-trifluoro-2-methylpropan-2-yl ((R or S)-4-((3-chloro-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-2-((S or R)- 2,2,2-trifluoro-1-hydroxyethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 81D::US9809561, 81D Nuclear receptor ROR-gamma Human 16.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352819&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187291 386393971 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945851 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)[C@@H](O)C(F)(F)F InChI=1S/C20H21ClF6N4O6S/c1-4-30-9-14(16(21)29-30)38(34,35)31-8-13(15(32)19(22,23)24)36-12-6-5-10(7-11(12)31)28-17(33)37-18(2,3)20(25,26)27/h5-7,9,13,15,32H,4,8H2,1-3H3,(H,28,33)/t13-,15-/m1/s1 RNWFUCOEQSFFSU-UKRRQHHQSA-N 352820 1,1,1-trifluoro-2-methylpropan-2-yl ((R or S)-4-((3-chloro-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-2-((S or R)- 2,2,2-trifluoro-1-hydroxyethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 81E::US9809561, 81E Nuclear receptor ROR-gamma Human 9.03 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352820&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187287 386393972 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945852 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)[C@@H](O)C(F)(F)F InChI=1S/C20H21ClF6N4O6S/c1-4-30-9-14(16(21)29-30)38(34,35)31-8-13(15(32)19(22,23)24)36-12-6-5-10(7-11(12)31)28-17(33)37-18(2,3)20(25,26)27/h5-7,9,13,15,32H,4,8H2,1-3H3,(H,28,33)/t13-,15+/m0/s1 RNWFUCOEQSFFSU-DZGCQCFKSA-N 352821 1,1,1-trifluoro-2-methylpropan-2-yl ((R or S)-4-((3-chloro-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-2-((S or R)- 2,2,2-trifluoro-1-hydroxyethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 81F::US9809561, 81F Nuclear receptor ROR-gamma Human 3.33 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352821&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187302 386393973 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945853 CC(C)(OC(=O)Nc1ccc2OC(CN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(O)C(F)(F)F)C(F)(F)F InChI=1S/C21H19F7N2O6S/c1-19(2,21(26,27)28)36-18(32)29-12-5-8-15-14(9-12)30(10-16(35-15)17(31)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16-17,31H,10H2,1-2H3,(H,29,32) UGHBPFCUSOGZFE-UHFFFAOYSA-N 352822 1,1,1-trifluoro-2-methylpropan-2-yl ((S and R)-4-((4- fluorophenyl)sulfonyl)-2-((S and R)- 2,2,2-trifluoro-1-hydroxyethyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 81G::US9809561, 81G Nuclear receptor ROR-gamma Human 27.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352822&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118180908 386393974 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945854 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)[C@@H](N)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F7N3O5S/c1-19(2,21(26,27)28)36-18(32)30-12-5-8-15-14(9-12)31(10-16(35-15)17(29)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16-17H,10,29H2,1-2H3,(H,30,32)/t16-,17+/m0/s1 DYXCPJAJSCHBLW-DLBZAZTESA-N 352823 US10745364, Example 82A::US9809561, 82A Nuclear receptor ROR-gamma Human 231 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352823&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187226 386393975 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945855 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)[C@H](N)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F7N3O5S/c1-19(2,21(26,27)28)36-18(32)30-12-5-8-15-14(9-12)31(10-16(35-15)17(29)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16-17H,10,29H2,1-2H3,(H,30,32)/t16-,17+/m1/s1 DYXCPJAJSCHBLW-SJORKVTESA-N 352826 US10745364, Example 82B::US9809561, 82D Nuclear receptor ROR-gamma Human 8.85 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352826&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187219 386393978 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945856 CC(C)(OC(=O)Nc1ccc2O[C@@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)[C@H](N)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F7N3O5S/c1-19(2,21(26,27)28)36-18(32)30-12-5-8-15-14(9-12)31(10-16(35-15)17(29)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16-17H,10,29H2,1-2H3,(H,30,32)/t16-,17-/m0/s1 DYXCPJAJSCHBLW-IRXDYDNUSA-N 352824 US10745364, Example 82C::US9809561, 82B Nuclear receptor ROR-gamma Human 158 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352824&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187220 386393976 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945857 CC(C)(OC(=O)Nc1ccc2O[C@H](CN(c2c1)S(=O)(=O)c1ccc(F)cc1)[C@@H](N)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F7N3O5S/c1-19(2,21(26,27)28)36-18(32)30-12-5-8-15-14(9-12)31(10-16(35-15)17(29)20(23,24)25)37(33,34)13-6-3-11(22)4-7-13/h3-9,16-17H,10,29H2,1-2H3,(H,30,32)/t16-,17-/m1/s1 DYXCPJAJSCHBLW-IAGOWNOFSA-N 352825 US10745364, Example 82D::US9809561, 82C Nuclear receptor ROR-gamma Human 7.90 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352825&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187225 386393977 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945858 CCS(=O)(=O)CC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H29F3N2O7S2/c1-5-37(31,32)12-11-18-15-29(38(33,34)19-8-6-7-16(13-19)24(25,26)27)20-14-17(9-10-21(20)35-18)28-22(30)36-23(2,3)4/h6-10,13-14,18H,5,11-12,15H2,1-4H3,(H,28,30)/t18-/m0/s1 HPENRQZPQZCKKG-SFHVURJKSA-N 352827 US10745364, Example 83::US9809561, 83 Nuclear receptor ROR-gamma Human 4.81 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352827&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187559 386393979 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945859 CCS(=O)(=O)CC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C24H26F6N2O7S2/c1-4-40(34,35)11-10-17-14-32(41(36,37)18-7-5-6-15(12-18)23(25,26)27)19-13-16(8-9-20(19)38-17)31-21(33)39-22(2,3)24(28,29)30/h5-9,12-13,17H,4,10-11,14H2,1-3H3,(H,31,33)/t17-/m0/s1 GFYNZOYGUQBZSS-KRWDZBQOSA-N 352828 US10745364, Example 84::US9809561, 84 Nuclear receptor ROR-gamma Human 7.49 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352828&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187414 386393980 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945860 CNS(=O)(=O)NC[C@@H]1Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc2N([C@@H]1C)S(=O)(=O)c1cn(nc1C)C(F)F InChI=1S/C21H27F5N6O7S2/c1-11-17(10-31(30-11)18(22)23)40(34,35)32-12(2)16(9-28-41(36,37)27-5)38-15-7-6-13(8-14(15)32)29-19(33)39-20(3,4)21(24,25)26/h6-8,10,12,16,18,27-28H,9H2,1-5H3,(H,29,33)/t12-,16+/m1/s1 FVNXQBLQMLAZRY-WBMJQRKESA-N 352829 US10745364, Example 85::US9809561, 85 Nuclear receptor ROR-gamma Human 13.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352829&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187224 386393981 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945861 C[C@@H]1[C@H](CNC(=O)Oc2ccccc2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc2N1S(=O)(=O)c1ccc(F)c(F)c1 InChI=1S/C28H26F5N3O7S/c1-16-24(15-34-25(37)41-18-7-5-4-6-8-18)42-23-12-9-17(35-26(38)43-27(2,3)28(31,32)33)13-22(23)36(16)44(39,40)19-10-11-20(29)21(30)14-19/h4-14,16,24H,15H2,1-3H3,(H,34,37)(H,35,38)/t16-,24+/m1/s1 SBIZDEPYOUOMNQ-GYCJOSAFSA-N 458813 US10745364, Example 86 Nuclear receptor ROR-gamma Human 64.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458813&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903355 441290077 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945862 CC(=O)NC[C@H]1COc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc2N1S(=O)(=O)c1ccc(F)cc1 InChI=1S/C22H23F4N3O6S/c1-13(30)27-11-16-12-34-19-9-6-15(28-20(31)35-21(2,3)22(24,25)26)10-18(19)29(16)36(32,33)17-7-4-14(23)5-8-17/h4-10,16H,11-12H2,1-3H3,(H,27,30)(H,28,31)/t16-/m0/s1 UJHUCNYMJXBBDP-INIZCTEOSA-N 352831 US10745364, Example 87::US9809561, 87 Nuclear receptor ROR-gamma Human 233 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352831&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267881 386393983 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945863 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC2(CC2)C(N)=O)Oc2ccc(cc12)N(C([O-])=O)C(C)(C)C(F)(F)F InChI=1S/C23H27ClF3N5O6S/c1-4-30-12-17(18(24)29-30)39(36,37)31-11-14(10-22(7-8-22)19(28)33)38-16-6-5-13(9-15(16)31)32(20(34)35)21(2,3)23(25,26)27/h5-6,9,12,14H,4,7-8,10-11H2,1-3H3,(H2,28,33)(H,34,35)/p-1/t14-/m1/s1 YRNXFMHODJWOID-CQSZACIVSA-M 352832 US10745364, Example 88A::US9809561, 88A Nuclear receptor ROR-gamma Human 7.65 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352832&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267882 386393984 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945864 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC2(CC2)C(N)=O)Oc2ccc(cc12)N(C([O-])=O)C(C)(C)C(F)(F)F InChI=1S/C23H27ClF3N5O6S/c1-4-30-12-17(18(24)29-30)39(36,37)31-11-14(10-22(7-8-22)19(28)33)38-16-6-5-13(9-15(16)31)32(20(34)35)21(2,3)23(25,26)27/h5-6,9,12,14H,4,7-8,10-11H2,1-3H3,(H2,28,33)(H,34,35)/p-1/t14-/m0/s1 YRNXFMHODJWOID-AWEZNQCLSA-M 352833 US10745364, Example 88B::US9809561, 88B Nuclear receptor ROR-gamma Human 5.95 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352833&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267883 386393985 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945865 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](C[C@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H29ClF3N5O6S/c1-4-32-12-19(20(25)31-32)40(36,37)33-11-15(10-16(21(29)34)13-5-6-13)38-18-8-7-14(9-17(18)33)30-22(35)39-23(2,3)24(26,27)28/h7-9,12-13,15-16H,4-6,10-11H2,1-3H3,(H2,29,34)(H,30,35)/t15-,16+/m0/s1 JHQBNOCIYPOGFX-JKSUJKDBSA-N 352834 US10745364, Example 89A::US9809561, 89A Nuclear receptor ROR-gamma Human 22.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352834&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187476 386393986 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945866 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](C[C@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H29ClF3N5O6S/c1-4-32-12-19(20(25)31-32)40(36,37)33-11-15(10-16(21(29)34)13-5-6-13)38-18-8-7-14(9-17(18)33)30-22(35)39-23(2,3)24(26,27)28/h7-9,12-13,15-16H,4-6,10-11H2,1-3H3,(H2,29,34)(H,30,35)/t15-,16-/m1/s1 JHQBNOCIYPOGFX-HZPDHXFCSA-N 458899 US10745364, Example 89B Nuclear receptor ROR-gamma Human 12.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458899&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903369 441290163 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945867 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC(C)(C)C(N)=O)Oc2ccc(cc12)N(C([O-])=O)C(C)(C)C(F)(F)F InChI=1S/C23H29ClF3N5O6S/c1-6-30-12-17(18(24)29-30)39(36,37)31-11-14(10-21(2,3)19(28)33)38-16-8-7-13(9-15(16)31)32(20(34)35)22(4,5)23(25,26)27/h7-9,12,14H,6,10-11H2,1-5H3,(H2,28,33)(H,34,35)/p-1/t14-/m1/s1 LWKLDKJNJVZVRD-CQSZACIVSA-M 352836 US10745364, Example 90A::US9809561, 90A Nuclear receptor ROR-gamma Human 26.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352836&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267884 386393988 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945868 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(cc12)N(C([O-])=O)C(C)(C)C(F)(F)F InChI=1S/C23H29ClF3N5O6S/c1-6-30-12-17(18(24)29-30)39(36,37)31-11-14(10-21(2,3)19(28)33)38-16-8-7-13(9-15(16)31)32(20(34)35)22(4,5)23(25,26)27/h7-9,12,14H,6,10-11H2,1-5H3,(H2,28,33)(H,34,35)/p-1/t14-/m0/s1 LWKLDKJNJVZVRD-AWEZNQCLSA-M 352837 US10745364, Example 90B::US9809561, 90B Nuclear receptor ROR-gamma Human 6.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352837&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267885 386393989 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945869 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H29ClF3N5O6S/c1-6-31-12-17(18(24)30-31)39(35,36)32-11-14(10-21(2,3)19(28)33)37-16-8-7-13(9-15(16)32)29-20(34)38-22(4,5)23(25,26)27/h7-9,12,14H,6,10-11H2,1-5H3,(H2,28,33)(H,29,34)/t14-/m1/s1 UDXDJCVNQFMCSQ-CQSZACIVSA-N 352838 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(3- amino-2,2-dimethyl-3- oxopropyl)-4-((3-chloro-1- ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91A::US9809561, 91A Nuclear receptor ROR-gamma Human 26.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352838&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187507 386393990 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945870 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H29ClF3N5O6S/c1-6-31-12-17(18(24)30-31)39(35,36)32-11-14(10-21(2,3)19(28)33)37-16-8-7-13(9-15(16)32)29-20(34)38-22(4,5)23(25,26)27/h7-9,12,14H,6,10-11H2,1-5H3,(H2,28,33)(H,29,34)/t14-/m0/s1 UDXDJCVNQFMCSQ-AWEZNQCLSA-N 352839 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(3- amino-2,2-dimethyl-3- oxopropyl)-4-((3-chloro-1- ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91B::US9809561, 91B Nuclear receptor ROR-gamma Human 6.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352839&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187508 386393991 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945871 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H29F4N3O7S/c1-23(2,21(30)33)12-15-13-32(40(35,36)16-7-8-17(26)20(11-16)37-5)18-10-14(6-9-19(18)38-15)31-22(34)39-24(3,4)25(27,28)29/h6-11,15H,12-13H2,1-5H3,(H2,30,33)(H,31,34)/t15-/m0/s1 OZDVEWLASYJNGA-HNNXBMFYSA-N 352840 2,2,2-trifluoro-1,1- dimethylethyl {(2S)-2-(3- amino-2,2-dimethyl-3- oxopropyl)-4-[(4-fluoro-3- methoxyphenyl)sulfonyl]- 3,4-dihydro-2H-1,4- benzoxazin-6-yl}carbamate::US10745364, Example 91C::US9809561, 91C Nuclear receptor ROR-gamma Human 6.97 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352840&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633236 386393992 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945872 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H29F4N3O7S/c1-25(2,26(28,29)30)40-24(35)32-15-6-9-21-20(10-15)33(13-16(39-21)11-18(23(31)34)14-4-5-14)41(36,37)17-7-8-19(27)22(12-17)38-3/h6-10,12,14,16,18H,4-5,11,13H2,1-3H3,(H2,31,34)(H,32,35)/t16-,18-/m0/s1 IUODAKKMTWLWRV-WMZOPIPTSA-N 352841 1,1,1-trifluoro-2- methylpropan-2-yl ((S)-2- ((S or R)-3-amino-2- cyclopropyl-3-oxopropyl)- 4-((4-fluoro-3- methoxyphenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91D::US9809561, 91D Nuclear receptor ROR-gamma Human 15.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352841&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633084 386393993 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945873 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](C[C@@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H34F3N5O7S/c1-5-33-14-21(23(32-33)39-6-2)42(37,38)34-13-17(12-18(22(30)35)15-7-8-15)40-20-10-9-16(11-19(20)34)31-24(36)41-25(3,4)26(27,28)29/h9-11,14-15,17-18H,5-8,12-13H2,1-4H3,(H2,30,35)(H,31,36)/t17-,18-/m0/s1 UDUCCIKREUYYQQ-ROUUACIJSA-N 352842 1,1,1-trifluoro-2- methylpropan-2-yl ((S)-2- ((S or R)-3-amino-2- cyclopropyl-3-oxopropyl)- 4-((3-ethoxy-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91E::US9809561, 91E Nuclear receptor ROR-gamma Human 13.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352842&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633204 386393994 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945874 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H29F4N3O7S/c1-25(2,26(28,29)30)40-24(35)32-15-6-9-21-20(10-15)33(13-16(39-21)11-18(23(31)34)14-4-5-14)41(36,37)17-7-8-19(27)22(12-17)38-3/h6-10,12,14,16,18H,4-5,11,13H2,1-3H3,(H2,31,34)(H,32,35)/t16-,18+/m0/s1 IUODAKKMTWLWRV-FUHWJXTLSA-N 352843 1,1,1-trifluoro-2- methylpropan-2-yl ((S)-2- ((S or R)-3-amino-2- cyclopropyl-3-oxopropyl)- 4-((4-fluoro-3- methoxyphenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91F::US9809561, 91F Nuclear receptor ROR-gamma Human 18.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352843&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187518 386393995 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945875 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](C[C@H](C2CC2)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H34F3N5O7S/c1-5-33-14-21(23(32-33)39-6-2)42(37,38)34-13-17(12-18(22(30)35)15-7-8-15)40-20-10-9-16(11-19(20)34)31-24(36)41-25(3,4)26(27,28)29/h9-11,14-15,17-18H,5-8,12-13H2,1-4H3,(H2,30,35)(H,31,36)/t17-,18+/m0/s1 UDUCCIKREUYYQQ-ZWKOTPCHSA-N 352844 1,1,1-trifluoro-2- methylpropan-2-yl ((S)-2- ((S or R)-3-amino-2- cyclopropyl-3-oxopropyl)-4- ((3-ethoxy-1-ethyl-1H- pyrazol-4-yl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 91G::US9809561, 91G Nuclear receptor ROR-gamma Human 148 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352844&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187519 386393996 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945876 CC(C)(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cncc(c1)C(F)(F)F)C(N)=O InChI=1S/C24H26F6N4O6S/c1-21(2,19(31)35)9-15-12-34(41(37,38)16-7-13(10-32-11-16)23(25,26)27)17-8-14(5-6-18(17)39-15)33-20(36)40-22(3,4)24(28,29)30/h5-8,10-11,15H,9,12H2,1-4H3,(H2,31,35)(H,33,36)/t15-/m0/s1 XUEOUICCPHMPOF-HNNXBMFYSA-N 352845 2,2,2-trifluoro-1,1- dimethylethyl [(2S)-2-(3- amino-2,2-dimethyl-3- oxopropyl)-4-{[5- (trifluoromethyl)pyridin-3- yl]sulfonyl}-3,4-dihydro- 2H-1,4-benzoxazin-6- yl]carbamate::US10745364, Example 91H::US9809561, 91H Nuclear receptor ROR-gamma Human 9.30 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352845&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633162 386393997 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945877 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H34F3N5O7S/c1-7-32-14-19(20(31-32)38-8-2)41(36,37)33-13-16(12-23(3,4)21(29)34)39-18-10-9-15(11-17(18)33)30-22(35)40-24(5,6)25(26,27)28/h9-11,14,16H,7-8,12-13H2,1-6H3,(H2,29,34)(H,30,35)/t16-/m0/s1 WRJVYNPGSKELHZ-INIZCTEOSA-N 352846 2,2,2-trifluoro-1,1- dimethylethyl {2-(3-amino- 2,2-dimethyl-3-oxopropyl)- 4-[(3-ethoxy-1-ethyl-1H- pyrazol-4-yl)sulfonyl]-3,4- dihydro-2H-1,4-benzoxazin- 6-yl}carbamate::US10745364, Example 91i::US9809561, 91i Nuclear receptor ROR-gamma Human 24.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352846&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187602 386393998 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945878 CCn1cc(c(OCCO)n1)S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H34F3N5O8S/c1-6-32-14-19(20(31-32)39-10-9-34)42(37,38)33-13-16(12-23(2,3)21(29)35)40-18-8-7-15(11-17(18)33)30-22(36)41-24(4,5)25(26,27)28/h7-8,11,14,16,34H,6,9-10,12-13H2,1-5H3,(H2,29,35)(H,30,36)/t16-/m0/s1 WAJODPXYCZBOTG-INIZCTEOSA-N 352847 2,2,2-trifluoro-1,1- dimethylethyl [2-(3-amino- 2,2-dimethyl-3-oxopropyl)- 4-{[1-ethyl-3-(2- hydroxyethoxy)-1H-pyrazol- 4-yl]sulfonyl}-3,4-dihydro- 2H-1,4-benzoxazin-6- yl]carbamate::US10745364, Example 91J::US9809561, 91J Nuclear receptor ROR-gamma Human 70.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352847&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187595 386393999 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945879 CCn1cc(c(OCC(=O)OC)n1)S(=O)(=O)N1C[C@H](CC(C)(C)C(N)=O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H34F3N5O9S/c1-7-33-13-19(21(32-33)41-14-20(35)40-6)44(38,39)34-12-16(11-24(2,3)22(30)36)42-18-9-8-15(10-17(18)34)31-23(37)43-25(4,5)26(27,28)29/h8-10,13,16H,7,11-12,14H2,1-6H3,(H2,30,36)(H,31,37)/t16-/m0/s1 LXOWSZRWDTVUOW-INIZCTEOSA-N 352848 (S)-methyl 2-((4-((2-(3- amino-2,2-dimethyl-3- oxopropyl)-6-((((1,1,1- trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-2H- benzo[b][1,4]oxazin-4(3H)- yl)sulfonyl)-1-ethyl-1H- pyrazol-3-yl)oxy)acetate::US10745364, Example 91K::US9809561, 91K Nuclear receptor ROR-gamma Human 42.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352848&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187598 386394000 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945880 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCC#N)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C23H21F6N3O5S/c1-21(2,23(27,28)29)37-20(33)31-15-8-9-19-18(12-15)32(13-16(36-19)6-4-10-30)38(34,35)17-7-3-5-14(11-17)22(24,25)26/h3,5,7-9,11-12,16H,4,6,13H2,1-2H3,(H,31,33)/t16-/m0/s1 WXLXSUMZKGTEDL-INIZCTEOSA-N 352849 US10745364, Example 92::US9809561, 92 Nuclear receptor ROR-gamma Human 3.11 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352849&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187279 386394001 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945881 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC2(CC2)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H25ClF3N5O5S/c1-4-31-12-18(19(24)30-31)38(34,35)32-11-15(10-22(13-28)7-8-22)36-17-6-5-14(9-16(17)32)29-20(33)37-21(2,3)23(25,26)27/h5-6,9,12,15H,4,7-8,10-11H2,1-3H3,(H,29,33)/t15-/m0/s1 JKZUEBHCLZJCSV-HNNXBMFYSA-N 352850 US10745364, Example 93A::US9809561, 93A Nuclear receptor ROR-gamma Human 5.39 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352850&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187299 386394002 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945882 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC2(CC2)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H25ClF3N5O5S/c1-4-31-12-18(19(24)30-31)38(34,35)32-11-15(10-22(13-28)7-8-22)36-17-6-5-14(9-16(17)32)29-20(33)37-21(2,3)23(25,26)27/h5-6,9,12,15H,4,7-8,10-11H2,1-3H3,(H,29,33)/t15-/m1/s1 JKZUEBHCLZJCSV-OAHLLOKOSA-N 352851 US10745364, Example 93B::US9809561, 93B Nuclear receptor ROR-gamma Human 32.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352851&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187303 386394003 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945883 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H27ClF3N5O5S/c1-6-31-12-18(19(24)30-31)38(34,35)32-11-15(10-21(2,3)13-28)36-17-8-7-14(9-16(17)32)29-20(33)37-22(4,5)23(25,26)27/h7-9,12,15H,6,10-11H2,1-5H3,(H,29,33)/t15-/m1/s1 QPWPRXLTYGNTEJ-OAHLLOKOSA-N 352853 US10745364, Example 94A::US9809561, 94B Nuclear receptor ROR-gamma Human 74.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352853&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187362 386394005 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945884 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C23H27ClF3N5O5S/c1-6-31-12-18(19(24)30-31)38(34,35)32-11-15(10-21(2,3)13-28)36-17-8-7-14(9-16(17)32)29-20(33)37-22(4,5)23(25,26)27/h7-9,12,15H,6,10-11H2,1-5H3,(H,29,33)/t15-/m0/s1 QPWPRXLTYGNTEJ-HNNXBMFYSA-N 352852 US10745364, Example 94B::US9809561, 94A Nuclear receptor ROR-gamma Human 4.79 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352852&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187364 386394004 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945885 CC(C)(C[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C#N InChI=1S/C25H24F7N3O5S/c1-22(2,13-33)11-15-12-35(41(37,38)16-6-7-18(26)17(10-16)24(27,28)29)19-9-14(5-8-20(19)39-15)34-21(36)40-23(3,4)25(30,31)32/h5-10,15H,11-12H2,1-4H3,(H,34,36)/t15-/m1/s1 YKWITBMKJSBLHE-OAHLLOKOSA-N 352854 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((4-fluoro-3- (trifluoromethyl)phenyl)sulfonyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95A::US9809561, 95A Nuclear receptor ROR-gamma Human 32.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352854&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633213 386394006 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945886 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H27F4N3O6S/c1-23(2,14-30)12-16-13-32(39(34,35)17-7-8-18(26)21(11-17)36-5)19-10-15(6-9-20(19)37-16)31-22(33)38-24(3,4)25(27,28)29/h6-11,16H,12-13H2,1-5H3,(H,31,33)/t16-/m1/s1 HXUONNWKNPPYDN-MRXNPFEDSA-N 352855 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95B::US9809561, 95B Nuclear receptor ROR-gamma Human 138 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352855&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187411 386394007 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945887 Cc1cc(ccc1F)S(=O)(=O)N1C[C@@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H27F4N3O5S/c1-15-10-18(7-8-19(15)26)38(34,35)32-13-17(12-23(2,3)14-30)36-21-9-6-16(11-20(21)32)31-22(33)37-24(4,5)25(27,28)29/h6-11,17H,12-13H2,1-5H3,(H,31,33)/t17-/m1/s1 SXUXNMVJXDZPEM-QGZVFWFLSA-N 352857 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((4-fluoro-3- methylphenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95C::US9809561, 95C Nuclear receptor ROR-gamma Human 78.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352857&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187410 386394008 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945888 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H27F4N3O6S/c1-23(2,14-30)12-16-13-32(39(34,35)17-7-8-18(26)21(11-17)36-5)19-10-15(6-9-20(19)37-16)31-22(33)38-24(3,4)25(27,28)29/h6-11,16H,12-13H2,1-5H3,(H,31,33)/t16-/m0/s1 HXUONNWKNPPYDN-INIZCTEOSA-N 352858 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95D::US9809561, 95D Nuclear receptor ROR-gamma Human 5.73 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352858&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187407 386394009 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945889 Cc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H27F4N3O5S/c1-15-10-18(7-8-19(15)26)38(34,35)32-13-17(12-23(2,3)14-30)36-21-9-6-16(11-20(21)32)31-22(33)37-24(4,5)25(27,28)29/h6-11,17H,12-13H2,1-5H3,(H,31,33)/t17-/m0/s1 SXUXNMVJXDZPEM-KRWDZBQOSA-N 352859 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((4-fluoro-3- methylphenyl)sulfonyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95E::US9809561, 95E Nuclear receptor ROR-gamma Human 4.52 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352859&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187413 386394010 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945890 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H32F3N5O6S/c1-7-32-14-20(21(31-32)37-8-2)40(35,36)33-13-17(12-23(3,4)15-29)38-19-10-9-16(11-18(19)33)30-22(34)39-24(5,6)25(26,27)28/h9-11,14,17H,7-8,12-13H2,1-6H3,(H,30,34)/t17-/m1/s1 FIFCMGIWDBTMKW-QGZVFWFLSA-N 352860 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((3-ethoxy- 1-ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95F::US9809561, 95F Nuclear receptor ROR-gamma Human 524 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352860&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633165 386394011 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945891 CCOc1nn(CC)cc1S(=O)(=O)N1C[C@H](CC(C)(C)C#N)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H32F3N5O6S/c1-7-32-14-20(21(31-32)37-8-2)40(35,36)33-13-17(12-23(3,4)15-29)38-19-10-9-16(11-18(19)33)30-22(34)39-24(5,6)25(26,27)28/h9-11,14,17H,7-8,12-13H2,1-6H3,(H,30,34)/t17-/m0/s1 FIFCMGIWDBTMKW-KRWDZBQOSA-N 352861 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (2-(2-cyano- 2-methylpropyl)-4-((3-ethoxy- 1-ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 95G::US9809561, 95G Nuclear receptor ROR-gamma Human 10.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352861&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633208 386394012 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945892 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCC(=O)NS(=O)(=O)C3CC3)CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(F)(F)F InChI=1S/C26H26F7N3O8S2/c1-24(2,26(31,32)33)44-23(38)34-14-3-9-21-20(11-14)36(46(41,42)17-7-8-19(27)18(12-17)25(28,29)30)13-15(43-21)4-10-22(37)35-45(39,40)16-5-6-16/h3,7-9,11-12,15-16H,4-6,10,13H2,1-2H3,(H,34,38)(H,35,37)/t15-/m0/s1 PPQLGKRAULIEGJ-HNNXBMFYSA-N 352862 US10745364, Example 96::US9809561, 96 Nuclear receptor ROR-gamma Human 26.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352862&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633206 386394013 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945893 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](C[C@H](C)C(=O)NS(=O)(=O)C2CC2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H31ClF3N5O8S2/c1-5-33-13-20(21(26)31-33)44(39,40)34-12-16(10-14(2)22(35)32-43(37,38)17-7-8-17)41-19-9-6-15(11-18(19)34)30-23(36)42-24(3,4)25(27,28)29/h6,9,11,13-14,16-17H,5,7-8,10,12H2,1-4H3,(H,30,36)(H,32,35)/t14-,16-/m0/s1 KLPMNVSWRBTTPW-HOCLYGCPSA-N 352863 US10745364, Example 97A::US9809561, 97A Nuclear receptor ROR-gamma Human 12.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352863&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122633017 386394014 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945894 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](C[C@H](C)C(=O)NS(=O)(=O)C2CC2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C25H31ClF3N5O8S2/c1-5-33-13-20(21(26)31-33)44(39,40)34-12-16(10-14(2)22(35)32-43(37,38)17-7-8-17)41-19-9-6-15(11-18(19)34)30-23(36)42-24(3,4)25(27,28)29/h6,9,11,13-14,16-17H,5,7-8,10,12H2,1-4H3,(H,30,36)(H,32,35)/t14-,16+/m0/s1 KLPMNVSWRBTTPW-GOEBONIOSA-N 458903 US10745364, Example 97B Nuclear receptor ROR-gamma Human 29.0 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458903&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903370 441290167 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945895 Cc1ccc(cc1)S(=O)(=O)NC(=O)CC[C@@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C30H28F7N3O8S2/c1-17-4-8-20(9-5-17)49(43,44)39-26(41)13-7-19-16-40(50(45,46)21-10-11-23(31)22(15-21)29(32,33)34)24-14-18(6-12-25(24)47-19)38-27(42)48-28(2,3)30(35,36)37/h4-6,8-12,14-15,19H,7,13,16H2,1-3H3,(H,38,42)(H,39,41)/t19-/m1/s1 HXLYTJIJPSKSEX-LJQANCHMSA-N 458907 2,2,2-trifluoro-1,1-dimethylethyl [(2S)- 4-{[4-fluoro-3- (trifluoromethyl)phenyl]sulfonyl}-2-(3- {[(4-methylphenyl)sulfonyl]amino}-3- oxopropyl)-3,4-dihydro-2H-1,4- benzoxazin-6-yl]carbamate::US10745364, Example 98A Nuclear receptor ROR-gamma Human 40.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458907&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 155903371 441290171 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945896 Cc1ccc(cc1)S(=O)(=O)NC(=O)CC[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F InChI=1S/C30H28F7N3O8S2/c1-17-4-8-20(9-5-17)49(43,44)39-26(41)13-7-19-16-40(50(45,46)21-10-11-23(31)22(15-21)29(32,33)34)24-14-18(6-12-25(24)47-19)38-27(42)48-28(2,3)30(35,36)37/h4-6,8-12,14-15,19H,7,13,16H2,1-3H3,(H,38,42)(H,39,41)/t19-/m0/s1 HXLYTJIJPSKSEX-IBGZPJMESA-N 352866 2,2,2-trifluoro-1,1-dimethylethyl [(2S)- 4-{[4-fluoro-3- (trifluoromethyl)phenyl]sulfonyl}-2-(3- {[(4-methylphenyl)sulfonyl]amino}-3- oxopropyl)-3,4-dihydro-2H-1,4- benzoxazin-6-yl]carbamate::US10745364, Example 98B::US9809561, 98B Nuclear receptor ROR-gamma Human 46.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352866&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122614897 386394017 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945897 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCC(=O)NS(=O)(=O)C(F)(F)F)CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(F)(F)F InChI=1S/C24H21F10N3O8S2/c1-21(2,23(29,30)31)45-20(39)35-12-3-7-18-17(9-12)37(46(40,41)14-5-6-16(25)15(10-14)22(26,27)28)11-13(44-18)4-8-19(38)36-47(42,43)24(32,33)34/h3,5-7,9-10,13H,4,8,11H2,1-2H3,(H,35,39)(H,36,38)/t13-/m0/s1 HZTQYPUCHIXRMS-ZDUSSCGKSA-N 352867 2,2,2-trifluoro-1,1-dimethylethyl [(2S)- 4-{[4-fluoro-3- (trifluoromethyl)phenyl]sulfonyl}-2-(3- oxo-3-{[(trifluoro- methyl)sulfonyl]amino}propyl)- 3,4-dihydro-2H-1,4-benzoxazin-6- yl]carbamate::US10745364, Example 98C::US9809561, 98C Nuclear receptor ROR-gamma Human 1436 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352867&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187322 386394018 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945898 CC(C[C@H]1CN(c2cc(NC(=O)OC(C)(C)C(F)(F)F)ccc2O1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(=O)NS(=O)(=O)C1CC1 InChI=1S/C27H29F6N3O8S2/c1-15(23(37)35-45(39,40)19-8-9-19)11-18-14-36(46(41,42)20-6-4-5-16(12-20)26(28,29)30)21-13-17(7-10-22(21)43-18)34-24(38)44-25(2,3)27(31,32)33/h4-7,10,12-13,15,18-19H,8-9,11,14H2,1-3H3,(H,34,38)(H,35,37)/t15?,18-/m0/s1 VSGFMXADRZZHBV-PKHIMPSTSA-N 352868 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-2-((R and S)-3- (cyclopropanesulfonamido)-2-methyl- 3-oxopropyl)-4-((3- (trifluoromethyl)phenyl)sulfonyl)-3,4- dihydro-2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 98D::US9809561, 98D Nuclear receptor ROR-gamma Human 29.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352868&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187647 386394019 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945899 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](C[C@@H](C)C(=O)NS(=O)(=O)C(C)(C)C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H35ClF3N5O8S2/c1-8-34-14-20(21(27)32-34)44(38,39)35-13-17(11-15(2)22(36)33-45(40,41)24(3,4)5)42-19-10-9-16(12-18(19)35)31-23(37)43-25(6,7)26(28,29)30/h9-10,12,14-15,17H,8,11,13H2,1-7H3,(H,31,37)(H,33,36)/t15-,17+/m1/s1 ADLIJFJHJSCAPR-WBVHZDCISA-N 352869 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-4-((3-chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-((R or S)-3-(1,1- dimethylethylsulfonamido)-2-methyl-3- oxopropyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 98E::US9809561, 98E Nuclear receptor ROR-gamma Human 44.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352869&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187646 386394020 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945900 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@@H](C)C(=O)NS(=O)(=O)C2CC2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C27H31F4N3O9S2/c1-15(24(35)33-44(37,38)18-6-7-18)11-17-14-34(45(39,40)19-8-9-20(28)23(13-19)41-4)21-12-16(5-10-22(21)42-17)32-25(36)43-26(2,3)27(29,30)31/h5,8-10,12-13,15,17-18H,6-7,11,14H2,1-4H3,(H,32,36)(H,33,35)/t15-,17+/m1/s1 ZDERWKQIPAHQOC-WBVHZDCISA-N 352870 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-2-((R or S)-3- (cyclopropanesulfonamido)-2-methyl- 3-oxopropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 98F::US9809561, 98F Nuclear receptor ROR-gamma Human 10.8 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352870&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187652 386394021 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945901 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@@H](C)C(=O)NS(=O)(=O)C(C)(C)C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C28H35F4N3O9S2/c1-16(24(36)34-46(40,41)26(2,3)4)12-18-15-35(45(38,39)19-9-10-20(29)23(14-19)42-7)21-13-17(8-11-22(21)43-18)33-25(37)44-27(5,6)28(30,31)32/h8-11,13-14,16,18H,12,15H2,1-7H3,(H,33,37)(H,34,36)/t16-,18+/m1/s1 CQIFACCXEYBLHY-AEFFLSMTSA-N 352871 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-2-((R or S)-3-(1,1- dimethylethylsulfonamido)-2-methyl-3- oxopropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 98G::US9809561, 98G Nuclear receptor ROR-gamma Human 38.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352871&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187650 386394022 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945902 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@H](C)C(=O)NS(=O)(=O)C2CC2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C27H31F4N3O9S2/c1-15(24(35)33-44(37,38)18-6-7-18)11-17-14-34(45(39,40)19-8-9-20(28)23(13-19)41-4)21-12-16(5-10-22(21)42-17)32-25(36)43-26(2,3)27(29,30)31/h5,8-10,12-13,15,17-18H,6-7,11,14H2,1-4H3,(H,32,36)(H,33,35)/t15-,17-/m0/s1 ZDERWKQIPAHQOC-RDJZCZTQSA-N 352872 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-2-((R or S)-3- (cyclopropanesulfonamido)-2-methyl- 3-oxopropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 98H::US9809561, 98H Nuclear receptor ROR-gamma Human 6.33 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352872&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187651 386394023 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945903 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](C[C@H](C)C(=O)NS(=O)(=O)C(C)(C)C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C28H35F4N3O9S2/c1-16(24(36)34-46(40,41)26(2,3)4)12-18-15-35(45(38,39)19-9-10-20(29)23(14-19)42-7)21-13-17(8-11-22(21)43-18)33-25(37)44-27(5,6)28(30,31)32/h8-11,13-14,16,18H,12,15H2,1-7H3,(H,33,37)(H,34,36)/t16-,18-/m0/s1 CQIFACCXEYBLHY-WMZOPIPTSA-N 352873 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-2-((R or S)-3-(1,1- dimethylethylsulfonamido)-2-methyl-3- oxopropyl)-4-((4-fluoro-3- methoxyphenyl)sulfonyl)-3,4-dihydro- 2H-benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 98i::US9809561, 98i Nuclear receptor ROR-gamma Human 41.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352873&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187645 386394024 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945904 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](C[C@H](C)C(=O)NS(=O)(=O)C(C)(C)C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C26H35ClF3N5O8S2/c1-8-34-14-20(21(27)32-34)44(38,39)35-13-17(11-15(2)22(36)33-45(40,41)24(3,4)5)42-19-10-9-16(12-18(19)35)31-23(37)43-25(6,7)26(28,29)30/h9-10,12,14-15,17H,8,11,13H2,1-7H3,(H,31,37)(H,33,36)/t15-,17-/m0/s1 ADLIJFJHJSCAPR-RDJZCZTQSA-N 352874 1,1,1-trifluoro-2-methylpropan-2-yl ((S)-4-((3-chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-((R or S)-3-(1,1- dimethylethylsulfonamido)-2-methyl-3- oxopropyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 98J::US9809561, 98J Nuclear receptor ROR-gamma Human 28.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352874&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187523 386394025 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945905 CC(C)(OC(=O)Nc1ccc2O[C@@H](CC3COC3)CN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(F)(F)F InChI=1S/C24H23F7N2O6S/c1-22(2,24(29,30)31)39-21(34)32-14-3-6-20-19(8-14)33(10-15(38-20)7-13-11-37-12-13)40(35,36)16-4-5-18(25)17(9-16)23(26,27)28/h3-6,8-9,13,15H,7,10-12H2,1-2H3,(H,32,34)/t15-/m0/s1 ANHHGWIKKZPZOU-HNNXBMFYSA-N 352875 US10745364, Example 99::US9809561, 99 Nuclear receptor ROR-gamma Human 8.29 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352875&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187358 386394026 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945906 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2n[nH]c(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H23ClF3N7O6S/c1-4-32-11-16(18(23)31-32)40(36,37)33-10-13(6-8-17-28-19(34)30-29-17)38-15-7-5-12(9-14(15)33)27-20(35)39-21(2,3)22(24,25)26/h5,7,9,11,13H,4,6,8,10H2,1-3H3,(H,27,35)/t13-/m0/s1 JKBZARGJYWKUPX-ZDUSSCGKSA-N 352876 US10745364, Example 100::US9809561, 100 Nuclear receptor ROR-gamma Human 10.4 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352876&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267886 386394027 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945907 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2n[nH]c(=O)n2C)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 359991 (S)-1,1,1-trifluoro-2-methylpropan-2-yl(4-((3-chloro-1-ethyl-1H-pyrazol-4-yl)sulfonyl)-2-(2-(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (Example 101)::US10221146, Example 101::US10745364, Example 101 Nuclear receptor ROR-gamma Human 11.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359991&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187659 386399430 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945908 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3noc(=O)[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C24H22F6N4O7S/c1-22(2,24(28,29)30)40-20(35)31-14-6-8-18-17(11-14)34(12-15(39-18)7-9-19-32-21(36)41-33-19)42(37,38)16-5-3-4-13(10-16)23(25,26)27/h3-6,8,10-11,15H,7,9,12H2,1-2H3,(H,31,35)(H,32,33,36)/t15-/m0/s1 RAMKHHMPKQNNOA-HNNXBMFYSA-N 352878 US10745364, Example 104A::US9809561, 102 Nuclear receptor ROR-gamma Human 11.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352878&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267888 386394029 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945909 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352888 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-methyl-2-(5- oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)propyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104H::US9809561, 104H Nuclear receptor ROR-gamma Human 120 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352888&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267899 386394039 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945910 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352886 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-methyl-2-(5- oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)propyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104F::US9809561, 104F Nuclear receptor ROR-gamma Human 28.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352886&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267897 386394037 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945911 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3noc(=O)[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C24H22F6N4O7S/c1-22(2,24(28,29)30)40-20(35)31-14-6-8-18-17(11-14)34(12-15(39-18)7-9-19-32-21(36)41-33-19)42(37,38)16-5-3-4-13(10-16)23(25,26)27/h3-6,8,10-11,15H,7,9,12H2,1-2H3,(H,31,35)(H,32,33,36)/t15-/m0/s1 RAMKHHMPKQNNOA-HNNXBMFYSA-N 352878 US10745364, Example 104A::US9809561, 102 Nuclear receptor ROR-gamma Human 11.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352878&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267888 386394029 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945912 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3noc(=O)[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C1CC1)C(F)(F)F 352882 2,2,2-trifluoro-1,1- dimethylethyl {(2S)-4-[(3- cyclopropylphenyl)sulfonyl]-2- [2-(5-oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)ethyl]-3,4- dihydro-2H-1,4-benzoxazin-6- yl}carbamate::US10745364, Example 104B::US9809561, 104B Nuclear receptor ROR-gamma Human 12.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352882&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267893 386394033 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945913 CC(C)(C)OC(=O)Nc1ccc2O[C@@H](CCc3noc(=O)[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C1CC1 352883 US10745364, Example 104C::US9809561, 104C::tert-butyl {(2S)-4-[(3- cyclopropylphenyl)sulfonyl]-2- [2-(5-oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)ethyl]-3,4- dihydro-2H-1,4-benzoxazin-6- yl}carbamate Nuclear receptor ROR-gamma Human 8.77 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352883&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267894 386394034 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945914 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352884 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-(5-oxo-4,5- dihydro-1,2,4-oxadiazol-3- yl)ethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104D::US9809561, 104D Nuclear receptor ROR-gamma Human 11.9 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352884&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267895 386394035 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945915 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C)cc12 352885 (S)-tert-butyl (4-((3-chloro-1- ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-(5-oxo-4,5- dihydro-1,2,4-oxadiazol-3- yl)ethyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104E::US9809561, 104E Nuclear receptor ROR-gamma Human 9.24 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352885&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267896 386394036 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945916 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352886 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-methyl-2-(5- oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)propyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104F::US9809561, 104F Nuclear receptor ROR-gamma Human 50.7 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352886&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267897 386394037 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945917 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352887 (R)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((4- fluoro-3- methoxyphenyl)sulfonyl)-2-(2- methyl-2-(5-oxo-4,5-dihydro- 1,2,4-oxadiazol-3-yl)propyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104G::US9809561, 104G Nuclear receptor ROR-gamma Human 120 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352887&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267898 386394038 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945918 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352888 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((3- chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-2-(2-methyl-2-(5- oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)propyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104H::US9809561, 104H Nuclear receptor ROR-gamma Human 15.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352888&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267899 386394039 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945919 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(C)(C)c2noc(=O)[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352889 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((4- fluoro-3- methoxyphenyl)sulfonyl)-2-(2- methyl-2-(5-oxo-4,5-dihydro- 1,2,4-oxadiazol-3-yl)propyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US10745364, Example 104i::US9809561, 104i Nuclear receptor ROR-gamma Human 28.2 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352889&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139267900 386394040 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945920 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2n[nH]c(=O)o2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 360004 (S)-1,1,1-trifluoro-2-methylpropan-2-yl(4-((3-chloro-1-ethyl-1H-pyrazol-4-yl)sulfonyl)-2-(2-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)ethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (Example 105)::US10221146, Example 105::US10745364, Example 105 Nuclear receptor ROR-gamma Human 6.30 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=360004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=360004&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122632992 386399437 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945921 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CC(C)(C)c2n[nH]c(=O)o2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H28ClF3N6O7S/c1-6-33-12-17(18(25)32-33)42(37,38)34-11-14(10-22(2,3)19-30-31-21(36)40-19)39-16-8-7-13(9-15(16)34)29-20(35)41-23(4,5)24(26,27)28/h7-9,12,14H,6,10-11H2,1-5H3,(H,29,35)(H,31,36)/t14-/m0/s1 XXKCVXNTWGEVCS-AWEZNQCLSA-N 352891 US10745364, Example 106::US9809561, 106 Nuclear receptor ROR-gamma Human 5.71 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352891&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163325 386394042 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945922 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3n[nH]c(=O)o3)CN(c2c1)S(=O)(=O)c1cccc(c1)C1CC1)C(F)(F)F 352892 2,2,2-trifluoro-1,1- dimethylethyl {(2S)-4-[(3- cyclopropylphenyl)sulfonyl]- 2-[2-(5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)ethyl]- 3,4-dihydro-2H-1,4- benzoxazin-6-yl}carbamate::US10745364, Example 107A::US9809561, 107A Nuclear receptor ROR-gamma Human 6.08 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352892&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187495 386394043 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945923 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CC(C)(C)c2n[nH]c(=O)o2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352893 2,2,2-trifluoro-1,1- dimethylethyl {(2S)-4-[(4- fluoro-3- methoxyphenyl)sulfonyl]- 2-[2-methyl-2-(5-oxo-4,5- dihydro-1,3,4-oxadiazol-2- yl)propyl]-3,4-dihydro-2H- 1,4-benzoxazin-6- yl}carbamate::US10745364, Example 107B::US9809561, 107B Nuclear receptor ROR-gamma Human 7.53 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352893&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187497 386394044 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945924 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3nnn[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C(F)(F)F)C(F)(F)F 360008 (S)-1,1,1-trifluoro-2-methylpropan-2-yl(2-(2-(1H-tetrazol-5-yl)ethyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (Example 108)::US10221146, Example 108::US10745364, Example 108 Nuclear receptor ROR-gamma Human 6.62 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=360008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=360008&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187627 386399438 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945925 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3nnn[nH]3)CN(c2c1)S(=O)(=O)c1cccc(c1)C1CC1)C(F)(F)F 352895 2,2,2-trifluoro-1,1-dimethylethyl {(2S)-4-[(3- cyclopropylphenyl)sulfonyl]-2-[2- (1H-tetrazol-5-yl)ethyl]-3,4- dihydro-2H-1,4-benzoxazin-6- yl}carbamate::US10745364, Example 109A::US9809561, 109A Nuclear receptor ROR-gamma Human 12.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352895&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187633 386394046 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945926 CC(C)(OC(=O)Nc1ccc2O[C@@H](CCc3nnn[nH]3)CN(c2c1)S(=O)(=O)c1ccnc(c1)C(F)(F)F)C(F)(F)F 352896 2,2,2-trifluoro-1,1-dimethylethyl [(2S)-2-[2-(1H-tetrazol-5-yl)ethyl]- 4-{[2-(trifluoromethyl)pyridin-4- yl]sulfonyl}-3,4-dihydro-2H-1,4- benzoxazin-6-yl]carbamate::US10745364, Example 109B::US9809561, 109B Nuclear receptor ROR-gamma Human 39.6 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352896&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187632 386394047 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945927 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCc2nnn[nH]2)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 352897 (S)-1,1,1-trifluoro-2-methylpropan- 2-yl (2-(2-(1H-tetrazol-5-yl)ethyl)- 4-((3-chloro-1-ethyl-1H-pyrazol-4- yl)sulfonyl)-3,4-dihydro-2H- benzo[b][1,4]oxazin-6-yl)carbamate::US10745364, Example 109C::US9809561, 109C Nuclear receptor ROR-gamma Human 8.26 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352897&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187634 386394048 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945928 Cc1c(NC(=O)OC(C)(C)C(F)(F)F)ccc2O[C@@H](CO)CN(c12)S(=O)(=O)c1cccc(c1)C(F)(F)F InChI=1S/C22H22F6N2O6S/c1-12-16(29-19(32)36-20(2,3)22(26,27)28)7-8-17-18(12)30(10-14(11-31)35-17)37(33,34)15-6-4-5-13(9-15)21(23,24)25/h4-9,14,31H,10-11H2,1-3H3,(H,29,32)/t14-/m1/s1 OGKQVEGWRJRMKJ-CQSZACIVSA-N 360012 (R)-1,1,1-trifluoro-2-methylpropan-2-yl(2-(hydroxymethyl)-5-methyl-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)carbamate (Example 110)::US10221146, Example 110::US10745364, Example 110 Nuclear receptor ROR-gamma Human 62.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=360012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=360012&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187424 386399441 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945929 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CS(=O)(=O)CC)Oc2ncc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C20H25ClF3N5O7S2/c1-5-28-10-15(16(21)27-28)38(33,34)29-9-13(11-37(31,32)6-2)35-17-14(29)7-12(8-25-17)26-18(30)36-19(3,4)20(22,23)24/h7-8,10,13H,5-6,9,11H2,1-4H3,(H,26,30)/t13-/m0/s1 IIZFGMQMLXWNNR-ZDUSSCGKSA-N 458874 US10745364, Example 111A Nuclear receptor ROR-gamma Human 2724 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458874&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139524576 441290138 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945930 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CS(=O)(=O)CC)Oc2ncc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C20H25ClF3N5O7S2/c1-5-28-10-15(16(21)27-28)38(33,34)29-9-13(11-37(31,32)6-2)35-17-14(29)7-12(8-25-17)26-18(30)36-19(3,4)20(22,23)24/h7-8,10,13H,5-6,9,11H2,1-4H3,(H,26,30)/t13-/m1/s1 IIZFGMQMLXWNNR-CYBMUJFWSA-N 458904 US10745364, Example 111B Nuclear receptor ROR-gamma Human 78.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=458904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=458904&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139524577 441290168 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945931 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCC(O)=O)Cc2ncc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H25ClF3N5O6S/c1-4-29-11-16(18(22)28-29)37(34,35)30-10-12(5-6-17(31)32)7-14-15(30)8-13(9-26-14)27-19(33)36-20(2,3)21(23,24)25/h8-9,11-12H,4-7,10H2,1-3H3,(H,27,33)(H,31,32)/t12-/m1/s1 AFENLFHJSSFJRD-GFCCVEGCSA-N 352903 US10745364, Example 112A::US9809561, 112B Nuclear receptor ROR-gamma Human 72.1 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352903&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163515 386394053 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945932 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CCC(O)=O)Cc2ncc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H25ClF3N5O6S/c1-4-29-11-16(18(22)28-29)37(34,35)30-10-12(5-6-17(31)32)7-14-15(30)8-13(9-26-14)27-19(33)36-20(2,3)21(23,24)25/h8-9,11-12H,4-7,10H2,1-3H3,(H,27,33)(H,31,32)/t12-/m0/s1 AFENLFHJSSFJRD-LBPRGKRZSA-N 352902 US10745364, Example 112B::US9809561, 112A Nuclear receptor ROR-gamma Human 289 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352902&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163634 386394052 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945933 CC(C)(OC(=O)Nc1ccc2CCCN(c2c1)S(=O)(=O)c1ccc(F)cc1)C(F)(F)F InChI=1S/C20H20F4N2O4S/c1-19(2,20(22,23)24)30-18(27)25-15-8-5-13-4-3-11-26(17(13)12-15)31(28,29)16-9-6-14(21)7-10-16/h5-10,12H,3-4,11H2,1-2H3,(H,25,27) ZMYSNNXURAGURN-UHFFFAOYSA-N 352904 US10745364, Example 113::US9809561, 113 Nuclear receptor ROR-gamma Human 12.3 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352904&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187811 386394054 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945934 CCn1cc(c(Cl)n1)S(=O)(=O)N1CCCc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C19H22ClF3N4O4S/c1-4-26-11-15(16(20)25-26)32(29,30)27-9-5-6-12-7-8-13(10-14(12)27)24-17(28)31-18(2,3)19(21,22)23/h7-8,10-11H,4-6,9H2,1-3H3,(H,24,28) RLMHELJJJIKERR-UHFFFAOYSA-N 352905 2,2,2-trifluoro-1,1- dimethylethyl {l-[(3- chloro-1-ethyl-1H-pyrazol- 4-yl)sulfonyl]-1,2,3,4- tetrahydroquinolin-7- yl}carbamate::US10745364, Example 114A::US9809561, 114A::US9809561, 118 Nuclear receptor ROR-gamma Human 3.87 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352905&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187576 386394055 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945935 CCn1cc(c(OCCO)n1)S(=O)(=O)N1CCCc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H27F3N4O6S/c1-4-27-13-17(18(26-27)33-11-10-29)35(31,32)28-9-5-6-14-7-8-15(12-16(14)28)25-19(30)34-20(2,3)21(22,23)24/h7-8,12-13,29H,4-6,9-11H2,1-3H3,(H,25,30) IAQFZEGYLDKAFS-UHFFFAOYSA-N 352906 2,2,2-trifluoro-1,1- dimethylethyl (1-{[1-ethyl- 3-(2-hydroxyethoxy)-1H- pyrazol-4-yl]sulfonyl}- 1,2,3,4-tetrahydroquinolin- 7-yl)carbamate::US10745364, Example 114B::US9809561, 114B Nuclear receptor ROR-gamma Human 4.19 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352906&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187772 386394056 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945936 CCOc1nn(CC)cc1S(=O)(=O)N1CCCc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C21H27F3N4O5S/c1-5-27-13-17(18(26-27)32-6-2)34(30,31)28-11-7-8-14-9-10-15(12-16(14)28)25-19(29)33-20(3,4)21(22,23)24/h9-10,12-13H,5-8,11H2,1-4H3,(H,25,29) UGIYEAILYBQBSD-UHFFFAOYSA-N 352907 2,2,2-trifluoro-1,1- dimethylethyl {1-[(3- ethoxy-1-ethyl-1H-pyrazol- 4-yl)sulfonyl]-1,2,3,4- tetrahydroquinolin-7- yl}carbamate::US10745364, Example 114C::US9809561, 114C Nuclear receptor ROR-gamma Human 6.86 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352907&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187769 386394057 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945937 CC(C)(OC(=O)Nc1ccc2CCCN(c2c1)S(=O)(=O)c1ccnc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C20H19F6N3O4S/c1-18(2,20(24,25)26)33-17(30)28-13-6-5-12-4-3-9-29(15(12)10-13)34(31,32)14-7-8-27-16(11-14)19(21,22)23/h5-8,10-11H,3-4,9H2,1-2H3,(H,28,30) ANCOQONFZLLAHL-UHFFFAOYSA-N 352908 2,2,2-trifluoro-1,1- dimethylethyl (1-{[2- (trifluoromethyl)pyridin-4- yl]sulfonyl}-1,2,3,4- tetrahydroquinolin-7- yl)carbamate::US10745364, Example 114D::US9809561, 114D Nuclear receptor ROR-gamma Human 3.46 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352908&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187771 386394058 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945938 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](CNC(C)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H27F4N3O6S/c1-14(32)29-12-15-9-16-5-6-17(30-22(33)37-23(2,3)24(26,27)28)10-20(16)31(13-15)38(34,35)18-7-8-19(25)21(11-18)36-4/h5-8,10-11,15H,9,12-13H2,1-4H3,(H,29,32)(H,30,33)/t15-/m1/s1 ZLZMKMIKOVNBMM-OAHLLOKOSA-N 352910 US10745364, Example 115A::US9809561, 115B Nuclear receptor ROR-gamma Human 2.03 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352910&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187587 386394060 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945939 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CNC(C)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H27F4N3O6S/c1-14(32)29-12-15-9-16-5-6-17(30-22(33)37-23(2,3)24(26,27)28)10-20(16)31(13-15)38(34,35)18-7-8-19(25)21(11-18)36-4/h5-8,10-11,15H,9,12-13H2,1-4H3,(H,29,32)(H,30,33)/t15-/m0/s1 ZLZMKMIKOVNBMM-HNNXBMFYSA-N 352909 US10745364, Example 115B::US9809561, 115A Nuclear receptor ROR-gamma Human 4.96 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352909&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187835 386394059 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945940 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@H](CCC(O)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H26ClF3N4O6S/c1-4-29-12-17(19(23)28-29)37(34,35)30-11-13(5-8-18(31)32)9-14-6-7-15(10-16(14)30)27-20(33)36-21(2,3)22(24,25)26/h6-7,10,12-13H,4-5,8-9,11H2,1-3H3,(H,27,33)(H,31,32)/t13-/m1/s1 RIKARMDYRWWJIE-CYBMUJFWSA-N 352911 US10745364, Example 116A::US9809561, 116A Nuclear receptor ROR-gamma Human 9.58 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352911&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163696 386394061 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945941 CCn1cc(c(Cl)n1)S(=O)(=O)N1C[C@@H](CCC(O)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C22H26ClF3N4O6S/c1-4-29-12-17(19(23)28-29)37(34,35)30-11-13(5-8-18(31)32)9-14-6-7-15(10-16(14)30)27-20(33)36-21(2,3)22(24,25)26/h6-7,10,12-13H,4-5,8-9,11H2,1-3H3,(H,27,33)(H,31,32)/t13-/m0/s1 RIKARMDYRWWJIE-ZDUSSCGKSA-N 352912 US10745364, Example 116B::US9809561, 116B Nuclear receptor ROR-gamma Human 8.80 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352912&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118163744 386394062 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945942 CC(C)(OC(=O)Nc1ccc2C[C@H](CCC(O)=O)CN(c2c1)S(=O)(=O)c1cncc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C23H23F6N3O6S/c1-21(2,23(27,28)29)38-20(35)31-16-5-4-14-7-13(3-6-19(33)34)12-32(18(14)9-16)39(36,37)17-8-15(10-30-11-17)22(24,25)26/h4-5,8-11,13H,3,6-7,12H2,1-2H3,(H,31,35)(H,33,34)/t13-/m0/s1 NUKFICLDGLANNU-ZDUSSCGKSA-N 352913 (R or S)-3-(7-((((1,1,1- trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-1- ((5-(trifluoromethyl)pyridin- 3-yl)sulfonyl)-1,2,3,4- tetrahydroquinolin-3- yl)propanoic acid::US10745364, Example 117A::US9809561, 117A Nuclear receptor ROR-gamma Human 10.5 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352913&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187538 386394063 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945943 COc1cc(ccc1F)S(=O)(=O)N1C[C@@H](CCC(O)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H26F4N2O7S/c1-23(2,24(26,27)28)37-22(33)29-16-6-5-15-10-14(4-9-21(31)32)13-30(19(15)11-16)38(34,35)17-7-8-18(25)20(12-17)36-3/h5-8,11-12,14H,4,9-10,13H2,1-3H3,(H,29,33)(H,31,32)/t14-/m0/s1 VPALZSDNWAYHGC-AWEZNQCLSA-N 352914 (R or S)-3-(1-((4-fluoro-3- methoxyphenyl)sulfonyl)-7- ((((1,1,1-trifluoro-2- methylpropan-2- yl)oxy)carbonyl)amino)- 1,2,3,4-tetrahydroquinolin-3- yl)propanoic acid::US10745364, Example 117B::US9809561, 117B Nuclear receptor ROR-gamma Human 6.51 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352914&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187539 386394064 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945944 CC(C)(OC(=O)Nc1ccc2C[C@@H](CCC(O)=O)CN(c2c1)S(=O)(=O)c1cncc(c1)C(F)(F)F)C(F)(F)F InChI=1S/C23H23F6N3O6S/c1-21(2,23(27,28)29)38-20(35)31-16-5-4-14-7-13(3-6-19(33)34)12-32(18(14)9-16)39(36,37)17-8-15(10-30-11-17)22(24,25)26/h4-5,8-11,13H,3,6-7,12H2,1-2H3,(H,31,35)(H,33,34)/t13-/m1/s1 NUKFICLDGLANNU-CYBMUJFWSA-N 352915 (R or S)-3-(7-((((1,1,1- trifluoro-2-methylpropan-2- yl)oxy)carbonyl)amino)-1- ((5-(trifluoromethyl)pyridin- 3-yl)sulfonyl)-1,2,3,4- tetrahydroquinolin-3- yl)propanoic acid::US10745364, Example 117C::US9809561, 117C Nuclear receptor ROR-gamma Human 7.75 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352915&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187537 386394065 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945945 COc1cc(ccc1F)S(=O)(=O)N1C[C@H](CCC(O)=O)Cc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C24H26F4N2O7S/c1-23(2,24(26,27)28)37-22(33)29-16-6-5-15-10-14(4-9-21(31)32)13-30(19(15)11-16)38(34,35)17-7-8-18(25)20(12-17)36-3/h5-8,11-12,14H,4,9-10,13H2,1-3H3,(H,29,33)(H,31,32)/t14-/m1/s1 VPALZSDNWAYHGC-CQSZACIVSA-N 352916 (R or S)-3-(1-((4-fluoro-3- methoxyphenyl)sulfonyl)-7- ((((1,1,1-trifluoro-2- methylpropan-2- yl)oxy)carbonyl)amino)- 1,2,3,4-tetrahydroquinolin-3- yl)propanoic acid::US10745364, Example 117D::US9809561, 117D Nuclear receptor ROR-gamma Human 5.75 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352916&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122614913 386394066 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945946 CCn1cc(c(Cl)n1)S(=O)(=O)N1CCC(=O)c2ncc(NC(=O)OC(C)(C)C(F)(F)F)cc12 InChI=1S/C18H19ClF3N5O5S/c1-4-26-9-13(15(19)25-26)33(30,31)27-6-5-12(28)14-11(27)7-10(8-23-14)24-16(29)32-17(2,3)18(20,21)22/h7-9H,4-6H2,1-3H3,(H,24,29) MBDZCSPNEAQXHD-UHFFFAOYSA-N 360030 1,1,1-trifluoro-2-methylpropan-2-yl (5-((3-chloro-1-ethyl-1H-pyrazol-4-yl)sulfonyl)-8-oxo-5,6,7,8-tetrahydro-1,5-naphthyridin-3-yl)carbamate (Example 118)::US10221146, Example 118::US10745364, Example 118 Nuclear receptor ROR-gamma Human 720 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=360030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=360030&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187544 386399454 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 945947 CC(C)(OC(=O)Nc1ccc2C(=O)CCN(c2c1)S(=O)(=O)c1ccc(F)c(c1)C(F)(F)F)C(F)(F)F InChI=1S/C21H17F7N2O5S/c1-19(2,21(26,27)28)35-18(32)29-11-3-5-13-16(9-11)30(8-7-17(13)31)36(33,34)12-4-6-15(22)14(10-12)20(23,24)25/h3-6,9-10H,7-8H2,1-2H3,(H,29,32) IBRHZWGFJKZVAQ-UHFFFAOYSA-N 352918 US10745364, Example 119::US9809561, 119 Nuclear receptor ROR-gamma Human 4.49 US Patent 10.7270/Q25H7K92 aid1804729 US10745364 Aicher, TD; VanHuis, CA; Thomas, WD; MacLean, JK; Andresen, BM; Barr, KJ; Bienstock, CE; Anthony, NJ; Daniels, M; Liu, K; Liu, Y; White, CM; Lapointe, BT; Sciammetta, N; Simov, V 8/18/2020 4/13/2021 Lycera Corporation; Merck Sharp & Dohme Corp. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352918&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 118187551 386394067 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8